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1. CHALLENGES REGARDING REARING CALVES ON MODERN DAIRY HERDS 
 
Dairy herds need calves to grow as fast and healthy as possible to produce high yielding 
dairy cows, since milk production is the direct economic profit of dairy farmers. Although 
recent data have demonstrated the potential to alter future performance of dairy cattle through 
nutrition and management during the first few months of life, all too often the young stock 
management is neglected on a dairy herd (Anderson, 2011). Two main management practices 
have been identified as having the greatest impact on future performance: energy intake 
preweaning and colostrum management (Robison et al., 1988; Denise et al., 1989; Faber et al., 
2005; Berge et al., 2009b; Chand et al., 2009; Anderson, 2011; Furman-Fratczak et al., 2011). 
In comparison to the survey of Heinrichs et al. (1987), improvements have been made with 
regard to colostrum management (Kehoe et al., 2007). Despite this, the rate of calf morbidity 
and mortality is still high on some farms, indicating a further need to educate producers on 
issues related to hygienic storage and timely feeding of high quality colostrum to increase 
passive transfer of colostral components (Kehoe et al., 2007; Godden, 2008). 
 
Regarding this morbidity and mortality, one of the major health challenges in dairy 
young stock management is the occurrence of neonatal calf diarrhea (NCD; USDA, 2010). This 
disease brings along large economic losses due to costs of therapy (almost 75% of preweaned 
calves affected with diarrhea receive a treatment with antibiotics) and mortality (56.5% of all 
preweaned heifer deaths is attributable to NCD) as direct losses and retarded growth as main 
indirect loss (Stott and Gunn, 1995; Anderson et al., 2003; USDA, 2010). For example, the 
economic losses associated with preweaned heifer deaths in Norway was estimated to be 
approximately 9 million euro in 2006 (Østerås et al., 2007). At the herd level, the total cost of 
an outbreak of NCD is estimated at 35 euro per calf at risk (Cortese, 2014). Although the 
importance of a good colostrum management leading to an adequate passive transfer of 
immunity is undebatable in the prevention of NCD (Koch and Kaske, 2008; Berge et al., 2009a; 
Chand et al., 2009; Furman-Fratczak et al., 2011), a variety of other risk factors contribute to 
this complex multifactorial disease (Lorenz et al., 2011).  
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2. IMMATURITY OF THE BOVINE NEONATAL IMMUNE SYSTEM 
 
During the foetal period, the immune system develops inside the sterile environment of 
the uterus without external antigenic stimulation. Calves are thus born into an environment 
filled with micro-organisms without the benefit of a primed immune system to respond to these 
pathogens. In some species with a short gestation period, such as mice, the acquired immune 
system may not even be fully developed at birth. In animals with a long gestation period, such 
as the domestic mammals, the acquired immune system is fully developed at birth but cannot 
function at full adult levels for several weeks (Chase et al., 2008). Apart from the protective 
environment of the uterus, neonatal calves are further handicapped by hormonal influences of 
parturition and by their lack of circulating antibodies. The placenta produces progesterone 
which down-regulates the Th1-inducing cytokine IL-12 and up-regulates the Th2-inducing 
cytokines IL-4, IL-5, IL-10, IL-13 and prostaglandin E2 (Yagel et al., 1987; Wang et al., 1993; 
Szekeres-Bartho et al., 1996; Szekeres-Bartho and Wegmann, 1996). Neonatal Th1 cells appear 
to be highly sensitive to apoptosis induced by IL-4 and IL-13 (Li et al., 2004; Miller et al., 
2014). Around parturition, the secretion of foetal cortisol stimulates the placenta to produce 
oestrogen. Both hormones have immunosuppressive effects (Mao et al., 1994; Goff and Horst, 
1997). The cumulative effect of peripartum hormones and cytokines is a suppression of immune 
responses and a diversion of the immune response away from the Th1 response (primarily cell-
mediated, memory) towards a Th2 immune response (primarily production of antibodies, short-
term; Raghupathy et al., 2000; Morein et al., 2002; Chase et al., 2008). This Th2-skewing in 
neonatal animals may not be accidental as some Th1 cytokines such as IFN- appear to cause 
placental damage (Chaouat et al., 2004). 
 
Despite the aforementioned disadvantages of the immature neonatal immune system, 
the bovine neonatal calf is capable of responding to antigenic stimuli and can hence be called 
‘immunocompetent’ (Menge et al., 1999; Barrington and Parish, 2001). Nonetheless, the bovine 
neonatal immune system has both decreased native defence mechanisms and decreased 
acquired immune mechanisms. Decreased native defence mechanisms are illustrated by (a) a 
lower complement activity (12 to 60% of adult levels), (b) decreased phagocytic and 
bactericidal capacity of neutrophils, (c) decreased macrophage activity, (d) lower interferon 
production, (e) lower natural killer cell function, and (f) less dendritic cells (Chase et al., 2008). 
Chapter 1  General Introduction 
11 
Decreased acquired immune mechanisms are exemplified by (a) a decreased lymphocyte 
responsiveness, (b) a predominant Th2 response, (c) less major histocompatibility complex II 
(MHC-II) which equals less antigen being presented to T-lymphocytes, and (d) antibody 
production with a low CD40 and low CD40 ligand B-lymphocyte differentiation (Chase et al., 
2008; Cortese, 2009). All acquired immune responses in the newborn calf are slow primary 
responses with a prolonged lag period and low concentrations of antibodies being produced 
(Husband and Lascelles, 1975; Nagahata et al., 1991). Again, this does not mean that a young 
calf cannot respond to antigens, but the response is weaker, slower and easier to overcome. In 
calves, B-lymphocyte numbers reach adult levels after approximately 20 weeks of age and 
CD4+, CD8+ and + T-lymphocytes do not reach peak levels until the animal is 8 months of 
age (Senogles et al., 1978; Cortese, 2009). 
 
Newborn mammals such as calves are thus vulnerable to infections for the first few 
weeks of life and need assistance in defending themselves at this time. This temporary help is 
provided by the passive transfer of colostral antibodies and leukocytes (Riedel-Caspari, 1993; 
Besser and Gay, 1994), as discussed below.  
 
3. COLOSTRUM 
 
3.1 Definition 
 
In literature, different definitions of colostrum are found. In some studies, it is defined 
as the first milk meal post partum while in other studies it is defined as the milk meals during 
the first 2 days post partum (Archambault et al., 1988a; Ohtsuka et al., 2010). Throughout this 
thesis, colostrum is defined as the very first milk meal post partum.  
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3.2 Composition of colostrum 
 
Table 1. Average composition of bovine colostrum and milk (adapted from Meganck et al., 2012; 
Elfstrandt et al., 2002; Cheng et al., 2008). 
Parameter 
 
Colostrum Milk 
Density 1056 1032 
Solids (%) 23.90-27.64 12.90 
Fat (%) 6.7 4.0 
Total protein (%) 14.00-14.92 3.10 
Casein (%) 4.8 2.5 
Albumin (%) 6.0 0.5 
Antibodies (%) 6.00 0.09 
     IgG (g/l) 32.00-76.00 0.06-0.8 
     IgG1 (g/l) 34.96-90.00 0.51 
     IgG2 (g/l) 
 
2.80-6.00 0.03 
     IgG3 (g/l)                           ? ? 
     IgA (g/l) 1.60-1.66 0.02-0.14 
     IgM (g/l) 
 
4.32-4.50 0.04-0.10 
     IgE (g/l) ? ? 
     IgD (g/l) ? ? 
Lactose (%) 2.49-2.70 5.00 
Lactoferrin (mg/ml) 0.82 0.02-0.12 
IGF-I (g/l) 341-870 15-150 
TGF- (ng/ml) 289 66 
Growth hormone (ng/ml) 0.17 < 0.03 
Insulin (g/l) 4.2-65.9 0.042-1.100 
Cortisol (ng/ml) 4.40 0.35 
Prolactin (ng/ml) 150 50 
Progesterone (ng/ml) 2.6 0.8 
Plasmin (g/ml) 0.49 0.04 
1-antitrypsine (g/ml) 250-800 6-20 
Ash (%) 1.11 0.74 
 Calcium (%) 0.26 0.13 
 Magnesium (%) 0.04 0.01 
 Phosphor (mg/kg) 4452.10 590.0-119.00 
 Natrium (mg/kg) 1058.93 580.00 
 Potassium (mg/kg) 2845.89 1060.00-1630.00 
 Copper (mg/kg) 0.34 0.1.-0.80 
 Sulphur (mg/kg) 2595.67 - 
 Zinc (mg/100 ml) 1.22-3.81 0.30 
 Manganese (mg/100 ml) 0.010-0.020 0.004 
 Iron (mg/100 g) 0.20-0.53 0.05 
 Cobalt (g/100g) 0.50 0.10 
 Vitamin A (g/100ml) 295 17-50 
 Vitamin E (g/g vet) 77.17-84.00 15.00 
 Riboflavin  (g/ml) 4.55-4.83 1.47 
 Vitamin B12 (g/100ml) 4.9 0.6 
 Thiamine (g/ml) 0.58-0.90 0.38 
 Folic acid (g/100ml) 0.8 0.2 
 Choline (mg/ml) 0.70 0.13 
 Ascorbic acid 
(mg/100ml) 
2.5 2.2 
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3.2.1 Antibodies 
 
Colostrogenesis is the process whereby antibodies (also called immunoglobulins) are 
transferred prepartum from the maternal circulation into the mammary secretions. In cattle, this 
process begins several weeks before parturition and ends abruptly at the moment of parturition. 
During this period, up to 500 g/week of IgG are transferred into mammary secretions (Brandon 
et al., 1971). Colostrogenesis is dependent on a combination of lactogenic hormones such as 
oestrogen, progesterone, prolactin, corticosteroids, and growth hormone and local regulatory 
factors (Winger et al., 1995; Barrington et al., 1999; Barrington et al., 2001).  
 
Recognized Ig types in the bovine are IgG (with 3 subclasses: IgG1, IgG2, and IgG3), 
IgA, IgM, IgE, and IgD (Thatcher and Gershwin, 1989; Elfstrandt et al., 2002; Tizard, 2009).  
The predominant antibody in the colostrum of most domestic animals is IgG1 which may 
account for 65 to 90% of the total colostral antibody content (Table 1; Larson et al., 1980; 
Kehoe et al., 2007). The major portion of IgG1 in colostrum is serum-derived. Only a minor 
contribution comes from IgG1-producing plasma cells in the mammary tissue. The transfer of 
IgG1 from serum to the mammary gland is an active IgG1-specific receptor-based process. This 
neonatal receptor (FcRn), also known as the Brambell receptor, is an MHC-I like molecule that 
functions to protect IgG1 from catabolism and mediates transport of IgG1 across epithelial cells 
(Figure 1; Brambell et al., 1964; Brambell, 1969; Brandon et al., 1971; Larson et al., 1980; 
Mayer et al., 2002). Immunoglobulin A and IgM are mainly derived from local synthesis by 
plasma cells in the mammary tissue (Butler, 1983). Relatively little is known about IgE and IgD 
in neonatal calves. Immunoglobulin E is believed to be involved in parasitic infections and in 
type I mediated allergic diseases (Thatcher and Gershwin, 1989). Allergen mediated 
crosslinking of IgE bound to high affinity Fcɛ-receptors on mast cells and basophils stimulates 
cellular degranulation and release of inflammatory mediators and cytokines. 
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Figure 1. Mechanism for selective transfer of antibodies from the blood to the udder (adapted from 
Hammer et al., 1978). IgG1 = immunoglobulin G type 1, IgG1-FcR: neonatal Fc receptor specific for 
IgG1. 
 
As lactation progresses and colostrum changes to milk, differences among species 
emerge (Larson et al., 1980; Table 2). As mentioned in the definition of colostrum, there is 
discussion concerning the time period that mammary secretions can be called colostrum 
(Archambault et al., 1988a; Ohtsuka et al., 2010). In the author’s opinion, in the bovine species 
only the very first milk meal post partum can be defined as colostrum.  
Canine colostrum is rich in both IgG and IgA. By contrast, canine milk contains 
significantly more IgA than IgG (Day, 2007). In primates and rabbits, IgA predominates in both 
colostrum and milk (Sell, 1967; Ogra and Ogra, 1978b). In pigs and horses, IgG predominates 
in colostrum but its concentration drops rapidly as lactation proceeds, with IgA predominating 
in milk (Curtis and Bourne, 1971; McGuire and Crawford, 1972; Sheoran et al., 2000). In 
ruminants and cats, IgG is the predominant Ig class in both milk and colostrum (Claus et al., 
2006; Georgiev, 2008). These species differences are adaptations to the reproductive strategies 
of the animals and the degree of maturation of the offspring at birth. For animals like dogs, cats, 
pigs, horses and ruminants, the role of colostrum and milk antibodies is to provide immune 
protection both systemically and later for the gastro-intestinal tract which is reflected in the 
remarkable changes in the profile of antibodies during the transition from colostrum to mature 
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milk (Tables 1-2). This will be further discussed in the section “Passive transfer of colostral 
antibodies”. 
 
Table 2. Colostral and milk antibody levels in man and some domestic animals (adapted from Curtis 
and Bourne, 1971; Eddie et al., 1971; Mickleson, 1982; Claus et al., 2006; Day, 2007; Tizard, 2009). 
 
 
  Antibody (g/l) 
Species Fluid IgA IgM IgG 
Horse Colostrum 5-15 1.0-3.5 15-50 
 Milk 0.5-1.0 0.05-0.10 0.2-0.5 
     
Cow Colostrum 1-7 3-13 24-80 
 Milk 0.1-0.5 0.1-0.2 0.5-7.5 
     
Sheep Colostrum 1-7 4-12 40-60 
 Milk 0.05-0.12 0.00-0.07 0.6-1.0 
     
Pig Colostrum 9.5-10.5 2.5-3.2 30-70 
 Milk 3.04 0.89 1.37 
     
Dog Colostrum 2.5-22.0 0.14-0.57 1.2-15.68 
 Milk 1.1-6.2 0.10-0.54 0.01-0.03 
     
Cat Colostrum 1.4-14.3 0.4-2.0 32.5-62.0 
 Milk 0.3-6.2 2.0 1.0-5.3 
     
Rabbit Colostrum 4.8 0.2 2.4 
 Milk Nd Nd Nd  
     
Man Colostrum 32.00 1.13 0.53 
 Milk 0.75 0.15 0.04 
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Colostral IgG concentration is an important factor that affects whether calves receive 
sufficient passive immunity from colostrum (Godden et al., 2012). Unfortunately, the amount 
of IgG in maternal colostrum varies dramatically among cows (<1-241 g/l) with 16.0-57.8% of 
samples that do not reach the desired amount of 50 g IgG/l (Swan et al., 2007; Gulliksen et al., 
2008; Chigerwe et al., 2009; Morrill et al., 2012; Meganck, unpublished results). In Belgium, 
the two most common breeds are the Belgian Blue and the Holstein Friesian which have an 
average colostral quality of 99 g/l and 84 g/l, respectively (Fiems et al., 2005; Meganck et al., 
2015). Colostral quality is difficult to estimate by the farmer based on produced volume or 
appearance of the colostrum. Use of weight at first milking as a screening test to identify bovine 
colostrum with inadequate IgG concentration is not justified because of the low sensitivity 
(Chigerwe et al., 2008a). Collecting colostrum more than 2 hours post partum significantly 
lowers the colostral IgG concentration (Moore et al., 2005; Morin et al., 2010), probably 
because of dilutional effects and because colostral antibodies diffuse passively into the cow’s 
systemic circulation if colostrum is not milked out as soon as possible post partum. Colostrum 
from cows without a dry period has a lower IgG concentration compared with colostrum from 
cows having a dry period of 28 or 56 days (Rastani et al., 2005). Pooling of colostrum is not 
advised since this is a risk factor for diluting good quality colostrum (Beam et al., 2009). Cows 
in their 3rd or 4th parity or older usually have significantly higher levels of colostral IgG than 
heifers or 2nd parity cows (Gulliksen et al., 2008; Chigerwe et al., 2009; Morrill et al., 2012). 
However, this correlation between parity and colostrum IgG concentration is not always evident 
(Chigerwe et al., 2008a). Discarding colostrum from heifers is thus not advisable. For all these 
reasons, it is better to measure the colostral IgG content indirectly by using a colostrometer (50 
g IgG/l = density of 1045) or a brix refractometer (50 g IgG/l = 21-22 Brix) or directly by a 
cow-side immunoassay kit (single line = IgG concentration > 50 g IgG/l (Chigerwe et al., 2005; 
Chigerwe et al., 2008a; Bielmann et al., 2010; Quigley et al., 2013). To measure colostrum 
antibody quality it should be avoided to use forestripping samples for testing purposes, as these 
samples may overestimate the IgG concentration (Godden et al., 2011).  
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3.2.2 Leukocytes 
 
Leukocytes in human colostrum were first observed in 1844 by Alexander Donné, who 
is credited with obtaining the first photograph of them (Donné, 1844). More than 100 years 
later, Smith and Goldman (1968) examined the debris that was obtained after centrifuging 
human colostrum and they rediscovered the fact that colostrum was packed with living 
leukocytes. 
The most significant physiological changes in the milk somatic cell count occur around 
parturition when leukocytes accumulate in the bovine mammary gland. Most studies are related 
to milk leukocytes and information concerning colostral leukocytes is limited. The leukocyte 
compartment of bovine colostrum is composed primarily of macrophages comprising 40% to 
50% of the CL (Table 3; Concha, 1986; Duhamel et al., 1987). The remaining CL consist of 
22% to 25% lymphocytes and 25% to 37% neutrophils (Table 3; Concha, 1986; Duhamel et 
al., 1987).  
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Table 3. Differential cell counts of mammary secretions*  
 
* Means expressed as percent of identified cells, ** Nd: not determined 
 
3.2.2.1 Macrophages 
 
This type of phagocytic cells are called monocytes when resident in peripheral blood or 
macrophages when resident in tissues. In contrast to the macrophages of most other tissues, 
milk macrophages exhibit a pronounced vacuolization (Figure 2). Electron microscopic 
Species 
Time post 
partum 
Neutrophils Macrophages Lymphocytes Authors 
Man 
 
Prepartum 
Colostrum 
Milk 
 
21 
42 
20 
 
66 
48 
72 
 
11 
7 
5 
 
Ho et al., 1979 
      
Pig 
 
Prepartum 
Colostrum 
Milk 
 
93 
62 
37 
 
3 
21 
20 
 
2 
8 
12 
 
Lee et al., 1983 
      
Cattle 
Dry period 
Colostrum 
Milk 
15 
25 
12 
45 
50 
60 
40 
25 
28 
Concha, 1986 
      
Sheep 
Dry period 
Colostrum 
Milk 
40 
66 
2 
51 
24 
84 
9 
34 
13 
Lee and 
Outerridge, 
1981 
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analysis in man and pigs revealed that these vacuoles contain cell fragments, casein micelles 
and lipid droplets (Smith and Goldman, 1968; Lee et al., 1983). Vacuolization of bovine milk 
macrophages is intensified during the colostral period, decreases during lactation and increases 
again at the beginning of the dry period (Lee et al., 1980). Macrophages, as well as neutrophils, 
contribute to the reabsorption of milk lipids during the involution of the mammary gland and 
these phagocytes serve as ‘street cleaners’ in the gland during lactation (Riedel-Caspari, 2001). 
Nevertheless, it remains unclear why their numbers rise at the beginning of lactation and what 
the importance is of their large scale phagocytosis of non-pathogenic particles which could also 
be removed mechanically with the flow of milk. The ingested material may even compromise 
the ability of the milk garbage-laden macrophage to ingest and destroy pathogens. 
 
 
 
 
 
 
 
 
 
 
Figure 2. Lipid-laden colostral macrophages after cell sorting and eosin-Giemsa-staining 
(Hemacolor®, adapted from Meganck et al., 2014). 
 
In vitro studies on the macrophages of mammary secretions have revealed a wide range 
of activities similar to those of macrophages residing in other organs. These activities include 
migration and phagocytosis and killing of opsonized and non-opsonized pathogens (Jensen and 
Eberhart, 1975), antigen presentation to lymphocytes (Smith and Goldman, 1970; Smith et al., 
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1971; Crago et al., 1979), and production of cytokines and antibacterial substances including 
lysozyme, lactoferrin and the complement factors C3 and C4 (Pitt, 1979; Politis et al., 1991).  
 
3.2.2.2 Neutrophils 
 
Mammary phagocytic cells also include varying numbers of neutrophils (Figure 3). 
These cells are part of the polymorphonuclear leukocytes or granulocytes. Granulocytes are a 
category of white blood cells characterized by the presence of granules in their cytoplasm and 
can be subdivided in neutrophils, eosinophils, basophils, and mast cells. In contrast to the long-
lived, antigen-presenting and immuno-regulatory macrophages, neutrophils are short-lived and 
have only one purpose which is to invade sites of acute inflammation and perform phagocytosis 
and killing of pathogens, after which the neutrophil dies. Neutrophils may approach 100% of 
the differential cell count in secretions of severely inflamed mammary glands (Schalm, 1977). 
In nearly all species investigated, neutrophils comprise a higher proportion of the somatic cell 
count in colostrum than in mature milk (Table 3). This may reflect an inflammation-like 
condition in the gland at parturition or simply an easy passage through the vascular wall at this 
stage.  
 
 
 
 
 
 
 
Figure 3. Milk neutrophils after density gradient isolation and eosin-Giemsa-staining (Hemacolor®; 
adapted from Mehrzad, 2002). 
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As a short-lived and non-dividing leukocyte population, neutrophils enter the mammary 
gland directly from the blood and do not undergo morphological changes like the macrophage. 
Although neutrophils seem to be less effective in phagocytosis than macrophages, they are also 
able to absorb debris in cytoplasmic vacuoles, thereby contributing to mammary involution (Ho 
et al., 1979; Lee et al., 1983). In contrast to macrophages, neutrophils are able to release large 
quantities of oxygen radicals into mammary secretions (Sandgren et al., 1991). The oxidative 
activity of colostral neutrophils (amount of H2O2 produced) was higher in first milking 
colostrum compared to the second milking (Gomes et al., 2014). Milk neutrophils have been 
subjected to a variety of functional tests and comparisons have been made with their 
counterparts in the blood. The phagocytic activity of milk neutrophils is low in comparison with 
that of blood neutrophils. Moreover, milk neutrophils contain fewer primary granules and less 
glycogen than blood neutrophils, ingest fewer bacteria than blood neutrophils in vitro and kill 
ingested organisms less effectively (Smith and Goldman, 1968; Paape et al., 1975). The reduced 
microbicidal activity of milk neutrophils in these studies can be partly attributed to a reduced 
oxidative burst. The uptake of milk lipids is considered to be the reason for the lower phagocytic 
activity of milk neutrophils. These cells appear to become "exhausted" by the massive uptake 
of particulate material. This view is supported by in vitro findings with blood neutrophils which 
show similarly depressed phagocytic activity when they are cultivated in a medium that 
contains milk (Paape et al., 1975; Russell and Reiter, 1975; Russel et al., 1976; Ho and Lawton, 
1978; Pickering et al., 1980; Heyermann and Senft, 1985; Schollenberger et al., 1986c). The 
milk medium, rather than the advanced age of milk neutrophils, is responsible for the low 
phagocytic activity of these cells. Neutrophils entering the mammary gland are in a permanently 
activated state (Sandgren et al., 1992).  
 
3.2.2.3 Lymphocytes 
 
Lymphocytes represent the phylogenetically “modern” part of the immune system 
(Riedel-Caspari, 2001; Figure 4). There are 3 major types of bovine colostral lymphocytes. 
These are T-lymphocytes that regulate acquired immunity and are responsible for cell-mediated 
immunity, B-lymphocytes that are responsible for antibody production, and natural killer cells 
that play a role in innate immunity. Despite the local synthesis of IgA and IgM in the mammary 
gland, B-lymphocytes constitute a minor population in colostrum compared to peripheral blood 
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(Table 4; Duhamel et al., 1987; Park et al., 1992; Kiku et al., 2010; Meganck et al., 2014). 
Several distinct subsets of T-lymphocytes have been revealed in mammary secretions, including 
CD4+, CD8+ and + T-lymphocytes (Crago et al., 1979; Richie et al., 1982; Moro et al., 1985; 
Bertotto et al., 1990a; Bertotto et al., 1990b).  
 
Table 4. Differential lymphocyte counts of bovine colostrum and peripheral blood*. 
 
*Means expressed as percent of identified mononuclear cells. 
 
 
 
 
 
 
 
Peripheral blood 
 
Colostrum  
T-lymphocytes B-lymphocytes 
 
T-lymphocytes B-lymphocytes Authors 
52.5 20.0 
 
16.2 10.7 
Park et al., 
1992 
 
18.3 22.3 
 
19.3 12.2 
 
Kiku et al., 
2010 
 
32.4 25.0 
 
25.4 2.9 
 
Meganck et 
al., 2014; 
Meganck et 
al., 
unpublished 
data 
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Figure 4. CD3+ lymphocytes in colostrum after cell sorting and eosin-Giemsa-staining (Hemacolor®; 
adapted from Meganck et al., 2014). 
 
Proportions of T-lymphocyte subsets differ significantly between blood and milk, 
particularly around calving. Bovine and human milk T-lymphocytes express mainly  T-
lymphocyte receptors and are predominantly CD8+ when compared  to blood T-lymphocytes 
(Richie et al., 1982; Wirt et al., 1992; Taylor et al., 1994; Yang et al., 1997; Asai et al., 1998; 
Van Kampen et al., 1999; Harp et al., 2004; Hagiwara et al., 2008). In contrast, there were 
minimal to no significant differences in percentages of CD4+ or + T-lymphocytes between 
milk and blood (Harp et al., 2004). Non-sensitized "naive" or “virginal” T-lymphocytes, 
identified by monoclonal antibodies against a series of differentiation antigens, were less 
frequent in human milk than in blood (Bertotto et al., 1990b; Wirt et al., 1992; Taylor et al., 
1994). A large proportion of the CD8+ T-lymphocytes in bovine milk co-express the activation 
molecule ACT2 (Park et al., 1992, 1993; Asai et al., 1998; Asai et al., 2000). Expression of 
adhesion molecules was consistently higher on all subsets of milk lymphocytes compared with 
blood lymphocytes (Harp et al., 2004). At calving, L-selectin and CD44 were expressed on a 
significantly higher percentage of milk lymphocytes than at sampling times later in lactation 
(Van Kampen et al., 1999; Harp et al., 2004). Variations in adhesion molecule expression may 
indicate a role for these molecules in regulating the movement of T-lymphocytes into the bovine 
mammary gland. All these results indicate that in milk, and more specifically in colostrum, T-
lymphocytes are an activated type of cell (antigen-primed memory T-lymphocytes), different 
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from the T-lymphocytes predominantly distributed in peripheral blood. Milk T-lymphocytes 
seem to be of a type similar to CD8+ intra-epithelial lymphocytes which are distributed in the 
gut- or bronchial- associated epithelial layers (Waters et al., 1995; Asai et al., 2000). It may be 
that memory and effector T-lymphocytes preferentially accumulate into the mammary gland. 
This selective colonization may be one of the mechanisms whereby the suckling newborn 
animal benefits from its dam’s immunological experience. Also, the enhanced proportions of 
CD8+ T-lymphocytes are likely to be involved in immunosuppressive properties of colostrum, 
allowing for a more controlled activation of the neonatal immune system (Le Jan, 1996). 
 
An enhanced responsiveness of milk lymphocytes to gut-specific antigens, together with 
some clinical observations in humans and lymphocyte homing experiments in mice and pigs 
gave rise to speculations that certain clones of gut-derived lymphocytes might preferentially 
home to the mammary gland and that the mammary gland should thus be regarded as part of 
the common mucosal immune system (Allardyce et al., 1974; Goldblum et al., 1975; Parmely 
and Beer, 1977; Roux et al., 1977; Lamm et al., 1978; McDermott and Bienenstock, 1979; 
Williams, 1993). This is in contrast with ruminants, whose mammary immune system seems to 
be more closely linked to the peripheral rather than to the mucosal immune system. This 
peripheral link was demonstrated by Harp et al. (1988) who infused lactating cows with their 
own labeled lymphocytes prepared from ileal mesenteric lymph nodes. These labeled cells were 
recovered in proportionally high numbers from intestinal mesenteric lymph nodes, and in low 
numbers from mammary and prescapular lymph nodes. Also, this peripheral-mammary gland 
link was confirmed by an increased percentage of lymphocytes expressing adhesion molecules 
in milk in the immediate postpartum period compared to later lactational stages as discussed 
above (Harp et al., 2004). All these findings provide a rationale for parenteral rather than 
mucosal immunization of cows prepartum to generate humoral and cellular passive immune 
transfer to the newborn calf. It is also likely that the mammary gland provides offspring with 
both gut associated lymphoid tissue-specific and systemic lymphocytes without any preference 
regarding the origin of the lymphocytes.  
 
In vitro, bovine colostral and milk lymphocytes proliferate as a response to contact with 
a variety of stimuli (Smith and Schultz, 1977; Meriläinen et al., 1979; Ayanwale et al., 1981; 
Archambault et al., 1988a). Colostrum and milk lymphocytes are generally less responsive in 
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proliferation assays than blood lymphocytes (Parmely et al., 1976; Parmely and Williams, 1979; 
Archambault et al., 1988a). The memory cell phenotype of milk and colostrum lymphocytes 
may explain their apparent inability to respond to mitogens. Also, a factor in bovine colostrum 
(colostrum inhibitory factor) inhibits IL-2 production in activated T-helper-lymphocytes 
(Sambasivarao et al., 1996). However, some studies also report a higher responsiveness of milk 
lymphocytes, e.g. in response to the K1-antigen of Escherichia coli (Parmely et al., 1976), 
cytomegalovirus (Meggs and Beer, 1979), and lipopolysaccharide from E. coli (Nonnecke and 
Harp, 1985). 
 
3.2.3 Nutritional components 
 
Colostrum is also important as a source of nutrients. In comparison to milk, colostrum 
contains higher concentrations of proteins, fat, minerals, and vitamins (p. 12, Table 1; Foley 
and Otterby, 1978; Hadjipanayiotou, 1995).  
 
3.2.4 Other humoral substances 
 
Colostrum is also rich in cytokines such as IL-1, IL-2, IL-6, TNF-, and IFN- (p. 12, 
Table 1; Sordillo et al., 1991; Tokuyama and Tokuyama, 1993; Rewinski and Yang, 1994; 
Hagiwara et al., 2000). Colostral CD8+ T-lymphocytes play a role as producers of IFN- 
(Lawton et al., 1979; Hagiwara et al., 2008). Interferon- is a cytokine that plays an important 
role in cellular immunity. Other components that are present in colostrum in a higher 
concentration than in milk are iron-binding antimicrobial proteins such as lactoferrin and 
transferrin, antibacterial enzymes such as lactoperoxidase and lysozyme, hormones (insulin, 
prolactin, thyroid hormones, cortisol, glucagon), antimicrobial heat stable peptides (defensins), 
soluble CD14, growth factors (IGF-1, TGF-), prostaglandins, enzymes, immune-related 
microRNAs, and oligosaccharides that function as analogues of microbial ligands on mucosal 
surfaces (p. 12, Table 1; Oda et al., 1989; Blum and Hammon, 2000; Blum, 2006; Hurley and 
Theil, 2011; Izumi et al., 2012).  
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3.3 Relevance of colostrum 
 
The passive transfer of immune parameters is essential for the survival of the neonatal 
calf. This concept was already described in 1922 by Theobald Smith (Smith and Little, 1922). 
Colostrum provides the main barrier against infections in neonatal calves, until their immune 
system becomes fully mature (Butler, 1979). Not only does a sufficient passive transfer have 
an impact on morbidity and mortality in the neonatal calf, but it even has a positive impact on 
intestinal growth and development, long-term health, growth rate, and later milk production 
(Rischen, 1981; Donovan et al., 1986; Robison et al., 1988; Denise et al., 1989; Wittum and 
Perino, 1995; Faber et al., 2005; Dewell et al., 2006). 
 
3.3.1 Passive transfer of colostral antibodies 
 
Newborn mammals obtain antibodies from their mother either by direct transfer across 
the placenta or by ingestion of colostrum immediately after birth. Related to the species 
differences in antibody concentrations of colostrum and milk (p. 15, Table 2), animal species 
are classified in categories based on their placental type (Figure 5). The route by which 
maternal antibodies reach the foetus is determined by the structure of the placenta (Table 5).  
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Table 5. Transmission of passive immunity in mammals. 
 
In humans and other primates, lagomorphs and rodents the placenta is haemochorial: 
the maternal blood is in direct contact with the trophoblast (Carter, 2007). Haemochorial 
placentas can be divided in 3 subtypes according to the number of trophoblast layers present, 
resulting in the following groups: haemomonochorial (1 trophoblast layer, present in monkeys, 
rodents, and humans at the end of gestation, Figure 5F), haemodichorial (2 trophoblast layers, 
present in lagomorphs and humans in early gestation, Figure 5E), and haemotrichorial (3 
trophoblast layers, present in rodents in early gestation, Figure 5D). These types of placenta 
allow maternal IgG (160 kDa), IgA (360 kDa) or IgE (200 kDa) but not IgM (900 kDa; with 
the exception of the rabbit) to be transferred to the foetus (Gitlin et al., 1964; Merad and Wild, 
1992). This antibody transfer is an active transport via the neonatal Fc receptor (Saji et al., 
1999). Dogs and cats have an endotheliochorial placenta (Figure 5C; Anderson, 1969; Leiser 
and Koob, 1993). In these species 5% to 10% of IgG may be transferred transplacentally from 
the mother to the puppy or kitten, but most must be obtained through colostrum (Stoffel et al., 
2000). The placenta of ruminants is synepitheliochorial (Figure 5B): the chorionic epithelium 
is in direct contact with uterine tissues. The placenta of horses and pigs is epitheliochorial 
(Figure 5A): the foetal chorionic epithelium is in contact with the intact uterine epithelium 
(Sterzl et al., 1966; Arthur, 1996). These 2 last types of placenta prevent in utero transmission 
Species Transplacental Colostrum 
Cow, goat, sheep (+) +++ 
Dog, cat + +++ 
Horse (+) +++ 
Man +++ (+) 
Mouse, rat + +++ 
Pig (+) +++ 
Rabbit +++ (+) 
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of antibodies from the dam to the young animal and thus newborn animals of pigs, horses, and 
cows are born virtually agammaglobulinemic.  
These species differences have their consequences for both the distribution of antibodies 
in colostrum and milk (as discussed above, p. 15, Table 2), and for the role of this particular 
colostrum. For animals like dogs, cats, horses, pigs and ruminants, uptake of enough good 
quality colostrum is of utmost importance for the systemic immune function. In humans and 
lagomorphs, uptake of colostrum provides only protection for the gastro-intestinal tract. Gut 
closure in humans occurs before birth and little antibody is absorbed intact in the intestine after 
birth (Brandtzaeg and Johansen, 2007). Despite the haemochorial type of placenta in rodents, 
IgG is mainly transmitted after birth through colostrum in these animals (Hurley and Theil, 
2011). 
 
 
 
 
 
 
 
 
 
 
Figure 5.  Types of the placental barrier: [A] epitheliochorial, [B] synepitheliochorial, [C] 
endotheliochorial, [D] haemotrichorial, [E] haemodichorial and [F] haemomonochorial. Components 
of the placental barrier: (1) maternal endothelium, (2) maternal connective tissue, (3) uterine epithelium, 
(4) trophoblast, (4a) syncytiotrophoblast, (4b) cytotrophoblast, (5) foetal connective tissue, (6) foetal 
endothelium, and (7) trophoblast giant cell (adapted from Borghesi et al., 2014). 
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In young calves, the level of protease activity in the digestive tract is low and is further 
reduced by trypsin inhibitors in colostrum (Quigley et al., 1995). Colostral proteins are thus not 
degraded but reach the small intestine intact. In most species, antibody absorption is transient 
and unselective: newborn animals absorb all proteins during the first hours after birth through 
a non-specific endocytosis of macromolecules (Hardy, 1969; Jeffcott, 1974; Mayer et al., 2002; 
Sangild, 2003). In general, permeability is highest immediately after birth and by 6 hours after 
birth only approximately 50% of the absorptive capacity remains; by 8 hours even only 33% 
(Cortese, 2009). The intestinal cells of the neonatal calf become unable to absorb 
macromolecules within 24-36 hours after birth (Stott et al., 1979; Staley and Bush, 1983). This 
process is called ‘closure of the gut’. The exact mechanism leading to ‘gut closure’ is unknown, 
although maturation of the lysosomal system is suspected (Butler, 1999). Also, antibody 
absorption is initiated by the presence of macromolecules in the gut, but the process of 
absorption is finite and declines over time irrespective of the presence of macromolecules (Stott 
and Marx, 1979; Stott et al., 1979). An adequate passive transfer of colostral antibodies is thus 
a function of quality and quantity of the colostrum in addition to the timing of colostrum 
administration.  
In contrast to the non-specific absorption of macromolecules in the neonatal gut, a large 
proportion of the absorbed IgG1 is recycled back into the small intestinal lumen, probably 
through the FcRn receptor (Newby and Bourne, 1976; Besser et al., 1988b; Mayer et al., 2002). 
The FcRn receptor thus may play an important role in mediating mucosal immunity in 
ruminants (Besser et al., 1988a; Besser et al., 1988b; Mayer et al., 2002).  
 
Calves with serum IgG concentrations of less than 10 g/l at 24 to 48 hours of age are 
defined as suffering from failure of passive transfer (FPT; Gay, 1983). These calves have 
mortality rates more than twice as those of calves with higher IgG levels (Wittum and Perino, 
1995). There are 3 major causes for FPT in calves. First, the mother may produce insufficient 
or poor-quality colostrum: production failure (Chigerwe et al., 2008a). Second, there may be 
sufficient colostrum produced but inadequate intake by the newborn animal: ingestion failure 
(Godden, 2008). Third, there may be a failure of absorption from the intestine despite an 
adequate intake of colostral IgG: absorption failure (Jacobsen et al., 2002).  
Calves allowed to nurse their dam have higher odds of FPT than calves separated from 
their dam within 3 hours of birth (Trotz-Williams et al., 2008; Beam et al., 2009). When allowed 
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to nurse, calves drink too late and too little colostrum. Feeding calves as much colostrum as 
they want by nipple bottle within 1–4 hours after birth and at 12 hours of age substantially 
reduces the probability of FPT (Trotz-Williams et al., 2008; Urday et al., 2008; Chigerwe et al., 
2009). Bottle-fed calves that do not ingest colostrum voluntarily, should be tube fed (Urday et 
al., 2008; Chigerwe et al., 2009). Feeding at least 150 to 200 g of colostral IgG is required for 
adequate passive transfer of colostral IgG when colostrum is administered once by oesophageal 
intubation < 2 h after birth (Chigerwe et al., 2008b). To estimate the exact amount of IgG given 
to a calf, colostrum quality should be measured as explained higher: if colostrum contains 50 g 
IgG/l, feeding 4 l of colostrum suffices to provide 200 g IgG to the calf. There is no added 
benefit in feeding 4 l of colostrum compared to 3 l when colostrum of comparable quality is fed 
once using an oesophageal tube (Russell Sakai et al., 2012). Larger IgG intakes are required by 
calves being fed > 2 h after birth (Chigerwe et al., 2008b). Hand feeding colostrum > 4 h after 
birth is a risk factor for FPT (Beam et al., 2009). A slight delay in the increase of serum IgG 
concentration was obvious in calves receiving 4 l of colostrum by oesophageal intubation 
compared with bottle-fed calves receiving 2 l. However, calves receiving colostrum by 
oesophageal intubation reached significantly higher IgG concentrations compared with bottle-
fed calves (Kaske et al., 2005). Because of the difference in administered volume (4 l versus 2 
l) between the two methods (oesophageal intubation versus bottle-fed), it can only be concluded 
from this study that an appropriate use of an oesophageal tube to feed 4 l colostrum is a safe 
and reliable method for an adequate passive immune transfer in healthy newborn calves. This 
study does not prove colostrum fed by oesophageal intubation to be better than bottle-feeding 
colostrum. Further research is needed to reveal if the rapid passage of IgG from the 
reticulorumen to the abomasum also occurs in weak born calves. Moreover, tube feeding can 
cause moderate depression or a more difficult adaptation to feeding with a nipple bucket (Kaske 
et al., 2005).  
Calves cared for by female workers are less likely to develop FPT (Trotz-Williams et 
al., 2008), probably because women are more patient with newborn calves that refuse to suckle. 
The odds of FPT are higher for calves experiencing dystocia (Furman-Fratczak et al., 2011) 
which can be explained by drinking too little colostrum and/or a lower apparent efficiency of 
absorption. 
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Several assays for estimating serum IgG are available. Possibilities are zinc sulphate 
turbidity, the single radial immunodiffusion, latex agglutination, semi-quantitative membrane-
filter enzyme-linked immunosorbent assay (ELISA), dipstick ELISA, serum protein 
electrophoresis, gamma-glutamyl transferase activity, refractometry, sodium sulphite 
precipitation, or whole blood glutaraldehyde coagulation (Naylor et al., 1977; Hudgens et al., 
1996; Tyler et al., 1996a-b; Parish et al., 1997; Güngör et al., 2004). Measurement of serum 
total solids by a hand-held refractometer offers a convenient, simple, rapid, and inexpensive 
on-farm tool by which producers can monitor the colostrum feeding program. 
 
3.3.2. Passive transfer of colostral antibodies, a double-edged sword for calves? 
 
The passive transfer of antibodies can be a double-edged sword for neonatal calves. 
There is protection from disease on one hand versus interference with a calf’s ability to 
effectively respond to an antigen challenge on the other hand (Husband and Lascelles, 1975; 
Heckert et al., 1991). This immunomodulation by passively transferred antibodies is called 
maternal interference. Maternal antibodies impair the ability of the newborn calf to mount its 
own immune response. This means that very young animals are unable to respond to active 
immunization (Figure 6; Brar et al., 1978; Menanteau-Horta et al., 1985; Kimman et al., 1987).  
In the absence of maternal antibodies, the newborn animal is able to produce antibodies soon 
after birth. The endogenous production of antibodies in colostrum-deprived calves occurs by 
about 1 week of age (Husband and Lascelles, 1975). In calves that have suckled and thus 
possess maternal antibodies, synthesis of antibodies does not commence until about 4 weeks of 
age (Husband and Lascelles, 1975). Maternal antibodies have a decay half-life of 10 to 28 days 
(Murakami et al., 1985; Fulton et al., 2004; Hassig, 2007). The inhibition of antibody synthesis 
may thus persist for months, depending on the concentration of maternal antibodies in the serum 
of the calf and the half-life of the antibodies involved.  
 
However, maternal interference of vaccines is not as absolute as once thought. When 
attenuated vaccines were used in the face of maternal antibodies, B-lymphocyte memory 
responses as well as cell-mediated immune responses were elicited (Figure 7; Brar et al., 1978; 
Menanteau-Horta et al., 1985; Kimman et al., 1987; Ellis et al., 1996). One of the most 
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successful strategies against maternal interference is the use of mucosal vaccines. An example 
is the orally administered rotavirus vaccine: onset of protection against disease and shedding in 
calves occurs before secretory IgA is produced 10 days after vaccination, implying that the 
orally administered vaccine may activate the innate immune system in the gastrointestinal tract 
and decrease disease (Van Zaane et al., 1986). Due to the poor penetration of colostral 
antibodies to mucosal surfaces, mucosal vaccines have the advantage of being able to replicate 
in the mucosae and prime the mucosal immune system with little interference from maternal 
antibodies. Moreover, priming mucosal immunity is also more likely to prevent infection rather 
than just reduce disease. Low or no systemic antibody titers often are detected after mucosal 
vaccination which makes it difficult to assess immunity using serology (Ellis et al., 2007). 
Another approach to circumvent maternal interference is the use of adjuvanted parenteral 
vaccines (Morein et al., 2002). After vaccination, it takes at least 3 weeks for the development 
of a primary immune response which can then be boosted to get a secondary immune response 
(Figure 8). 
 
 
 
 
 
 
 
 
Figure 6. Maternal colostral antibodies bind to specific B-lymphocyte vaccine epitopes, preventing 
access of neonatal B-lymphocytes to such epitopes (adapted from Siegrist, 2001). 
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Figure 7. Immune complexes of maternal colostral antibody-vaccine antigen are taken up by neonatal 
antigen presenting cells (APC). Peptide presentation at the surface of the antigen presenting cell allows 
priming of CD4+ and CD8+ T-lymphocytes, despite the inhibition of B-lymphocyte responses (adapted 
from Siegrist, 2001). 
 
 
 
 
 
 
 
 
 
 
Figure 8. Primary and secondary antibody response after vaccination. After the first (primary) 
vaccination, a lag phase occurs in which no antibodies are produced. The antibody concentration rises 
gradually but the amount of antibodies produced is usually relatively low. Over time, antibody levels 
decline again. After the second (booster) vaccination, the antibody concentration rises quickly, and the 
amount of antibodies produced rises to a high level which is maintained longer. 
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In conclusion, the ideal time frame for vaccination depends on the level of maternal 
antibodies (against the specific vaccine antigen), the vaccine antigen itself, the vaccine type 
(modified-live or inactivated), age, and the species concerned (Brar et al., 1978; Menanteau-
Horta et al., 1985; Ellis et al., 2010). This variation presents a major challenge for vaccine 
development. Antibody levels often decay to a level still high enough to block responses to 
vaccination but not high enough to resist a field infection which creates a window of 
susceptibility to infections (Figure 9; Morein et al., 2002; Chase et al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. The window of susceptibility to infectious diseases. During the time period, marked by the 
arrows, neither the levels of maternal antibodies (passive immunity) nor the endogenous produced 
antibodies (active immunity) are high enough to protect the calves against infections (adapted from 
Morein et al. (2002). 
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3.3.2 Passive transfer of colostral leukocytes 
 
The first role postulated for mammary leukocytes was to protect the mammary gland 
against infections (Schalm et al., 1976). Although some research has already been done 
concerning the importance of colostral leukocytes for the neonatal animal, very little is known 
concerning the contribution of the cellular content of colostrum to the protection of the newborn 
when compared to the current knowledge of colostral antibodies.  
 
It is well established that colostral leukocytes are able to cross the intestinal epithelium 
of the neonatal mouse (Arvola et al., 2000; Zhou et al., 2000), rat (Seelig and Billingham, 1981a; 
Sheldrake and Husband, 1985b), pig (Tuboly et al., 1988; Williams, 1993; Le Jan et al., 1995), 
sheep (Schnorr and Pearson, 1984; Sheldrake and Husband, 1985b; Tuboly et al., 1995), and 
calf (Liebler-Tenorio et al., 2002). In pigs and sheep, maternal cells appeared to peak in the 
blood at 5-7 hours post feeding (Schnorr and Pearson, 1984; Williams, 1993). The number of 
maternal cells decreased by 24 hours after ingestion in newborn lambs and calves (Schnorr and 
Pearson, 1984; Reber et al., 2006). This disappearance from the neonatal circulation could be 
due to sequestering of cells in the neonatal tissues and secondary lymphoid areas, with the 
potential of providing protection to the neonate. Maternal colostral leukocytes were detected in 
peripheral blood, liver, lung, mesenteric lymph nodes, spleen, and gastrointestinal tissues of the 
neonate (Williams, 1993; Le Jan et al., 1995; Aldridge et al., 1998). More research is needed to 
determine whether there is a ‘gut closure’ for maternal leukocyte absorption as is well-known 
for colostral antibody absorption (as discussed above). 
 
According to some, in sheep and pig only maternal colostral leukocytes can cross the 
intestinal epithelium (Tuboly et al., 1988; Williams, 1993; Tuboly et al., 1995; Bandrick et al., 
2008; Bandrick et al., 2011). Cells from unrelated animals and maternal peripheral blood 
leukocytes were unable to cross the intestinal epithelium in these studies. For example, Tuboly 
et al. (1995) divided their lambs in 5 groups: group 1 received maternal colostral leukocytes 
directly injected into the duodenum, group 2 received maternal colostral leukocytes via an 
oesophageal tube, group 3 received non-maternal colostral leukocytes directly injected into the 
duodenum, and group 4 received maternal peripheral blood leukocytes directly injected into the 
duodenum. In groups 1 and 2, cells were absorbed through the intestinal epithelium. In groups 
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3 and 4, cells were not absorbed. In contrast to immune cells, colostral antibodies cross the 
neonatal intestinal epithelium and enter the circulation whether or not the antibodies are from 
another dam or from another species (Klobasa et al., 1981). The mechanism involved in 
selective colostral leukocyte transfer remains to be clarified, but is presumably due to MHC 
incompatibility.  
Contrastingly, some studies report that even non-maternal colostral leukocytes, 
maternal or xenogeneic peripheral blood leukocytes, lymph node cells, and umbilical cord 
matrix stem cells appeared in the blood of newborn animals following oral or intestinal 
administration (Kmetz et al., 1970; Schultz et al., 1978; Seelig and Billingham, 1981a-b; 
Schnorr and Pearson, 1984; Sheldrake and Husband, 1985b; Seelig and Head, 1987; Jain, 1989; 
Reber et al., 2006).  
These contrasting findings are difficult to explain. Apart from the anatomic origin of 
maternal leukocytes, the genetic relationship between the donor and recipient may play a role 
in the passage of maternal cells across the intestinal wall.  
The uptake of colostral leukocytes takes place through the intercellular spaces of the 
epithelium (Tuboly et al., 1988; Williams, 1993; Tuboly et al., 1995). Migration of maternal 
colostral leukocytes occurs preferentially through the follicle-associated epithelium in the 
jejunum at the level of the Peyer’s patches (Figure 10; Williams, 1993; Liebler-Tenorio et al., 
2002).  
 
 
 
 
 
 
 
 
 
Chapter 1  General Introduction 
37 
 
 
 
 
 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. (A) Direct immunoperoxidase staining showing uptake of colostral leukocytes (black dots) 
at the level of a Peyer’s patch in the jejunum. D = follicle associated epithelium of the dome, S = sinuses 
around the lymphoid follicles. (B) Higher magnification of the dome in Figure 10A. One labeled cell 
(arrow) and several foci of labeled particulate material (arrowheads) are present in the follicle 
associated epithelium (adapted from Liebler-Tenorio et al., 2002). 
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Examples of the transfer of cellular immunity through colostrum can be found in various 
species. For example, in man, breast-fed children of tuberculosis-infected mothers exhibited 
anti-tuberculin skin sensitivity, whereas children who were breast-fed by tuberculosis-negative 
mothers or children of tuberculosis-positive mothers who were not breast-fed did not react to 
this skin test (Mohr, 1973; Schlesinger and Covelli, 1977). Tuberculin sensitivity was also 
passed on to calves consuming colostrum from tuberculosis-positive cows (Duhamel, 1986).  
Colostral transfer of T-helper-lymphocyte functions has been demonstrated in mice 
(Hale and Hanna, 1976). Homozygous nude mice (nu/nu) are unable to produce antibodies 
against antigens that need the mediation of T-lymphocytes. In contrast, heterozygous mice 
(nu/+) can generate T-lymphocyte dependent antibody responses. When homozygous (nu/nu) 
offspring were suckled on heterozygous (nu/+) foster mothers, the homozygous offspring 
developed the ability to form T-lymphocyte dependent antibody responses .   
In rats, colostral leukocytes provided effective protection against necrotizing 
enterocolitis and infection with Trichinella spiralis (Pitt et al., 1977; Kumar et al., 1989). The 
possible role of colostral leukocytes in protecting against neonatal calf diarrhea has been shown 
for E. coli and rotavirus. Calves fed colostral leukocytes of rotavirus-vaccinated dams, had a 
decreased duration of rotavirus shedding when compared with calves fed colostral leukocytes 
of rotavirus-infected control dams or of non-sensitized dams ( Archambault et al., 1988b). 
Calves that had received cell-supplemented colostrum excreted significantly less E. coli in their 
faeces and reached the lower limit of detectability earlier than calves that were fed cell-depleted 
colostrum (Riedel-Caspari, 1993).  
In contrast to calves fed with cell-depleted colostrum, calves fed with complete 
colostrum showed uniform blastogenic responses to 2 different mitogen concentrations and a 
higher spontaneous proliferation of blood lymphocytes during the first week of life (Riedel-
Caspari and Schmidt, 1991a), which shows that colostral leukocytes stimulate and regulate the 
proliferation of lymphocytes. Also, there was a slightly enhanced antibody formation against 
sheep erythrocytes in the calves receiving complete colostrum (Riedel-Caspari and Schmidt, 
1991a), indicating that colostral leukocytes enhance the T-lymphocyte dependent formation of 
antibodies. Moreover, enhancement of the passive immunity of the neonatal calf, especially in 
regard of antibodies and antibody classes which are essential for intestinal immunity, was 
shown by the higher concentration of antibodies against E. coli mainly of IgM specificity in the 
first week of life in the calves receiving complete colostrum (Riedel-Caspari and Schmidt, 
1991b; Riedel-Caspari, 1993). 
Chapter 1  General Introduction 
39 
Leukocytes of neonatal calves that had received whole colostrum effectively stimulated 
the mixed leukocyte response (MLR, response to allo-antigens) by 24 hours after ingestion of 
colostrum (Reber et al., 2005). In contrast, calves that had received acellular colostrum did not 
effectively stimulate the MLR until 2 to 3 weeks after birth (Figure 11). A stimulation of an 
MLR by neonatal leukocytes reflects the distribution of mature antigen presenting cells in the 
blood of calves. These results indicate a possible role of colostral leukocytes in the development 
of antigen-presenting capacity. Effective antigen presentation is crucial for the initiation of an 
effective antigen-specific response.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Results of a 1-way mixed leukocyte response (MLR) for cells obtained from adult cows and 
stimulated with leukocytes obtained from calves that received (A) whole colostrum or (B) cell-free 
colostrum. Values reported in the Y-axes represent the percentage of a reference MLR. Diamonds 
represent responses of dams and squares represent responses of unrelated cows. Time after birth in 
weeks is represented in the X-axes. * Within a time point, values differ significantly (P < 0.05; adapted 
from Reber et al., 2005).  
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The group of Reber and colleagues examined in a later study the expression of cell 
surface markers associated with cellular activation and physiological stress on neonatal 
lymphocytes and monocytes (Reber et al., 2008a-b). The results of these studies demonstrated 
that calves that had received whole colostrum had fewer CD11a+ lymphocytes and monocytes 
in circulation during the first 2 weeks of life than calves that had received cell-free colostrum. 
Moreover, CD11a was expressed at a lower density on monocytes and lymphocytes in calves 
that had received whole colostrum (compared to calves that had received cell-free colostrum). 
CD11a is a cell adhesion molecule that is important for the mobilization of leukocytes, and 
upregulation of its surface expression is an indication of an ensuing immune response. In 
addition to its upregulation upon cellular activation, CD11a is also a good indicator of a 
response to stress in humans (Kawabata et al., 2002). Upregulation of CD11a may thus be 
attributed to increased physiological stress or direct cellular activation by pathogenic organisms 
or components of those organisms (i.e. lipopolysaccharide). In addition, calves that had 
received whole colostrum had a higher percentage of lymphocytes and monocytes expressing 
the activation markers CD25 and CD26. It is likely that this level of enhancement of CD25 
expression reflects maturation of cells in calves that were fed whole colostrum. Also, during 
the first weeks of life, lymphocytes and monocytes from calves that had received whole 
colostrum had a higher density of MHC-I expression on their surfaces than cells from calves 
that had received cell-free colostrum. This higher MHC-I density is indicative of an increased 
capacity to present internal antigen and may account for previously reported differences in 
responsiveness in MLR (Reber et al., 2005). 
The results of Donovan et al. (2007) suggest that colostral leukocytes may provide 
immediate but transitory antigen-specific activity. Calves were fed fresh colostrum, frozen 
colostrum, or cell-free colostrum. Dams received a vaccine containing inactivated bovine viral 
diarrhea virus (BVDV). Calves that had received whole colostrum had enhanced responses to 
BVDV antigen 1 and 2 days after ingestion of colostrum. In contrast, calves that had received 
frozen colostrum or cell-free colostrum did not respond to BVDV. These results indicate that a) 
specific responsiveness against antigens to which the dam has mounted an immune response 
can be transferred to the neonatal calf by live maternal colostral leukocytes and b) cell-mediated 
immune transfer to neonates can be enhanced by maternal vaccination. The BVDV-induced 
proliferation of neonatal lymphocytes returned to background values at 1 week of age. The 
exact role of colostral leukocytes in the long-term development of pathogen-specific acquired 
immunity is thus not clear yet. 
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3.3.3 Passive transfer of colostral nutritional components 
 
Apart from the immunological properties of colostrum, it also provides the first source 
of extra-uterine energy. Moreover, as proteins, fat, and sugar contribute to the process of 
thermogenesis, colostrum is also important to maintain normal thermoregulation in the newborn 
calf (Vermorel et al., 1983). The laxative effect of colostrum ensures a normal passage of the 
meconium (Kuralkar and Kuralkar, 2010).  
 
3.3.4 Passive transfer of other colostral humoral substances 
 
Colostral cytokines may have an immunomodulatory activity and influence neonatal 
immunity (Yamanaka et al., 2003). Growth promoting factors such as IGF-1 stimulate DNA 
synthesis and cell division and thus help regulate intestinal growth in the newborn and may 
enhance early neonatal immune responses (Klagsbrun and Neumann, 1979; Baumrucker et al., 
1994). MicroRNA is a fairly new discovery and is shown to play a role in the regulation of the 
development of the mucosal immune system in the gastro-intestinal tract of the newborn. 
 
4. CHALLENGES OF DAIRY COWS AROUND PARTURITION 
 
The transition period in the dairy cow is defined as the period in which a change from a 
gestational non-lactating to a non-gestational lactating state occurs (Contreras and Sordillo, 
2011). This period which spans from 3 weeks before through 3 weeks after parturition, is 
associated with an impaired immunity and increased susceptibility to infections and diseases 
such as milk fever, retained placenta, metritis, ketosis, left displaced abomasum, lameness, and 
clinical mastitis (Ishikawa, 1987; Yamanaka, 1987; Nagahata et al., 1988; Hogan et al., 1989; 
Kehrli and Goff, 1989; Kehrli et al., 1989a-b; Nagahata et al., 1992; Kelton et al., 1998).  
Transition dairy cows experience sudden changes in both metabolic and immune 
functions. Some of these alterations are related to sudden increases in energy requirements 
driven by both foetal needs but more importantly by the onset of lactation. At the same time, 
dairy cows show a marked decrease in voluntary dry matter intake that is related to physical, 
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behavioural, metabolic, and hormonal changes around parturition (Goff et al., 2002; Grummer 
et al., 2004; Allen and Bradford, 2005). As a result, dairy cows enter a negative energy balance 
(NEB) that is further aggravated by the nutrient prioritization towards the mammary gland 
(Leroy et al., 2008). Most but not all animals are able to adapt to this NEB without life-
threatening health problems. Dairy cows adapt to this NEB by mobilizing adipose energy depots. 
Mobilization of fat from body stores releases non-esterified fatty acids (NEFA) and beta-
hydroxy-butyric acid (BHBA) into the blood stream. Also, skeletal muscle is turned into the 
major site for use of fat-derived fuels, such as NEFA and ketone bodies, allowing glucose to be 
redirected for foetal metabolism and lactose synthesis (Herdt, 2000). Metabolic adaptations 
such as lipid mobilization are accompanied by alterations in inflammatory responses that 
modify immune function. Research in humans and various animal models suggests that fatty 
acids are important modulators of immune cell function (Calder, 2008; Serhan et al., 2008). The 
dairy cow uses provided substrates mostly to support milk synthesis, pointing to a higher 
priority of lactation compared with immune function. Mastectomy of cows eliminated the 
decrease in leukocyte subset populations (CD3+, CD4+, and + T-lymphocytes, and monocytes) 
observed in intact cows around parturition (Goff et al., 2002). Also, the immunosuppressive 
effects of the NEB can be reverted by providing additional energy (Stabel et al., 2003). 
Moreover, in sheep, the degree of reduction of immunity in the peripartum period is related to 
the supply of dietary metabolizable protein (Houdijk et al., 2005). 
 
Increased rates of lipolysis have a profound impact on the body condition score (BCS), 
an important guideline for transition cow management with an optimum of 3.0 to 3.5 (5-point 
scale) at the time of calving (Edmonson et al., 1989; Roche et al., 2009). A BCS < 3 at 
parturition is associated with a reduced production and reproduction, whereas a BCS > 3.5 at 
the time of calving is associated with a reduction in early lactation dry matter intake and an 
increased risk of metabolic disorders. Excessive BCS reduction is linked directly with a greater 
incidence of transition cow diseases and reduced lactation performance (Bewley and Schutz, 
2008).  
Quantification of plasma NEFA levels is used as a diagnostic tool to assess the degree 
of NEB in transition cows.  The desired plasma concentration for NEFA is < 0.7 mmol/l for 
cows in early lactation (Whitaker et al., 1983). An increased BHBA serum concentration (cut 
off value 1.4 mmol/l) refers to an energy shortage. These values are often evaluated post partum  
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to estimate the depth of the NEB in dairy cows (Whitaker et al., 1983). Another important 
change is the decrease in the concentration of the omega 3 series long chain polyunsaturated 
fatty acids in plasma NEFA (Lock et al., 2009). These alterations in plasma fatty acid 
composition are rapidly reflected in the fatty acid profiles of cellular membrane phospholipids 
of peripheral blood mononuclear leukocytes (PBMC; Lock et al., 2009; Contreras et al., 2010). 
These changes in the cellular membrane of PBMC could potentially affect inflammatory 
responses in transition dairy cows.  
 
4.1 Neutrophils 
 
Neutrophil function is clearly impaired during the weeks immediately before and after 
parturition (Figure 12; Kehrli and Goff, 1989; Kehrli et al., 1989b; Kimura et al., 1999). A 
decrease in the chemotactic response of neutrophils was observed in correlation with high 
serum cortisol concentrations around parturition (Nagahata et al., 1988). The increased 
susceptibility to bacterial infections during the peripartum period may be attributable to this 
decreased neutrophil function. These findings were confirmed in later studies. A study of 46 
healthy and 51 diseased dairy cows reported that impaired neutrophil function was clearly 
associated with the occurrence of peripartum metritis and mastitis (Cai et al., 1994). 
Chemiluminescence and viability of resident milk neutrophils play a crucial role in the severity 
of subsequently induced mastitis (Mehrzad et al., 2004-2005). Apoptotic and necrotic processes 
might partly explain the down regulation of neutrophil functions shortly after calving. 
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Figure 12. Neutrophil function (iodination, squares) and lymphocyte function (blastogenesis, diamonds) 
are impaired during the weeks immediately before and after parturition. Values are expressed as 
percentages of control steers (adapted from Kehrli et al., 1989a-b). 
 
There is a negative relationship between chemiluminescence response of neutrophils 
and high plasma concentrations of BHBA and NEFA, demonstrating that the NEB can influence 
innate immunity (Hoeben et al., 2000). Also, apoptosis of circulatory and milk neutrophils is 
higher in early lactating than in mid-lactating cows (Van Oostveldt et al., 2001). In sheep, 
BHBA negatively affected chemotaxis but not phagocytosis of neutrophils (Sartorelli et al., 
2000). High in vitro NEFA concentrations are associated with a reduction in cell viability and 
a marked increase of necrosis of bovine neutrophils (Scalia et al., 2006). In the latter study, only 
the highest of the tested NEFA concentrations affected neutrophil function. Neutrophils have 
the capacity to metabolize fatty acids through different metabolic pathways which makes these 
cells more resistant to an overload of fatty acids when compared to lymphocytes (Burns et al., 
1976). 
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4.2 Lymphocytes 
  
Lymphocyte subpopulations in peripheral blood and mammary gland secretions of dairy 
cows have been shown to vary over the peripartum period (Park et al., 1992; Taylor et al., 1994; 
Shafer-Weaver et al., 1996). Specifically, within the mononuclear cell fraction, the percentage 
of T-lymphocytes was lowest in milk (16%) within 48 hours after parturition, but increased to 
62% in late lactation (Park et al., 1992). Conversely, the percentages of B-lymphocytes and 
macrophages were reported as 11% and 69%, respectively within 48 hours after parturition, but 
declined in late lactation to 7% and 21%, respectively.  
 
The ability of IgG production of B-lymphocytes from perinatal cows is decreased 
compared to cows further in lactation (Yamanaka, 1987; Nagahata et al., 1992). These results 
suggest that the ability of IgG production in perinatal dairy cows is decreased due to functional 
depression of B-lymphocytes. 
 
Studies by the group of Kehrli demonstrated decreased lymphocyte functions around 
the time of parturition in cattle (Figure 12; Kehrli and Goff, 1989; Kehrli et al., 1989a). This 
diminished response was confirmed by others reporting DNA synthesis in bovine lymphocytes 
in response to a mitogen stimulus to decline steadily from 3 weeks prepartum until the week of 
calving, again increasing at week 2 post partum (Saad et al., 1989; Goff and Horst, 1997; 
Schwarm et al., 2013). Also, a significant positive relationship was reported between the energy 
balance and the bovine lymphocyte response to mitogens (Ropstad et al., 1989; Schwarm et al., 
2013). High in vitro concentrations of NEFA and BHBA inhibit mitogen-induced proliferative 
responses and diminish DNA synthesis of PBMC (Franklin et al., 1991; Lacetera et al., 2004; 
Thanasak et al., 2005; Gorjão et al., 2007).  
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Neonatal calf diarrhea (NCD), defined in this thesis as diarrhea in calves aged 1-month-
old or younger is a complex disease that can be triggered by both infectious and non-infectious 
causes. In calves aged < 31 days, enteritis is the most common cause of death with a case fatality 
risk for NCD of 4.9% and a peak probability of dying due to enteritis during the second week 
of life (Svensson et al., 2006; Windeyer et al., 2014). Enterotoxic Escherichia coli K99/F5, 
rota- and coronavirus, and Cryptosporidium parvum are the 4 most important enteropathogens 
causing NCD worldwide with rotavirus and C. parvum most frequently identified in faecal 
samples from young calves (Trotz-Williams et al., 2007; Geurden et al., 2008; Gulliksen et al., 
2009; Bartels et al., 2010). The veterinarian has an important advisory role in the daily 
prevention and treatment challenge in practice. The first principal aim of this thesis was 
therefore to broaden our knowledge concerning the possibilities in the field to lower the 
percentage of NCD by the implementation of a preventive action plan consisting of giving 
halofuginone to newborn dairy calves and administration of a vaccine against E. coli, rotavirus, 
and coronavirus to their dams. 
 
The importance of a good colostrum management leading to an adequate passive 
transfer is undebatable in the prevention of NCD (Berge et al., 2009a; Chand et al., 2009; 
Furman-Fratczak et al., 2011). However, investigations concerning the transfer of passive 
immunity of cattle have primarily focused on the importance of colostral antibodies while 
currently increasing attention is given to other humoral and cellular components in colostrum 
(Hagiwara et al., 2000; Zhou et al., 2000; Liebler-Tenorio et al., 2002; Donovan et al., 2007). 
The concentration of antibodies in bovine colostrum is known to be affected by breed (Tyler et 
al., 1999), parity (Moore et al., 2005; Morin et al., 2010), yield of colostrum at first milking 
(Chigerwe et al., 2008a; Morin et al., 2010), season of calving (Gulliksen et al., 2008), and 
interval between parturition and first milking (Moore et al., 2005; Morin et al., 2010). In 
contrast, few articles describe factors affecting the type, number or proliferative capacity of 
lymphocytes in bovine colostrum. Therefore, the second principal aim of this thesis was to 
broaden our knowledge concerning colostral leukocytes. More specifically, we concentrated on 
the mononuclear cell fraction (lymphocytes and macrophages). We aimed to investigate 
whether body condition score, parity, and elevated BHBA and/or NEFA serum concentrations 
affect the phenotypic distribution and proliferative capacity of the colostral leukockytes. The 
latter would implicate that these factors might indirectly affect the establishment of the neonatal 
calf’s immunity and hence its sensitivity towards NCD. In the final study, we aimed  to learn 
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more concerning the influence of colostral leukocytes on the development of the cellular and 
humoral immunity in dairy calves. 
  
In detail, based on the studies performed in this thesis, we aimed to answer the following 
4 questions: 
1. Can we lower the incidence of neonatal calf diarrhea with the implementation of a 
2-step protocol consisting of giving halofuginone to newborn dairy calves and 
administration of a vaccine against Escherichia coli, rotavirus, and coronavirus to 
their dams (Chapter 3)? 
2. Can we optimize and validate a practical method to isolate bovine colostral 
monomorphonuclear leukocytes and further characterize the different subtypes and 
their functionality (Chapter 4.1)? 
3. Are body condition score, parity and elevated NEFA and/or BHBA serum 
concentrations associated with the phenotypic distribution and proliferative capacity 
of the colostral monomorphonuclear leukocytes (Chapter 4.2)? 
4. Is there a difference in cellular and humoral immune response to vaccination 
between neonatal dairy calves receiving colostral leukocytes or not (Chapter 4.3)? 
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ABSTRACT 
 
Calf diarrhea causes substantial economic losses in cattle herds worldwide. Neonatal 
calves are particularly sensitive to infections with enteropathogens. The present study focused 
on prevention against the main infectious causes of neonatal calf diarrhea i.e. Escherichia coli, 
rota- and coronavirus, and Cryptosporidium parvum.  
Dairy herds (n = 24) with a high percentage of calves with neonatal diarrhea (> 10%) 
were included and calves were sampled for the presence of these four enteropathogens. To 
decrease diarrhea problems among neonatal calves, a standard protocol was tested on 13 herds 
(treatment group) where both C. parvum and either E. coli or rota- or coronavirus were 
identified as being involved, the other 11 herds served as control group. The protocol consisted 
of 2 points of action: preventive vaccination of dams against E. coli, rota- and coronavirus and 
preventive administration of halofuginone lactate to newborn calves.  
The average percentage of calves suffering from neonatal diarrhea (39.7% vs. 14.3%, P 
< 0.01) and the average percentage of faecal samples positive for C. parvum (34% vs. 11%, P 
< 0.05) differed significantly between control herds and treatment herds after implementation 
of the protocol. No significant differences between control and treatment group were observed 
in the percentage of calves excreting E. coli, rota- and coronavirus, both before and at the end 
of the trial. Furthermore, risk factors potentially associated with the development of neonatal 
calf diarrhea were determined. Non-significant results were obtained for the effect of the 
protocol on duration of diarrhea and the effect of the colostral IgG quantity on the risk of 
diarrhea. Passive immunity transfer status of the calves, measured both before the onset and at 
the end of the study, were non-significant between groups.  
In herds where the colostrum management suffices, dam vaccination and metaphylactic 
halofuginone lactate administration can be successful in the reduction of incidence of calf 
diarrhea. Implementation of the described protocol in neonatal calf diarrhea problem herds is 
straightforward for practitioners. 
 
KEYWORDS: colostrum, diarrhea, halofuginone, vaccination, dairy calf  
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1. INTRODUCTION  
 
Neonatal calf diarrhea (NCD) is one of the major health challenges in both beef and 
dairy cattle herds (USDA, 2010). The prevalence and incidence risk for NCD has recently been 
reported to be 19.1% and 21.2%, respectively (Bartels et al., 2010; Windeyer et al., 2014). In 
the USA, diarrhea in neonatal calves accounts for more than 50% of unweaned dairy heifer 
deaths (USDA, 2010). Economic losses are also due to reduced growth rates, treatment costs, 
and time spent caring for the affected calves (Anderson et al., 2003; Ok et al., 2009). Moreover, 
NCD creates a problem in terms of animal welfare and farmer distress (Lorenz et al., 2011; 
Smith, 2012). The herd veterinarian is the most adequate person to advice farmers how to treat 
and how to prevent NCD (Smith, 2012). 
Diarrhea in neonatal calves is a complex, multifactorial and dynamic disease with the 
balance between the host’s resistance (i.e. active and passive immunity) and the pathogen 
pressure being cardinal (Lorenz et al., 2011). Enterotoxic Escherichia coli, rota- and 
coronavirus and Cryptosporidium parvum are the four most important enteropathogens causing 
NCD worldwide (Trotz-Williams et al., 2007; Gulliksen et al., 2009; Bartels et al., 2010; 
Silverlås et al., 2010). Rotavirus and C. parvum are most frequently identified in faecal samples 
from calves with NCD: prevalence in calves with diarrhea ranges from 2.6-45.1%, 17.7-79.9%, 
3.1-21.6% and 27.8-58.5%, for E. coli, rota- and coronavirus, and C. parvum, respectively 
(Geurden et al., 2008; Ok et al., 2009; Bartels et al., 2010; Izzo et al., 2011). The simultaneous 
or consecutive presence of more than one of these pathogens often causes an increased 
morbidity and mortality rate (Blanchard, 2012). 
Each strategy to prevent NCD should begin with a confirmed diagnosis and the setup of 
a farm interview. The herd anamnesis addressing young stock management creates a list with 
potential critical control points. Key questions in this anamnesis should focus on: colostrum 
management, housing and hygiene, feeding of the calves, periods of stress, and drugs used 
(Blanchard, 2012; Smith, 2012). 
The main objective of the present study was to evaluate the effect of a 2-step approach 
on the incidence of calves with NCD and on the excretion of E. coli, rota- and coronavirus, and 
C. parvum. This protocol consisted of vaccinating dams against E. coli and rota- and 
coronavirus and administering halofuginone lactate to newborn calves during their first seven 
days of life. 
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The secondary objectives were (1) to determine risk factors for developing NCD, (2) to 
evaluate the effect of this 2-step preventive approach on duration of diarrhea and mortality, (3) 
and to evaluate the influence of the total ingested amount of colostral IgG within the first 6 and 
the first 12 hours after birth on the risk for developing diarrhea.    
 
2. MATERIALS AND METHODS 
 
2.1 Herds and data collection 
 
In total, 79 veterinarians of Flanders and the Netherlands were asked to provide dairy 
herds with > 50 calving’s per year in which > 10% of the calves between 0-14 days of age were 
suffering from NCD and no measures to prevent NCD had been taken yet. To be included in 
the study, herds had to be positive for both C. parvum and either E. coli or rota- or coronavirus, 
in order to justify the protocol used (i.e. halofuginone lactate treatment of all calves and 
vaccination of the dams). A total of 75 dairy herds were provided by 13 veterinarians of which 
24 herds met the inclusion criteria. These herds were subsequently randomly assigned to either 
the control group (n = 11) or treated group (n = 13). The study was carried out from February 
2011 until July 2012. 
Each farmer was interviewed on several aspects related to colostrum management, 
feeding practices, hygiene, current diarrhea problems, and preventive and curative treatment of 
NCD. All interviews were performed by VM. Part of the questionnaire is presented in Table 6.  
On each of these herds, both before inclusion and at the end of the study, faecal samples 
of 5 randomly selected calves between 0 and 14 days of age were analysed with an ELISA 
(Rainbow Calf Scour 4, Bio-X Diagnostics, Jemelle, Belgium) to test for the presence of E. 
coli, rota- and coronavirus, and C. parvum. This ELISA kit detects Cryptosporidium spp., but 
as data worldwide show that C. parvum is the most common species found in calves of this age 
(Geurden et al., 2007; Langkjær et al., 2007; Xiao et al., 2007), we presumed the species to be 
C. parvum. Also, on each of these herds, both before and at the end of the study, blood samples 
of 5 randomly selected calves between 2 and 5 days old were collected for the determination of 
the serum IgG concentration using a commercial radial immunodiffusion kit (Bovine IgG Test 
Kit, Triple J Farms, Bellingham, USA). The herd status for failure of passive immunity transfer 
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(FPT) was defined as: (1) FPT10 being the % of calves with a serum IgG content of < 10 g/l 
and (2) FPT15 being the % of calves with a serum IgG content of < 15 g/l. 
 
Table 6. Univariable associations between herd management practices and the likelihood for neonatal 
calf diarrhea (NCD) within 14 days after birth on 18 Flemish and 6 Dutch dairy herds.  
Independent variable Nherds Ncalves % NCD Pcalves 
Presence of calving stable    0.295 
     No 11 224 21  
     Yes 13 299 31  
Cleaning and disinfecting calving stable post partum    0.112 
      Doing nothing 7 145 36  
      Removing dirty straw/faeces 4 94 34  
      Removing dirty straw/faeces and cleaning 2 60 7  
      No calving stable 11 224 21  
Use of calving stable for sick animals    0.591 
      No 5 117 31  
      Yes 8 182 31  
      No calving stable 11 224 21  
Cleaning and disinfecting of obstetric material    0.510 
     Cleaning 12 258 23  
     Cleaning and disinfecting 12 265 30  
Cleaning and disinfecting of hands    0.253 
     Doing nothing 3 59 19  
     Cleaning 10 219 23  
     Cleaning and disinfecting 11 245 32  
Cleaning and disinfecting rear of cow    0.313 
     Doing nothing 9 184 29  
     Cleaning 5 114 14  
     Cleaning and disinfecting 10 225 31  
Immediately separating calf from cow post partum    0.087 
    No 14 299 33  
    Yes 10 224 17  
Cleaning and disinfecting of calf box after each calf    0.109 
      Doing nothing 4 93 25  
      Removing dirty straw/faeces 6 125 32  
      Removing dirty straw/faeces and cleaning 7 140 36  
      Removing dirty straw/faeces, cleaning and disinfecting 7 165 13  
Contact between weaned and non-weaned calves is possible     0.108 
      No 15 328 21  
      Yes 9 195 36  
Herd clothes are being used for visitors    0.517 
      No 15 335 24  
      Yes 9 188 30  
Use of one bucket per calf    0.768 
      No 13 282 27  
      Yes 7 160 22  
      Use of automate feeder 4 81 32  
Cleaning of buckets after each feeding    0.789 
     No 14 311 24  
     Yes 6 131 29  
     Use of automate feeder 4 81 32  
Milk type    0.136 
      Full fresh milk 14 317 21  
      Artificial milk 10 206 34  
Temperature control of milk given    0.102 
      No 19 421 22  
      Yes 2 41 59  
      Use of automate feeder 3 61 32  
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Once included in the study, all herds (treatment and control) were asked to closely 
monitor the first 20 newborn calves during their first 14 days of life and to daily fill in a form 
per calf including information on: timing and amount of colostrum ingested, physical 
appearance of the faeces, appetite, demeanour, morbidity, eventual curative treatments, and 
mortality. Diarrhea was defined as faeces with a physical appearance of score 2 or 3 with scores 
being: 0 = normal firm faeces, 1 = normal soft faeces, 2 = runny faeces, 3 = watery faeces. 
Duration of diarrhea was defined as the number of days that a calf had faecal score 2 or 3. 
Mortality was defined as the percentage of calves that died while having diarrhea. 
Of each dam, a colostrum sample (1.5 ml, mixed four quarter sample) was frozen for 
later determination of the IgG content using a commercial radial immunodiffusion kit (Bovine 
IgG Test Kit, Triple J Farms, Bellingham, USA). The IgG data from these colostrum samples 
were used to estimate the total amount of IgG given to each calf.  
 
2.2 Protocol 
 
In the treated herds, extra preventive measures were taken, i.e.: 
(1) vaccination of the dams of the first 20 newborn calves against E. coli and rota- and 
coronavirus with one dose (2 ml IM) of a vaccine specific for E. coli, rota- and coronavirus 
(Rotavec-Corona®, MSD) at 3 months to 3 weeks before the expected calving date; 
(2) administration of halofuginone lactate (Halocur®, MSD, Boxmeer, The 
Netherlands) to the first 20 newborn calves at a dosage of 100 micrograms/kg per day (=2 
ml/10kg) during the first 7 days of life in the milk as a metaphylactic treatment against C. 
parvum. 
 
2.3 Protocol efficacy evaluation 
 
Protocol efficacy was assessed by: 
(1) comparing the incidence and duration of diarrhea and the mortality between control 
and treated herds (after full implementation of all preventive measures), based on the data of 
the individual calf sheets; 
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(2) comparing the shedding of E. coli, rota- and coronavirus, and C. parvum between 
control and treated herds based on the faecal samples taken at the onset and the end of the study.  
 
2.4 Evaluation of the colostrum management 
 
The herd FPT status of the control versus the treated herds was compared based on the 
blood samples taken at the onset and the end of the study. Furthermore, the influence of the 
amount of IgG administered to each calf within the first 6 and 12 h after birth on the presence 
of diarrhea during the study was evaluated -irrespective of groups- based on the data of the 
individual calf sheets. 
 
2.5 Statistical analysis  
 
In all models, a variance components correlation structure was used to take into account 
the clustering of observations within a herd. To evaluate the variance occurring at the herd level, 
null models were fit with herd as random effect for all dependent variables. 
(1) Risk factor analysis. To identify herd level risk factors associated with the likelihood 
of diarrhea within the first 14 days after birth, a logistic regression model was fit (Table 7). 
Initially, univariable associations were tested between the binary dependent variable 
‘occurrence of diarrhea’ at the calf level (0 = no; 1 = yes) and all categorical independent 
variables at the herd level presented in Table 6. Statistical significance in this step was assessed 
at P < 0.20. Secondly, Spearman correlation coefficients were calculated among the significant 
independent variables to check for multicollinearity. If two independent variables had a 
correlation coefficient ≥ 0.6, only one was selected for further analysis. Contact between 
weaned and non-weaned calves and cleaning and disinfecting of the calf box after each calf 
were correlated, as were milk type and temperature control of milk given. Cleaning and 
disinfecting of the calf box after each calf and type of milk were selected because these are the 
biologically most relevant factors. In the third step, a multivariable model was fit using a 
stepwise backward procedure. A variable was considered to act as a confounder if its removal 
made the regression coefficients of the remaining variables undergo a relative change > 25%, 
or in case the regression coefficient ranged between -0.4 and 0.4, or if an absolute change > 0.1 
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was observed (Noordhuizen et al., 2001). Statistical significance in this step was assessed at P 
< 0.05. 
(2) Protocol efficacy. First, to determine the association between the treatment groups 
(control or treatment) and the likelihood of diarrhea within the first 14 days after birth at the 
calf level and mortality within the first 14 days after birth while having diarrhea at the calf level, 
respectively, logistic mixed regression models with herd as random effect were fit (Table 7). 
The association between groups (control or treated) and the duration of diarrhea at the calf level 
was determined using survival analysis. Calves that died while having diarrhea were censored. 
A survival model was fit with herd as shared frailty effect to correct for clustering of calves 
within herds, and group as categorical fixed effect (Table 7).  
Secondly, separate logistic mixed regression models were fit (Table 7) to test the 
association between the binary dependent variables shedding of E. coli (0 = no and 1 = yes), 
shedding of rotavirus (0 = no and 1 = yes), shedding of coronavirus (0 = no and 1 = yes), and 
shedding of C. parvum (0 = no and 1 = yes) at the observation level, and group (control or 
treated), time of sampling (0 = before the onset of the study and 1 = at the end of the study) and 
the interaction term between group and time of sampling as categorical independent variables.  
(3) Evaluation of the colostrum management. Logistic mixed regression models were 
fit to determine (a) the association between the amount of IgG given to a calf within the first 6 
and 12 hours after birth (0: IgG < 200 g and 1: IgG ≥ 200 g) as independent variable and the 
likelihood of diarrhea within the first 14 days after birth as dependent variable, and (b) the 
association between colostral quality (0: < 50 g IgG/l and 1: ≥ 50 g IgG/l) as independent 
variable and the likelihood of diarrhea as dependent variable, and (c) the association between 
the group (control or treated) as independent variable and the colostrum quality (0: IgG < 50 
g/l and 1: IgG ≥ 50 g/l) as dependent variable. 
Subsequently, separate logistic mixed regression models were fit to test the association 
between the binary dependent variables FPT10 (0 = serum IgG content < 10 g/l and 1 = serum 
IgG content ≥ 10 g/l) and FPT15 (0 = serum IgG content < 15 g/l and 1 = serum IgG content ≥ 
15 g/l) and group (control or treated) as independent variable and time of sampling (0 = before 
the onset of the study and 1 = at the end of the study) and the interaction term between group 
and time of sampling as categorical independent variables (Table 7).  
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Table 7. Overview of the level at which the different dependent variables were measured (calf, 
observation), type of regression model and variance components at the herd level of the null models 
using data of 523 calves from 6 Dutch and 18 Flemish dairy herds. 
Dependent variable 
 
 
Level 
Variance herd 
random effect1 
 
Type of regression model 
SAS2 PROC 
function 
     
Likelihood of diarrhea calf 0.99 + 0.4 logistic mixed GLIMMIX 
     
Mortality calf 0.02 + 1.0 logistic mixed GLIMMIX 
     
Duration of diarrhea calf 0.09 + 0.1 survival frailty PHREG 
     
Colostrum quality calf    192.64 + 78.3 linear mixed MIXED 
     
Shedding of pathogens     
    E. coli observation 0.12 + 0.2 logistic mixed GLIMMIX 
    Rotavirus observation 0.24 + 0.2 logistic mixed GLIMMIX 
    Coronavirus observation 0.59 + 0.3 logistic mixed GLIMMIX 
    C. parvum observation 0.04 + 0.1 logistic mixed GLIMMIX 
     
Failure of passive transfer     
    Serum IgG  observation 8.48 + 7.3 linear mixed MIXED 
    FPT10 observation 0.44 + 0.5 logistic mixed GLIMMIX 
    FPT15 observation 0.83 + 0.5 logistic mixed GLIMMIX 
     
1 Variance estimated at the herd level determined in the model only including the intercept 
2 SAS Institute Inc., Cary, NC 
 
A linear mixed regression model was fit (Table 7) to test the association between group 
(control or treated) and time of sampling as independent variables and the serum IgG 
concentration before the onset of the study and at the end of the study as dependent variables.  
 
3. RESULTS 
 
Distribution and univariable analysis outcomes of risk factors extracted from the 
questionnaire are presented in Table 6. In the univariable step, 6 factors were significantly 
related to the likelihood of diarrhea within the first 14 days after birth (P < 0.20). In the 
multivariable model, no significant associations remained for any of these factors. 
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The percentage of calves with NCD during the study was significantly lower in the 
treated herds (14.3%) compared to the control herds (39.7%; OR = 0.26, P < 0.01, Table 8). 
No statistically significant difference in the duration of diarrhea was present between calves of 
treated and control herds (HR = 0.91; 95% CI [0.57 – 1.48]; P = 0.76, Table 8). Also the odds 
of mortality were not statistically significant (OR = 0.30, 95% CI [0.06 – 1.59], P = 0.16, Table 
8). 
Calves of treated herds showed a significantly lower risk of C. parvum shedding at the 
end of the study compared to the start of the study (11% versus 46%, P < 0.001, Table 9). This 
risk at the end of the study was also significantly reduced compared to calves of control herds 
(11% versus 34%, P < 0.01, Table 9).  Occurrence of coronavirus increased significantly (P < 
0.05, Table 9) during the study period in both groups; no significant differences existed 
between groups regarding the occurrence of E. coli and rotavirus (Table 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3                                          Evaluation of a protocol to reduce neonatal calf diarrhea 
62 
Table 8. Univariable mixed regression models for the dependent variables likelihood of diarrhea, 
duration of diarrhea, and mortality, using data of 523 calves from 6 Dutch and 18 Flemish dairy herds. 
Dependent variable 
Independent 
variable N Mean 
OR or 
HR 95% CI P-value 
       
Likelihood of diarrhea  Group     < 0.01 
      Control  234 39.7 % Ref.   
      Treated 296 14.3 % 0.26 0.12-0.60  
       
 g IgG < 12 h     0.59 
      < 200 231 28.6 % Ref.   
      > 200 93 23.7 % 0.77 0.51-1.47  
       
 Colostrum quality     0.42 
      < 50 g IgG/l 60 30.0 % Ref.   
      > 50 g IgG/l 322 24.3 % 0.75 0.39-1.45  
       
Duration of diarrheaa  Group     0.76 
      Control 234 2.35 d Ref.   
      Treated 296 2.10 d 0.91 0.57-1.48  
       
Mortality  Group     0.16 
      Control 234 2.2 % Ref.   
      Treated 296 0.7 % 0.30 0.06-1.59  
       
 
a Within the calves that had at least 1 day of diarrhea 
 
Calves from both treated and control herds received on average 1.9 l (range 0.0-6.0 l) 
of colostrum at the first colostrum feeding. The average time until a newborn calf received its 
first colostrum was 2.9 hours (range 0.1-20.0 hours) on control herds and 2.0 hours (range 0.1-
10.5 hours) on treated herds. Within the first 6 hours after birth, a calf received on average 1.8 
+ 1.1 l and 2.2 + 1.2 l on control and treated herds, respectively. These differences were not 
significant. Colostral quality was significantly lower (P < 0.05) on control herds (average 79 g 
IgG/l; range 1-187 g IgG/l) compared to treated herds (average 90 g IgG/l; range 2-241 g IgG/l). 
No significant differences were present between both groups regarding FPT10 and FPT15 (Table 
9).  
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The percentage of calves with NCD did not significantly differ between calves receiving 
at least 200 g IgG or less within the first 12 hours after birth (P = 0.59, Table 8) nor between 
calves receiving colostrum of inferior quality compared to calves receiving high quality 
colostrum (P = 0.42, Table 8). 
 
Table 9. Univariable mixed regression models to assess the effect of treatment on shedding of pathogens 
and failure of passive immunity transfer using data of 523 calves from 6 Dutch and 18 Flemish dairy 
herds. 
Dependent variable Before   After   Pbetween   Pwithin 
  Treated Control   Treated  Control   Beforea Afterb   Treatedc Controld 
Shedding of pathogens (%)            
      E. coli 16 15  15 25  0.93 0.19  0.91 0.17 
      Rotavirus 57 43  44 47  0.20 0.76  0.17 0.63 
      Coronavirus 14 9  32 34  0.52 0.79  0.02 0.002 
      C. parvum 46 31  11 34  0.09 0.004  <0.001 0.70 
            
Failure of passive transfer            
     Serum IgG (g/l) 24 21  22 25  0.32 0.28  0.49 0.09 
      FPT10 (%) 5 12  17 13  0.87 0.14  0.64 0.27 
      FPT15 (%) 16 24  27 15  0.15 0.33  0.34 0.33 
            
 
a P-value to assess statistical significance of differences between control and treated herds before the onset of the 
study. 
b P-value to assess statistical significance of differences between control and treated herds at the end of the study. 
c P-value to assess statistical significance of differences between treated herds before the onset of the study and at 
the end of the study. 
d P-value to assess statistical significance of differences between control herds before the onset of the study and at 
the end of the study. 
 
4. DISCUSSION 
 
Neonatal calf diarrhea is a disease with a major impact on the economic viability of 
cattle herds worldwide and can be triggered by both infectious and non-infectious causes. The 
present study focused on prevention of infectious causes of NCD with main emphasis on E. 
Chapter 3                                          Evaluation of a protocol to reduce neonatal calf diarrhea 
64 
coli, rota- and coronavirus and C. parvum. Rotavirus and C. parvum were the 2 most common 
enteropathogens found in faeces of calves in the present study, confirming data reported 
worldwide (Ok et al., 2009; Bartels et al., 2010; Izzo et al., 2011). 
No significant associations were present between diarrhea incidence during the study 
and the risk factors defined in the questionnaire. This can be explained by a lack of variation in 
NCD management along with a high variation in the incidence of neonatal diarrhea among the 
herds and the relatively small number of herds.  
The significantly lower percentage of calves with NCD in treated herds in comparison 
to control herds indicates the efficacy of the preventive 2-step program. The higher colostral 
quality on the treated herds might reflect the impact of the vaccination protocol. However, 
despite the use of a specific vaccine against E. coli, rota- and coronavirus, no significant 
differences existed between groups in the occurrence of E. coli, rota- and coronavirus. As the 
tetrakit used to determine pathogen excretion is not a quantitative but rather a qualitative to 
semi-quantitative test, the exact level of pathogen excretion per calf could not be assessed. 
Hence, we may state that fewer calves excreted enteropathogens following the implementation 
of the 2 step protocol, but not whether individual excretion was lowered. If so, this potentially 
also may contribute to fewer calves suffering from NCD. Also, calves born from vaccinated 
dams are significantly less likely to shed C. parvum (Trotz-Williams et al., 2007).  
The efficacy of halofuginone lactate (a cryptosporidiostatic) was evident from the 
significant reduction of the proportion of calves excreting C. parvum after protocol 
implementation within the treated herds while this did not occur in control herds. A prophylactic 
or metaphylactic treatment with halofuginone lactate is expected to decrease and delay the peak 
of oocyst excretion, delaying the onset of diarrhea to an age when calves are better able to cope 
with dehydration and acid-base balance disturbances (Silverlås et al., 2009; De Waele et al., 
2010; Trotz-Williams et al., 2011). 
The overall passive immunity for both treated and control herds was adequate, as 
indicated by the average IgG serum content which also did not differ significantly between 
groups. Several other authors reported lower average IgG values ranging from 12 to 19 g/l and 
FPT10 percentages up to 50% (Tyler et al., 1996b; Calloway et al., 2002; Filteau et al., 2003). 
McGuirk and Collins (2004) set the alarm level for FPT10 to be a herd problem at 20%, whilst 
Chigerwe et al. (2009) consider an FPT prevalence < 10% as a rational and achievable goal. 
Despite the adequate passive immunity in this study, several calves developed diarrhea which 
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may suggest that the cut off value of 10 g IgG/l is too low, and should be revised (Güngör et 
al., 2004; Chigerwe et al., 2008b; Windeyer et al., 2014). Also, the association between the 
level of passive immunity and the occurrence of NCD is less clear in comparison to the 
occurrence of respiratory disease (Donovan et al., 1998).  
  
5. CONCLUSIONS 
 
In herds where the colostrum management suffices, dam vaccination and metaphylactic 
halofuginone lactate administration can be successful in the reduction of incidence of calf 
diarrhea. Implementation of the described protocol in NCD problem herds is straightforward 
for practitioners. 
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ABSTRACT 
 
The present study reports a method for isolating bovine colostrum mononuclear cells 
(CMC) for phenotyping and functional studies. As well as being an important source of 
antibodies, colostrum also contains leukocytes that may be of greater importance for passive 
immunity than has previously been thought. Different protocols have been reported for isolating 
leukocytes from bovine colostrum, although none of these have been validated, and phenotypic 
analysis of cell populations has not always been performed. In this study, bovine CMC were 
isolated by density gradient centrifugation. Cell populations were identified by flow cytometry 
using antibodies against selected bovine cell surface markers and the proliferative capacity of 
these cells was determined using a 3H-thymidine proliferation assay. 
The mean cell count of isolated CMC was 3 × 104 and 1 × 105 per ml colostrum for the 
samples used in the flow cytometric assay and the proliferation assay, respectively. A mean of 
25.4 + 17.1% CMC were identified as T-lymphocytes, 2.9 + 3.0% as B-lymphocytes and 32.7 
+ 13.7% as macrophages. In terms of proliferation, the mean counts per minute were 4.3 × 103 
and 1.8 × 104 for cells cultured in medium only or in the presence of concanavalin A, 
respectively, showing that CMC are viable and capable of responding to mitogen stimulation. 
Isolation of CMC and the subsequent phenotypic analysis of the different subpopulations were 
repeatable, with agreement indices varying between 0.5 and 1.0. Agreement indices for the 
proliferation assay were estimated at 0.8. 
The present paper describes a robust density gradient centrifugation-based protocol for 
isolating, identifying and quantifying different mononuclear cell phenotypes in bovine 
colostrum, using flow cytometry. This isolation procedure can be used to determine the 
proliferative capacity of bovine CMC. 
 
 
KEYWORDS: cattle, colostrum, flow cytometry, leukocytes, cell proliferation 
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1. INTRODUCTION 
 
The synepitheliochorial placenta of ruminants does not allow passive transfer of 
immunity during gestation (Arthur, 1996), except under conditions whereby the placental 
barrier is damaged (Gabriel et al., 2007). Therefore, administration of sufficient amounts of 
high quality colostrum during the first 6–12 hours following parturition is recommended as one 
of the most effective measures of protecting neonatal animals against respiratory and 
gastrointestinal infections (Bourne et al., 1978; Donovan, 1998). High quality colostrum has 
traditionally been defined as having a high content of antibodies. Historically, scientific interest 
has mainly focused on IgG and IgA within colostrum, although increasing research is being 
applied for studying other humoral and cellular components. Colostrum leukocytes might play 
a greater role than previously thought in protecting neonatal animals against environmental 
pathogens. The transfer of colostrum-derived leukocytes to the neonate through the 
gastrointestinal epithelium has been reported in several species, including cattle (Schnorr, 1984; 
Jain, 1989; Liebler-Tenorio et al., 2002). Circulating leukocytes, obtained by the neonate from 
colostrum, seem to be viable and immunocompetent (Pitt, 1977; Xanthou, 1997), and could 
contribute to passive transfer of immunity (Riedel-Caspari, 1993; Donovan et al., 2007; Reber 
et al., 2008b). Maternally-derived colostrum leukocytes can prime immune responses and 
enhance T-lymphocyte help for antibody production (Riedel-Caspari and Schmidt, 1991a). 
Furthermore, calves receiving colostrum containing leukocytes have more potent lysozyme 
activity and greater bactericidal activity compared to calves deprived of colostrum leukocytes 
(Riedel-Caspari and Schmidt, 1991a-b; Riedel-Caspari et al., 1991). Colostrum derived 
leukocytes might also assist in combating gastro-intestinal pathogens such as Cryptosporidium 
parvum, since the cellular immune response plays a key role in overcoming this type of parasite 
infection (Harp et al., 1990).  
The population of leukocytes in colostrum consists of granulocytes and mononuclear 
cells, including neutrophils, macrophages, and lymphocytes. Validated and reliable methods to 
isolate and identify the different leukocyte subpopulations from colostrum are required to 
facilitate investigation of their potential role in passive immunity. Different protocols have been 
described for isolation of leukocytes or, more specifically, lymphocytes from colostrum and 
milk (Nonnecke and Kehrli, 1985; Nonnecke et al., 1986; Park et al., 1992). However, these 
studies have not necessarily reported validation or repeatability of the methodology and, in 
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some cases, large quantities of colostrum have been processed to obtain sufficient numbers of 
cells for experiments. 
The aim of the present study was to optimize and validate a method for isolating bovine 
colostrum mononuclear cells (CMC). Two assays are described that allow identification and 
enumeration of the different CMC subpopulations and permit determination of the proliferative 
capacity of the isolated cells. 
 
2. MATERIALS AND METHODS 
 
2.1 Animals and samples 
 
The study was approved by the Ethics Committee of the Faculty of Veterinary Medicine, 
Ghent University (authorization number EC2008/149). In the first experiment, 26 quarter 
colostrum samples (360 ml per quarter) from the first milking postpartum of seven clinically 
healthy primiparous (n = 2) and multiparous (n = 5) cows from different commercial dairy herds 
in Flanders (Belgium) were collected for isolation of CMC and identification of the different 
cell subpopulations. Two quarter samples were not available from cows that only had three 
productive quarters. Following sample collection, the milk somatic cell count (SCC) was 
determined using a commercial cell counter (DCC, DeLaval). For each cow, colostrum from 
the two quarters with SCC values closest to each other was combined. These samples 
(designated A and B from each cow) were divided into two identical aliquots (designated A1 
and A2, B1 and B2, respectively) and were subsequently processed in parallel (Figure 13A). 
The resulting samples were used to assess the repeatability of both the isolation procedure and 
identification of the different subpopulations by flow cytometry. Two of the 26 colostrum 
samples were excluded from the analysis because of a shortage of cells for further processing. 
All colostrum samples were stored on ice and analysed within 24 hours of collection.  
In a second set of experiments, CMC were isolated from 60 randomly selected 
primiparous (n = 15) and multiparous (n = 45) cows from different commercial herds, to 
determine their proliferative capacity. From each animal, 360 ml of colostrum were sampled 
during the first milking postpartum (90 ml from each individual quarter) and the SCC was 
determined (Figure 13B). All colostrum samples were stored on ice and processed within 24 
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hours of collection. A pilot experiment showed no significant differences between samples 
processed immediately or at 12 or 24 hours after sampling (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. (A) Schedule of the sampling protocol for testing the repeatability of the isolation method. 
Agreement analysis for isolation of CMC was performed between A1-A2 and B1-B2. Agreement analysis 
for the flow cytometer was done between A1-A1 and B1-B1. (B) Schedule of the sampling protocol for 
testing the repeatability of the proliferation assay. Agreement analysis for the proliferation protocol 
was done between two duplicate wells (same sample). 
 
A
Sample A Sample B
Sample A1 Sample A2 Sample B1 Sample B2
360 ml quarter 1 360 ml quarter 2 360 ml quarter 3 360 ml quarter 4
Lowest SCC Highest SCC
Sample
B
90 ml quarter 1 90 ml quarter 2 90 ml quarter 3 90 ml quarter 4
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2.2 Isolation of colostrum mononuclear cells 
 
Colostrum (360 ml) was poured over a gauze pad and subsequently diluted 3:5 in 50 ml 
conical tubes (BD Falcon, Becton Dickinson) with Dulbecco’s phosphate buffered saline (PBS; 
Invitrogen), containing 1% foetal bovine serum (PBS-FBS; Greiner Bio One). The diluted 
colostrum samples were centrifuged (15 min at 600 g), the cream layer removed and cell pellets 
washed twice in 20 ml PBS-FBS (10 min at 300 g). Cell pellets were then resuspended in 30 
ml of PBS-FBS, poured over a cell strainer (70 m, BD Falcon, Becton Dickinson) and over-
layered onto 20 ml Ficoll-Paque premium (specific gravity 1.084; GE Healthcare) followed by 
centrifugation (30 min at 900 g). Cells at the interface were aspirated, transferred to new 50 ml 
Falcon tubes and washed twice with ice cold PBS-FBS (10 min at 200 g). The resulting cell 
pellets were resuspended in 1 ml PBS-FBS for flow cytometric analysis or in 1 ml of culture 
medium, consisting of RPMI 1640 medium (Sigma–Aldrich) supplemented with 10% heat-
inactivated FBS, 2 mM L-glutamine (Gibco), 50 g/ml gentamycin (Sigma–Aldrich) and 50 
M 2-mercaptoethanol (Merck) for proliferation assays. The isolated CMC were counted in a 
Neubauer counting chamber using eosin-nigrosin. 
 
2.3 Phenotypic analysis of cells by flow cytometry 
 
Cells were diluted to 2 × 106 per ml in PBS-FBS and 100 l of cell suspension added to 
100 l of primary antibody (20 g/ml). Four monoclonal antibodies were used, namely, mouse 
anti-bovine CD21 (MCA1424G, AbD Serotec) for B-lymphocytes; mouse anti-bovine CD2 
(BAQ95A, VMRD), expressed on T-lymphocytes and NK cells, mouse-anti bovine CD3 
(MM1A, VMRD), a pan T-lymphocyte marker and mouse anti-bovine CD14 (MM61A, VMRD) 
for macrophages. All antibodies were added in separate wells of a 96-well V-bottomed plate 
and incubated with cells on ice for 30 min, followed by three wash steps in ice cold PBS-FBS 
(3 min at 200 g). Cell pellets were resuspended in 100 μl PBS-FBS and the secondary antibody, 
Alexa Fluor 647-conjugated donkey anti-mouse IgG (H + L) (Invitrogen) was added at 1 g/ml. 
After a further 30 min incubation at 4 °C, cells were again washed and resuspended in a final 
volume of 600 l PBS-FBS containing 400 l propidium iodide (PI; Sigma–Aldrich) for 
analysis with a FACScan flow cytometer (Becton Dickinson). Ten thousand events per sample 
were acquired and relative numbers of cells staining for PI, CD2, CD3, CD21, and CD14 
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determined with FACSDiva software (Becton Dickinson). Gating of the cells was performed, 
based on cell size (forward scatter; FSC), cellular granularity (side scatter; SSC), and 
fluorescence (FL-2 and FL-5 channels). Flow cytometric cell sorting of CD3+ and CD14+ CMC 
was performed (FACSAria II, BD Biosciences) and their morphology was subsequently 
confirmed by microscopy. 
 
2.4 Proliferation assays 
 
Cells were cultured in medium only (as a negative control for background proliferation), 
or in the presence of 5 g/ml concanavalin A (ConA; Sigma–Aldrich) in duplicate wells of 96-
well flat bottomed plates containing 2 × 105 cells per well, in a final volume of 200 l. Cells 
were incubated for 3 days at 37 °C in a humidified atmosphere, containing 5% CO2. Cells were 
pulse-labeled for 18 h with 1 Ci of 3H-thymidine per well and harvested on glass-fibre filters 
(Whatman), then radioactivity was measured using a Beckman -scintillation counter 
(Beckman). Data were acquired as counts per minute (CPM) and log10 transformed to obtain 
a normal distribution. Proliferative responses of cells cultured with medium only or stimulated 
with ConA were compared using a paired sample Student’s t test (SPSS 15.0), with significance 
set at P < 0.05.  
 
2.5 Assay validation 
 
The repeatability of the isolation method was evaluated by agreement analysis of the 
parallel samples as described by Bland and Altman (1986). First, the mean difference between 
identical samples A1 and A2, and between B1 and B2 for the proportion of PI+, CD2+, CD3+, 
CD21+, and CD14+ cells was calculated and tested against zero using a one sample Student’s t 
test (SPSS 15.0). Also, the regression line for deviation was drawn and tested to detect 
significant deviation from the line of equality, and the different correlation coefficients were 
calculated with Excel (Microsoft). Similar analyses were performed on the log10 CPM of 
duplicate wells to evaluate the repeatability of the proliferation assay. The repeatability of the 
flow cytometric measurement of the proportion of the different cell populations was tested by 
performing two repeated measurements on each tube of the A1- and B1-series. 
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In all analyses, the standardized agreement index (AI) was determined using the 
following formula: AI = 1 – (2SDdiff/MeanXY) where SDdiff is the standard deviation of the 
differences between the parallel samples X and Y, and MeanXY is the overall mean of the 
parallel X and Y samples. A positive AI supports agreement and a value larger than 0.5 indicates 
good agreement. The agreement limits were defined as DiffXY + 2SDdiff with DiffXY as the 
difference between the parallel samples X and Y. An agreement plot of the difference against 
the mean of X and Y was used to identify outliers, defined as differences lying outside of the 
agreement limits (Bland and Altman, 1986). 
 
3. RESULTS 
 
3.1 Isolation of CMC and validation of the methodology 
 
Of the 26 quarter colostrum samples assessed, the mean SCC was 2.6 × 105 cells/ml 
colostrum (interquartile range; IQR of 5.8 × 104 to 9.3 × 105 cells/ml). The mean cell count of 
the isolated CMC was 3 × 104 per ml colostrum. The differences between the obtained 
percentages of the A1- and A2-series and of the B1- and B2-series were not significantly 
different from zero (data not shown). The AIs for the dead cells and different subpopulations 
ranged from 0.5 to 0.7 (Table 10). The correlation coefficients varied between 0.87 and 0.97. 
Data points lying outside the limits of agreement in the Bland-Altman plots were limited to a 
maximum of one (8.3%; Figures 14A-D). 
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Figure 14a. (i) Scatter plots for the repeatability of the isolation protocol and (ii) Bland-Altman plots 
shown for CD2+ cells. In (ii), the full line corresponds to the mean difference in percentage of cells 
between two identical samples (A1 versus A2 or B1 versus B2). The hatched lines represent the 
intercepts y = mean ± 1.96 × SD, corresponding to the limits of agreement. 
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Figure 14b. (i) Scatter plots for the repeatability of the isolation protocol and (ii) Bland-Altman plots 
shown for CD3+ cells. In (ii), the full line corresponds to the mean difference in percentage of cells 
between two identical samples (A1 versus A2 or B1 versus B2). The hatched lines represent the 
intercepts y = mean ± 1.96 × SD, corresponding to the limits of agreement. 
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Figure 14c. (i) Scatter plots for the repeatability of the isolation protocol and (ii) Bland-Altman plots 
shown for CD21+ cells. In (ii), the full line corresponds to the mean difference in percentage of cells 
between two identical samples (A1 versus A2 or B1 versus B2). The hatched lines represent the 
intercepts y = mean ± 1.96 × SD, corresponding to the limits of agreement. 
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Figure 14d. (i) Scatter plots for the repeatability of the isolation protocol and (ii) Bland-Altman plots 
shown for CD14+ cells. In (ii), the full line corresponds to the mean difference in percentage of cells 
between two identical samples (A1 versus A2 or B1 versus B2). The hatched lines represent the 
intercepts y = mean ± 1.96 × SD, corresponding to the limits of agreement. 
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3.2 Phenotypic analysis by flow cytometry and validation of the assay 
 
Dead cells were excluded, based on their staining with PI. Cells in the lower left 
quadrant of the FSC versus SSC dot plot with positive fluorescence for CD2, CD3 or CD21 
were regarded as being T- or B-lymphocytes, respectively (Figure 15a). Cells in the upper right 
quadrant of the FSC versus SSC dot plot with positive fluorescence for CD14 were regarded as 
being macrophages (Figure 15b). Flow cytometric analysis of the isolated CMC showed that 
25.4 + 17.1% of the CMC were CD2+, 19.5 + 13.6% were CD3+, 2.9 + 3.0% were CD21+ and 
32.7 + 13.7% were CD14+. The overall percentage of dead cells was 15.5 + 9.3%. The mean 
differences between the obtained percentages of the repeated measurements of the A1- and B1-
series were not significantly different from zero. The AIs for the repeatability of the flow 
cytometry of the dead cells and different subpopulations varied between 0.5 and 0.9 (Table 10). 
The correlation coefficients ranged from 0.97 to 1.00 (Table 10). Also, data points lying outside 
the limits of agreement in the Bland-Altman plots were limited to a maximum of one (8.3%, 
data not shown). 
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Table 10. Overview of the Bland-Altman agreement indices (AI) with the corresponding 95% agreement 
limits and correlation coefficients for evaluating the repeatability of the isolation protocol, the flow 
cytometric analysis and proliferation assay. 
     CPM, counts per minute. Number of paired samples shown.  
1Minimum level of the 95% agreement limits interval; 2Maximum level of the 95% agreement limits interval; 
3Correlation coefficient. 
 
 
 
 
 
 
 
 
Protocol 
 
 
 Colostrum mononuclear cells (%)  CPM 
 PI+ CD2+ CD3+ CD21+ CD14+ 
 
Medium ConA 
          
Isolation  
(n = 12)   
AIISOL
 
0.7 0.7 0.6 0.5 0.5  … … 
AIMIN1 -5.7 -8.3 -7.0 -1.5 -15.8  … … 
 AIMAX2 4.3 9.0 7.8 1.4 14.1  … … 
 R3 0.97 0.97 0.97 0.97 0.87  … … 
Flow 
cytometry (n = 
12)  
AIFCM 0.9 1.0 0.9 0.5 0.9  … … 
AIMIN -0.8 -0.8 -1.6 -1.7 -2.4  … … 
 AIMAX 1.0 0.6 0.8 1.3 2.1  … … 
 R 1.00 1.00 1.00 0.97 1.00  … … 
Proliferation  
(n = 60)  
AIPROL … … … … …  0.8 0.8 
AIMIN … … … … …  0.7 0.7 
 AIMAX … … … … …  0.8 0.9 
 R … … … … …  0.89 0.90 
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Figure 15. Representative example of the flow cytometric analysis of colostral monomorphonuclear 
leukocytes, together with a microscopic image of the sorted cells. Plots of side scatter (SSC) against 
fluorescence signal were performed on events gated in a population excluding cell debris and dead cells. 
(A) SSC versus CD3-Alexa 647 dot-plot with lymphocytes (L) and (B) SSC versus CD14-Alexa 647 dot-
plot with macrophages (M).  
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3.3 Proliferation of CMC and validation of the assay 
 
The mean SCC was 8.5 × 105 cells/ml colostrum (IQR: 3.7 × 105 to 2.4 × 106 cells/ml) 
and the mean cell count of the isolated CMC was 1 × 105 per ml colostrum. The mean 
background proliferation was 4.3 × 103 CPM (IQR 1.2 × 103 to 1.5 × 104) and differed 
significantly for CMC stimulated with ConA, with a mean of 1.8 × 104 CPM (IQR: 7 × 103 to 
5.2 × 104; P < 0.001). The mean differences between the obtained log10 CPM values of the 
duplicate wells in medium only or stimulated with ConA were not significantly different from 
zero. The AIs for the proliferative response of cells in medium only or ConA stimulated were 
estimated at 0.8 (Table 10). Five to ten per cent of the data points lie outside the limits of 
agreement (Figure 16) and the correlation coefficients for the CPM of the medium and ConA 
cultured cells were estimated at 0.89 and 0.90, respectively (Table 10). 
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Figure 16. (A) Representative scatter plot for the repeatability of the proliferation assay. (B) Bland-
Altman plot, where the full line at intercept y = 0.1 corresponds to the mean difference in log10 CPM 
between a pair of duplicate wells, the hatched lines represent the intercepts y = mean ± 1.96 × SD, 
corresponding with the limits of agreement. 
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4. DISCUSSION 
 
To explore the role of colostrum leukocytes in passive immunity, a reliable method for 
identification and quantification of CMC and determination of their functionality is needed. In 
milk and colostrum, the concentration of lymphocytes is relatively low compared to blood, 
requiring rather large volumes of milk to be used (Nonnecke and Kehrli, 1985; Nonnecke et al., 
1986; Archambault et al., 1988a; Ebling et al., 2000). This amount of colostrum is not always 
available and sample processing is labour intensive and time consuming. In the assays described 
in the present manuscript, we reduced the number of cells required to 2 × 106 cells/ml, instead 
of the larger numbers proposed by others (Kiku et al., 2010). This approach allowed us to 
identify and quantify the different CMC subpopulations and to determine their proliferative 
capacity with a volume of colostrum of 360 ml. 
The final yield of CMC is dependent upon the initial SCC (Ebling et al., 2000), the 
proportion of the different cell types in the colostrum and the technique used to isolate the cells 
from the colostrum. Similar to milk, the proportion of CMC depends on the 
infection/inflammation status of the mammary gland (Ebling et al., 2000; Leitner et al., 2000). 
The more steps performed during isolation, the more likely that cells are lost throughout the 
procedure (Ebling et al., 2000). There is often an initial loss of cells, because they can be trapped 
in the fat layer which is discarded after the first centrifugation step (Concha et al., 1980). 
Subsequent density gradient centrifugation to isolate CMC from polymorphonuclear cells can 
also result in a poor yield, because of the altered buoyant density of lipid-laden colostrum 
leukocytes (Slade and Schwartz, 1989). Notwithstanding our use of density gradient 
centrifugation, the number of isolated CMC/ml was comparable to those obtained in other 
studies (Archambault et al., 1988a; Gomes et al., 2010). Moreover, except for two cases, 360 
ml colostrum was sufficient to isolate cells for both flow cytometric analysis and proliferation 
assays. 
Differentiating between leukocytes isolated from milk, and in particular from colostrum, 
is difficult because of the high fat content (Piepers et al., 2009b). Macrophages phagocytose fat 
globules, altering their normal morphology and therefore confounding their identification and 
differentiation from other cell types. In the present study, phenotyping of the different CMC 
populations was achieved, based on a combination of their morphology and labelling with 
antibodies against lineage-specific cell-surface CD markers. Light microscopic examination of 
the sorted CD3+ and CD14+ cells confirmed these to be lymphocytes and macrophages, 
Chapter 4.1  Development of a method 
88 
 
respectively (Figure 15). The CD3+ cells had the typical large nucleus/cytoplasm volume ratio 
expected of lymphocytes, whereas the CD14+ cells were much larger, had a high 
cytoplasm/nucleus volume ratio, as well as a high number of endocytosed fat globules in their 
cytoplasm. Flow cytometric analysis of CMC showed an overall viability of 84.5% which is 
only slightly lower than the results reported by Duhamel (1987). Studies focusing on the 
differential CMC counts (Kiku et al., 2010; Ohtsuka et al., 2010) are rather sparse, compared 
to those focusing on milk (Asai et al., 1998, 2000; Van Kampen et al., 1999). The proportion 
of CD14+ CMC found in the present study was similar to those reported by Kiku et al. (2010). 
A greater T:B lymphocyte ratio is consistent with results published by others processing either 
milk (Schore et al., 1981; Harp et al., 2004), dry cow secretion (Concha et al., 1980) or 
colostrum (Kiku et al., 2010). The lower proportion of CD3+ lymphocytes (19.5%), compared 
with the proportion of CD2+ lymphocytes (25.4%) has also been described by others (Ohtsuka 
et al., 2010). This can be explained by the fact that CD2 is expressed by NK cells as well as T-
lymphocytes, whereas CD3 is exclusively found on T-lymphocytes in the bovine species. The 
proportion of lymphocytes and macrophages within the CMC population varies in different 
studies, likely due to differences in techniques used to identify the CMC subpopulations 
(Concha et al., 1980), the gating strategy in flow cytometry (Ohtsuka et al., 2010), the definition 
of colostrum (Archambault et al., 1988a), the health status of the udder (Kiku et al., 2010), and 
the stage of lactation (Harp et al., 2004). In the present study, cell-mediated immunity was 
assessed through the use of a proliferation assay. In previous studies, CMC have been shown 
to respond to mitogens and specific antigens (Meriläinen et al., 1979; Archambault et al., 1988a), 
although direct comparison with other studies is difficult, since differences in methodology 
exist (Elsken and Nonnecke, 1986; Archambault et al., 1988a). Background proliferation is 
generally higher in CMC than in peripheral blood mononuclear cells (Concha et al., 1980). The 
latter finding might be explained by the activating effects of colostrum on the phenotype of 
leukocytes (Reber et al., 2006). Overall, CMC do not respond to mitogens and antigens as 
strongly as peripheral blood mononuclear cells. Colostrum contains a higher proportion of 
macrophages which could, in part, explain this observation (Goddeeris et al., 1987). The 
variability in proliferative capacity might be explained by differences in mammary secretions 
from dairy cows at different stages of lactation, or by the physiological/pathological status of 
the mammary gland. High yielding dairy cows, in early lactation, have a degree of impaired 
immunity, compared to those in mid to late lactation (Goff and Horst, 1997; Asai et al., 1998; 
Shafer-Weaver et al., 1999). This might also contribute to relatively low stimulation indices for 
mitogen- or antigen-stimulated CMC (Concha et al., 1980; Archambault et al., 1988a). 
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The agreement indices for quantification of the different CMC subpopulations, as well 
as their proliferative capacity, ranged between 0.5 and 1.0, indicating good agreement and 
repeatability. This was confirmed by the correlation coefficients (0.87-1.00) and the limited 
number of outliers in the Bland-Altman plots. 
 
5. CONCLUSIONS 
 
The present paper describes a robust density gradient centrifugation-based protocol for 
isolating, identifying and quantifying different mononuclear cell phenotypes in bovine 
colostrum, using flow cytometry. This isolation procedure can be used to determine the 
proliferative capacity of bovine CMC. 
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ABSTRACT 
 
In neonatal calves, the ingestion of colostrum is imperative for preventing infectious 
diseases. Investigations into the transfer of passive immunity of cattle have primarily focused 
on the importance of colostral antibodies with a recent increase in focus on understanding the 
role of colostral leukocytes.  
The main objective of the present study was to measure the influence of parity, body 
condition score, serum NEFA, and serum BHBA concentrations of periparturient cows on 
phenotypic distribution and mitogen- and antigen-induced proliferative capacity of bovine 
colostral leukocytes. Holstein Friesian cows (n = 141) were intramuscularly vaccinated at 60 
and 30 days before the expected parturition date with a tetanos toxoid vaccine. Of these 141 
animals, 28 primiparous and 72 multiparous cows were sampled immediately after parturition. 
Colostrum mononuclear cell populations were identified by flow cytometry using bovine 
cluster of differentiation markers, and the proliferative capacity of these cells was determined 
using a 3H-thymidine proliferation assay.  
Under-conditioned cows had a significantly higher percentage of colostral macrophages 
than normal conditioned animals, while over-conditioned cows had a significantly higher 
percentage of colostral B-lymphocytes. Higher serum BHBA concentrations were significantly 
associated with a higher percentage of colostral T-lymphocytes and macrophages. Heifers had 
significantly higher mitogen- and antigen-induced proliferation of their colostral lymphocytes 
than 3rd parity or older cows. In conclusion, body condition score, parity and serum BHBA 
concentration of periparturient high yielding dairy cows were shown to influence the 
phenotypic distribution and/or the mitogen- and/or antigen-induced proliferation of colostral 
leukocytes, possibly influencing the cellular immunity of the newborn calf. 
 
KEY WORDS: colostrum, dairy cows, leukocytes, negative energy balance  
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1. INTRODUCTION 
 
Investigations into the transfer of passive immunity of cattle have primarily focused on 
the importance of colostral antibodies but, currently increasing attention is given to other 
humoral and cellular components in colostrum (Hagiwara et al., 2000; Donovan et al., 2007). 
Bovine colostral leukocytes are mainly composed of neutrophils, macrophages, and 
lymphocytes (Duhamel et al., 1987). Uptake of these colostral leukocytes through the intestinal 
barrier has been shown in cattle, with a preferential route of uptake through the follicle-
associated epithelium of Peyer’s patches (Liebler-Tenorio et al., 2002). The functional 
importance of bovine colostral leukocytes is not yet fully understood, but they seem to enhance 
lymphocyte responses (Reber et al., 2005; Donovan et al., 2007), increase phagocytosis and 
bacterial killing ability (Riedel-Caspari and Schmidt, 1991), and stimulate humoral immune 
responses in the neonatal calf (Riedel-Caspari, 1993). 
 
The concentration of colostral antibodies in the bovine species is known to be affected 
by breed (Tyler et al., 1999), parity (Moore et al., 2005; Morin et al., 2010), yield of colostrum 
at first milking (Chigerwe et al., 2008; Morin et al., 2010), season (Gulliksen et al., 2008) and, 
the interval between parturition and first milking (Moore et al., 2005; Morin et al., 2010). In 
contrast, few articles describe factors affecting the phenotypic distribution or proliferative 
capacity of leukocytes in bovine colostrum. Moreover, when describing colostral leukocytes 
most manuscripts emphasize the importance of these cells on cow mammary gland immunity 
and not on adoptive immunity transfer to the newborn (Park et al., 1993; Shafer-Weaver et al., 
1996; Ohtsuka et al., 2010). Parity (Ohtsuka et al., 2010), infection state of the udder (Nonnecke 
and Harp, 1985; Park et al., 1993), and vitamin E and selenium supplementation (Wuryastuti et 
al., 1993) have been shown to influence the number and/or activation state of cow and sow 
mammary gland leukocytes. For example, colostral leukocytes of multiparous cows have a 
higher IFN-/IL-4 ratio than heifers (Ohtsuka et al., 2010) and the proliferative response of 
mammary gland leukocytes is lower in infected than uninfected mammary glands (Nonnecke 
and Harp, 1985; Park et al., 1993). Furthermore, the proliferative response of mammary gland 
leukocytes is generally lower than that of peripheral blood mononuclear leukocytes (PBMC) 
(Nonnecke and Harp, 1985; Harp and Nonnecke, 1986; Park et al., 1993). Also, high in vitro 
concentrations of non-esterified fatty acids (NEFA) and β-hydroxy-butyric acid (BHBA) 
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inhibit mitogen-induced proliferative responses and diminish DNA synthesis of PBMC 
(Franklin et al., 1991; Lacetera et al., 2004; Thanasak et al., 2005). Whether parity, body 
condition score, in vivo serum NEFA, and in vivo serum BHBA concentrations of periparturient 
cows affect the function of bovine colostral leukocytes has to the best of our knowledge not 
been studied. The main objective of the present study was therefore to measure the effect of 
these variables on phenotypic distribution and mitogen- and antigen-induced proliferative 
capacity of bovine colostral leukocytes. 
 
2. MATERIALS AND METHODS 
 
2.1 Herds, Animals and Study Design 
 
The study was approved by the Ethical Committee of the Faculty of Veterinary 
Medicine, Ghent University (EC2008/149). An observational cross-sectional study design was 
used. Holstein Friesian cows (n = 141) were randomly selected from 17 commercial dairy herds 
in Flanders (Belgium; Figure 17). The herds had, on average, 59 lactating cows (range 36 to 
95), and an average 305 day milk yield of 8,485 kg (range 4,938 to 10,756 kg). All 141 animals 
were intramuscularly vaccinated at 60 and 30 days before the expected parturition date with 2 
ml of a tetanos toxoid vaccine (Tetapur®, Merial Limited, Duluth, GA). The vaccine was 
chosen because tetanos is not a disease commonly vaccinated against in Belgium and because 
tetanos toxoid is a well-known strong inducer of humoral and cellular immunity. A pre-test 
performed on 3 cows vaccinated (versus 3 non-vaccinated cows) showed the vaccine to perform 
well in terms of eliciting a strong humoral and cellular immune response. Of the 141 selected 
cows, 41 cows were excluded from the study due to various reasons: culling (n = 6), abortion 
(n = 3), missed parturitions (n = 22), leaking of colostrum prepartum (n = 3) and/or parturition 
before administration of booster vaccination (n = 7; Figure 17). 
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Figure 17. Flow of study subjects throughout the trial. 
 
2.2 Data and Sample Collection  
 
To isolate colostrum mononuclear cells (CMC), colostrum (360 ml) was sampled 
aseptically during the first milking postpartum (90 ml from each individual quarter, composite 
sample). Following colostrum collection, the somatic cell count (SCC) was determined using a 
DeLaval cell counter (DeLaval, Tumba, Sweden). All colostral samples were processed within 
24 hours after collection and meanwhile stored on ice.  
 
Parity and body condition score (BCS) were recorded at the moment of parturition. 
Cows were divided in 3 classes based on their parity: (1) heifers (n = 28), (2) 2nd parity (n = 
39), (3) 3rd parity or older (n = 33). Body condition score was recorded by the same person 
immediately after parturition. Body condition score was expressed on a 5-point scale with 0.25 
increments as described by Edmonson et al. (1989). Cows were divided in 3 classes based on 
their BCS: (1) under-conditioned: <3, (2) normal condition: 3-3.5, (3) over-conditioned: >3.5. 
To determine NEFA and BHBA serum concentrations, all cows were blood sampled 
immediately postpartum. Animals were tethered in headlocks and were approached by the 
141 cows selected for the experiment 
41 cows lost 
due to culling (n = 6), abortion (n = 3), missed parturitions (n = 
22), leaking of colostrum prepartum (n = 3) and/or parturition 
before administration of booster vaccination (n = 7) 
100 cows sampled at calving 
60 samples for proliferation assay with ConA 
41 samples for proliferation assay with TT 
59 samples for flow cytometric analysis 
40 samples excluded for proliferation assay with ConA 
59 samples excluded for proliferation assay with TT 
41 samples excluded for flow cytometric analysis 
due to low harvest numbers because of low SCC or aggregated 
cell clumps in inflamed quarter 
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researcher as calmly as possible to avoid any stress. Immediately after parturition blood samples 
were taken from the coccygeal vein: (a) 2 tubes containing EDTA as an anticoagulant 
(Venosafe, Terumo Europe NV, Leuven, Belgium) to isolate PBMC as described below and (b) 
1 silicone coated tube (Venosafe, Terumo Europe NV, Leuven, Belgium) to quantify NEFA 
and BHBA. All samples except the EDTA tubes were centrifuged (2460 g, 20 min, 7°C) 
immediately after collection; serum was subsequently collected and frozen (-80°C) until further 
analysis. Concentrations of NEFA and BHBA were analyzed using an automated colorimetric 
analyzer (Konelab 20 XT Clinical Chemistry Analyzer, Thermo Scientific Inc., Waltham, MA) 
at the Animal Health Service Flanders (Drongen, Belgium).  
All herd visits were performed between July 2009 and May 2011. 
 
2.3 Isolation of PBMC 
 
The protocol was modified from a previously developed protocol (Goddeeris et al., 
1986). Fifteen ml of EDTA-blood was diluted into an equal volume of Alsever’s solution (AS;  
Sigma-Aldrich, Diegem, Belgium) and layered over 20 ml Lymfoprep (specific gravity 1.077, 
Axis-Shield, Oslo, Norway) in 50 ml conical tubes (BD Falcon, Becton Dickinson, Franklin 
Lakes, New Jersey) and centrifuged (30 min, 900 g, 18°C). Cells at the interface were aspirated, 
transferred to new 50 ml Falcon tubes and washed with ice-cold AS, containing 1% fetal bovine 
serum (AS-FBS; Greiner Bio One, Wemmel, Belgium; 10 min at 450 g followed by 10 min at 
300 g, 4°C). The resulting cell pellets were resuspended in 1 ml RPMI 1640 medium (Sigma-
Aldrich, Diegem, Belgium), containing 10% FBS, 2 mM L-glutamine (Gibco, Life 
Technologies, Carlsbad, CA), 50 µg/mL gentamicin (Sigma-Aldrich, Diegem, Belgium) and 5 
x 10-5 M 2-mercaptoethanol (Merck, Darmstadt, Germany; hereafter named ‘culture medium’). 
The isolated PBMC were counted in a Neubauer counting chamber using eosin-nigrosin. 
 
2.4 Isolation of CMC 
 
Isolation of CMC was performed as described in Meganck et al. (2014). Briefly, diluted 
colostrum samples were centrifuged (18°C), the cream layer removed and cell pellets washed 
twice. Cell pellets were then resuspended and over-layered onto 20 ml Ficoll-Paque premium 
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(GE Healthcare, Barrington, IL) followed by centrifugation (18°C). Cells at the interface were 
aspirated and washed twice (4°C). The resulting cell pellets were resuspended in 1 ml of culture 
medium. The isolated CMC were counted in a Neubauer counting chamber using eosin-
nigrosin. Due to a poor yield of CMC, data of only 60 animals could be used to perform the 
proliferation assay with concanavalin A (ConA), of 41 animals to perform the proliferation 
assay with tetanos toxoid (TT), and of 59 animals to perform the flow cytometric assay (Figure 
17). These relatively low yields were caused by low SCC or aggregated cell clumps in case of 
clinical mastitis.  
 
2.5 Leukocyte Phenotypic Analysis by Flow Cytometry 
 
The flow cytometric analysis was performed as described in Meganck et al. (2014). 
Monoclonal antibodies used were: mouse anti-bovine CD21 (MCA1424G, AbDSerotec, 
Puchheim, Germany) for B-lymphocytes; mouse anti-bovine CD2 (BAQ95A, VMRD, 
Pullman, WA), expressed on T-lymphocytes and NK-cells, and mouse anti-bovine CD14 
(MM61A, VMRD, Pullman, WA) for monocytes/macrophages. Alexa Fluor 647-conjugated 
donkey anti-mouse IgG (H+L; Invitrogen, Life Technologies, Carlsbad, CA) was used as 
secondary antibody. Propidium iodide (PI; Sigma-Aldrich, Diegem, Belgium) was used as a 
marker for dead cells. Ten thousand events per sample were acquired and relative numbers of 
cells positive for PI, CD2, CD21 and CD14 determined with FACSDiva Software (Becton 
Dickinson, Erembodegem, Belgium). Gating of the cells was performed, based on cell size 
(forward scatter), cellular granularity (side scatter), and fluorescence (FL-2 and FL-5 channels).  
 
2.6 Cellular Immune Response by 3H-thymidine Proliferation Assay 
 
Cells were cultured in plain medium as a negative control for background proliferation, 
in the presence of 5 µg/mL ConA (Sigma-Aldrich, Diegem, Belgium) as a positive control for 
mitogen-induced proliferation, or in the presence of various concentrations of purified TT 
(kindly provided by Merial Limited, Duluth, GA) for antigen-induced proliferation. The 
optimal stimulating concentration was used for further analysis (10 Lf/ml = 33.6 g/ml). All 
wells contained 2 x 105 cells in a final volume of 200 l and all added substances were 
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performed in triplicate. Cells were incubated for 3 (medium, ConA) or 5 days (TT) at 37°C in 
a humidified atmosphere, containing 5% CO2. Cells were pulse-labeled for 18 hours with 1 Ci 
of 3H-thymidine per well and harvested on glass fibre filters (Whatman, GE Healthcare, 
Barrington, IL), then radioactivity was measured using a Beckman -scintillation counter 
(Beckman, Suarlée, Belgium). Data were acquired as counts per minute (CPM). Mitogen-
induced proliferation in CMC is reported as CPM of CMC stimulated with ConA (CPMCMCConA) 
and antigen-induced proliferation in CMC is reported as CPM of CMC stimulated with TT 
(CPMCMCTT). 
 
 2.7 Statistical Analysis 
 
The distribution of all dependent variables was checked for normality and eventually 
data were transformed to approximate the Gaussian distribution. All CPM data and flow 
cytometric data for colostrum were therefore LOG-transformed before further analysis. 
Descriptive statistics were done using PROC MEANS and PROC FREQ of SASv9.4 (SAS 
Institute, Inc., Cary, NC). 
To determine the associations between parity, body condition of cows, NEFA and 
BHBA serum concentrations and CPMCMCConA, CPMCMCTT, percentage of CD2
+ CMC 
(CMCCD2), percentage of CD21
+ CMC (CMCCD21), and percentage of CD14
+ CMC (CMCCD14), 
respectively, linear regression models with parity, BCS, BHBA and NEFA concentrations 
measured immediately postpartum as independent variables of main interest were tested (PROC 
GLIMMIX, SASv9.4). Herd was tested as a random factor but the covariance parameter 
estimate was negligible and hence further inclusion of the variable herd was not needed. 
Initially, separate associations were tested between the outcome variables CPMCMCConA, 
CPMCMCTT, CMCCD2, CMCCD21 and CMCCD14 and all independent variables mentioned above. 
Statistical significance in these univariate univariable models was assessed at P < 0.20. 
Secondly, Pearson correlation coefficients were calculated among the significant independent 
variables using the CORR procedure in SASv9.4 to check for multi-collinearity. If two 
independent variables had a correlation coefficient > 0.6, only one was selected for further 
analysis. In the third step, a univariate multivariable or univariable model was fit. Statistical 
significance was assessed at P < 0.05. 
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To compare CPM of CMC and PBMC, and to identify differences between leukocyte 
phenotype of CMC and PBMC, separate one-way ANOVA tests were performed in SASv9.4 
for CD2+ and CD14+ cells and for TT-induced proliferation, and separate non-parametric 
ANOVA tests (Wilcoxon signed-rank test) were performed for the CD21+ cells and for the 
ConA-induced proliferation. Significance was assessed at P < 0.05. 
 
3. RESULTS 
 
3.1 Descriptive Statistics 
 
Descriptive statistics on SCC and isolation of PBMC and CMC can be found in Table 
11. Descriptive statistics for the leukocyte phenotypic analysis by flow cytometry and for the 
cellular immune response by 3H-thymidine proliferation assay can be found in Table 12.  
 
Table 11. Descriptive statistics on somatic cell count and isolation of peripheral blood mononuclear 
cells and colostrum mononuclear cells based on 100 cows. 
Variable Mean Median IQR1 
    
Isolated PBMC2 (cells/ml blood) 7.7 x 106 4.3 x 106 1.5 x 106 – 9.7 x 106 
Colostral SCC (cells/ml colostrum) 1.2 x 106 6.9 x 105 2.1 x 105 – 1.3 x 106 
Isolated CMC3 (cells/ml colostrum) 1.2 x 105 3.2 x 104 6.3 x 103 – 1.3 x 105 
 
1 IQR: interquartile range 
2 PBMC: peripheral blood mononuclear cells 
3 CMC: colostrum mononuclear cells 
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Table 12. Descriptive statistics for the phenotypic analysis by flow cytometry and for the cellular 
immune response by the 3H-thymidine proliferation assay. 
  Peripheral blood mononuclear cells  Colostral mononuclear cells 
PROTOCOL  n Mean  Median IQR1   n Mean  Median IQR 
Flow cytometry (%)      
     CD2+2   65 32a 33 26-41   49 16b 10 3-23 
     CD21+3   56 25a 26 20-28   41 2.0b 0.9 0.3-2.5 
     CD14+4   72 15a 14 9-20   59 28b 24 11-43 
     PI+5   74 2a 1 0-2   58 19b 18 12-24 
      
  n Mean Median IQR   n Mean Median IQR 
Proliferation  
(CPM6 x 103) 
     
    Medium   90 6a 1 0-3   60 15b 4 1-14 
 Concanavalin A  90 321a 346 176-425   60 86b 15 6-56 
Tetanos toxoid   51 15 1 
 
0-14   41 22 4 0-14 
1 IQR: interquartile range 
2 CD2+: cluster of differentiation 2, recognizes T-lymphocytes 
3 CD21+: cluster of differentiation 21, recognizes B-lymphocytes 
4 CD14+: cluster of differentiation 14, recognizes macrophages/monocytes 
5 PI: propidium iodide, recognizes dead cells 
6 CPM: counts per minute 
a-b Values within a row with different superscript letters are significantly different (P < 0.01) 
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3.2 Leukocyte Phenotypic Analysis by Flow Cytometry 
 
Only BHBA was significantly associated with the percentage of CD2+ CMC. The higher 
the BHBA serum concentration, the higher (P = 0.049) the percentage of CD2+ CMC (Table 
13). 
 
Table 13. Final univariate univariable model for the log-transformed percentage of colostral CD2+ 
leukocytes using data of 48 animals.  
Predictor Estimate (log[%]) n SE P-value 
Intercept 0.89 48 0.59 0.137 
     
BHBA 1.57 48 0.78 0.049 
 
 
Only BCS was significantly associated with the percentage of CD21+ CMC. Over-
conditioned cows (BCS > 3.5) had a significantly (P = 0.006) higher percentage of CD21+ CMC 
than normal-conditioned cows: 4.04 vs. 1.37% respectively (BCS 3-3.5; Table 14). 
A first reduction based on the univariable associations revealed all 4 variables (parity, 
BCS, NEFA, and BHBA) to be associated with CMCCD14. None of the parameters were 
correlated with each other (r between -0.06 and 0.13, P > 0.218). In the final multivariable 
model, under-conditioned cows (BCS < 3) had a significantly (P = 0.008) higher percentage of 
CD14+ CMC than normal conditioned animals (BCS 3-3.5): 40.25% vs. 25.88% respectively 
(Table 15, Figure 18). Also, the higher the BHBA serum concentration, the higher the 
percentage of CD14+ CMC (P = 0.023; Table 15). 
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Table 14. Final univariate univariable model for the log-transformed percentage of colostral CD21+ 
leukocytes using data of 35 animals.  
Predictor Estimate (log[%]) n SE P-value 
Intercept -0.08 48 0.23 0.726 
     
BCS1     
     < 3 0.19 6 0.49 0.695 
     3-3.5 Reference 21   
     > 3.5 1.30 8 0.44 0.006 
 
1: BCS: body condition score measured at the day of parturition 
 
Table 15. Final univariate multivariable model for the log-transformed percentage of colostral 
macrophages (CMCCD14) using data of 57 animals.  
Predictor Estimate (log[%]) n SE P-value 
Intercept 2.21 57 0.31 < 0.001 
     
BHBA1 0.96 57 0.41 0.023 
     
BCS2    0.028 
     < 3 0.85 8 0.31 0.008 
     3-3.5 Reference 39   
     > 3.5 0.22 10 0.28 0.439 
 
1: BHBA: serum beta-OH-butyric acid concentration measured on the day of parturition 
2: BCS: body condition score measured on the day of parturition 
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Figure 18. Under-conditioned cows (body condition score (BCS) < 3) had significantly more colostral 
macrophages than normal conditioned cows (BCS 3-3.5; P = 0.008). Results are represented as the raw 
logarithmic unmodelled data with the full black line denoting the median value. 
 
On average, lymphocyte percentages were lower (P < 0.001) in colostrum compared to 
blood, whereas the opposite was found for macrophages/monocytes (Table 12). 
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3.3 Cellular Immune Response by 3H-thymidine Proliferation Assay 
 
A first reduction based on the univariable associations and highly correlated variables 
revealed only 1 variable (parity) to be associated with CPMCMCConA. Heifers had significantly 
higher CMC mitogen-induced proliferation than 2nd (P = 0.049), respectively 3rd parity or older 
cows (P = 0.006): 1.9 x 105 CPM vs. 7.4 x 104 CPM vs.1.3 x 104 CPM (Figure 19, Table 16).  
 
 
 
Figure 19. Heifers had significantly higher mitogen-induced proliferation of colostral mononuclear 
cells (CPMCMCConA) than 2
nd (P = 0.049), respectively 3rd parity or older cows (P = 0.006). Results are 
represented as the raw logarithmic unmodelled data with the full black line denoting the median value. 
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Table 16. Final univariate univariable model for the log-transformed counts per minute of colostral 
mononuclear cells stimulated with the mitogen Concanavalin A (data of 60 animals) or tetanos toxoid 
(data of 41 animals).  
  Concanavalin A Tetanos toxoid 
Predictor 
 Estimate 
(log[CPM1]) 
n  SE P-value  Estimate 
(log[CPM1]) 
n  SE P-value 
Intercept  10.89  0.47 < 0.001  9.10 41 0.62 < 0.001 
           
Parity     0.019     0.104 
    Heifer  Reference 16    Reference 14   
    2nd parity  -1.25 27 0.59 0.049  -1.35 17 0.83 0.113 
   > 3rd parity  -1.97 17 0.67 0.006  -1.98 10 0.96 0.045 
     
 1CPM: counts per minute 
 
A first reduction based on the univariable associations revealed only 1 variable (parity) 
to be associated with CPMCMCTT. Heifers had significantly (P = 0.045) higher CMC antigen-
induced proliferation than 3rd parity or older cows: 4.4 x 104 vs. 1.3 x 104 CPM (Figure 20, 
Table 16).   
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Figure 20. Heifers had significantly higher tetanos toxoid-induced proliferation of colostral 
mononuclear cells (CPMCMCTT) than 3
rd parity or older cows (P = 0.045). Results are represented as the 
raw logarithmic unmodelled data with the red line denoting the median value. 
 
The mean background proliferation in PBMC was lower (P < 0.001) than that in CMC 
(Table 12). The mean PBMC mitogen-induced proliferation was higher (P < 0.001) than that 
of the CMC (Table 12). The mean antigen-induced proliferation for the PBMC was practically 
equal (P = 0.382) to that of the CMC (Table 12). 
 
4. DISCUSSION 
 
The main objective of the present study was to measure the effect of parity, body 
condition score, serum NEFA, and serum BHBA concentrations on the phenotypic distribution 
and mitogen- and antigen-induced proliferative capacity of bovine colostral leukocytes.  
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Over-conditioned cows have large amounts of adipose tissue and in times of energy 
deficiency this over-condition is linked with adverse health effects (Goff, 2006). Blood 
mononuclear leukocytes isolated from over-conditioned cows secreted less IFN- than those of 
under-conditioned and normal-conditioned cows 1 week before the expected parturition date. 
In the present study, body condition score of periparturient cows had a significant effect on the 
number of B-lymphocytes and macrophages resident in colostrum. The proposed causal 
relationship of Collard et al. (2000) that under-conditioned cows or cows in severe negative 
energy balance may be more susceptible to infection match our findings.  
High yielding dairy cows are known to have an impaired immunity in early lactation 
compared to the mid to late lactation period and are therefore more susceptible to all kinds of 
infections during the periparturient period (Ishikawa, 1987; Kehrli et al., 1989a-b). This 
impaired immunity explains the relatively low CMC mitogen- and antigen-induced 
proliferation found in the present and other studies (Concha et al., 1980; Archambault et al., 
1988a; Kehrli et al., 1989a). In man, increased plasma NEFA and oxidative stress are well 
known factors effecting systemic inflammation (Calder, 2008; Wood et al., 2009). Although 
neutrophils isolated from cows with high BHBA levels had a decreased respiratory burst 
activity (Opsomer et al., 1998; Hoeben et al., 2000; Lacetera et al., 2005), the present study 
could not show a significant effect of BHBA nor NEFA on mitogen- and antigen-induced 
proliferation in CMC. The latter might be (partly) explained by the fact that the number of 
animals with high values and thus expected to suffer from negative energy balance was almost 
negligible. On the other hand, serum BHBA was positively associated with colostral T-
lymphocytes and macrophages. The latter results comply to the theory of the impaired immunity 
of cows caused by ketosis. 
 
Parity was shown to have a significant effect on the mitogen- and antigen-induced 
proliferation of CMC. Older cows had lower mitogen- and antigen-induced CPM values than 
heifers. Studies investigating the effect of aging on immune function in humans have indicated 
a diminished role of type 1 cytokines, such as IFN- and IL-2, which promote cell-mediated 
immunity (Alberti et al., 2006). This is in line with the results of the current study. Ohtstuka et 
al. (2010) found 2 contradictory phenomena: activation of colostral lymphocytes versus 
suppression of the systemic type 1 reaction in cows with higher parity compared with heifers at 
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calving. Cows in the 4th or greater lactation suffered more profound periparturient impairment 
of neutrophil function than younger cows (Gilbert et al., 1993), again confirming the present 
results.  
 
In the present study, the mean percentages of CD2+ and CD14+ CMC were comparable 
or lower than percentages found in previous studies (Park et al., 1992; Yang et al., 1997; Kiku 
et al., 2010). The mean percentage of CD21+ CMC was much lower than the percentages of 
CD21+ cells found in bovine colostrum in other studies (Park et al., 1992; Kiku et al., 2010). 
Our results concerning B-lymphocytes however agree with others (Taylor et al., 1994; Harp et 
al., 2004) in that T-lymphocytes traffic selectively into bovine mammary gland secretions 
whereas B-lymphocytes represent a minor population as compared to peripheral blood. In 
general, the composition of the lymphoid compartment in the lactating mammary gland differs 
from that in peripheral blood, as demonstrated in the present and other studies (Park et al., 1992; 
Wirt et al., 1992; Van Kampen et al., 1999). The percentages of the different CMC 
subpopulations depend furthermore on differences in the techniques used to identify them 
(Prescott and Breed, 1910; Concha et al., 1980; Nonnecke and Kehrli, 1985), the gating strategy 
in flow cytometer experiments (Ohtsuka et al., 2010), the definition of colostrum (Archambault 
et al., 1988a), and the health status of the udder (Kiku et al., 2010).  
 
Cell mediated immunity was tested in vitro through mitogen- and antigen-induced 
proliferation of lymphocytes. Several research groups reported CMC to respond to mitogens 
and specific antigens (Archambault et al., 1988a-b). Background CPM are generally higher in 
mammary gland leukocytes than in PBMC (Parmely et al., 1976; Concha et al., 1980; Nonnecke 
and Kehrli, 1985), as demonstrated in the current study. Specifically for CMC, this higher 
background CPM might be explained by the activating effects of colostrum on leukocytes 
(Sugisawa et al., 2001; Reber et al., 2006). Overall, mammary gland leukocytes, both in cattle 
and in man, seem not to react as strong as PBMC when confronted in vitro with mitogens and 
certain antigens (Parmely et al., 1976; Nonnecke and Harp, 1985; Park et al., 1993), as 
demonstrated in the present study for the mitogen ConA, but not for the antigen TT. However, 
antigen-induced proliferation strongly depends on the antigen used (Smith and Goldman, 1968; 
Parmely et al., 1977; Archambault et al., 1988b). Various reasons can be proposed for the lower 
proliferation of mammary gland leukocytes vs. PBMC: fewer CD4+ cells producing growth 
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promoting cytokines (Shafer-Weaver et al., 1996), a higher percentage of CD8+ lymphocytes 
that have a suppressive effect (Park et al., 1993; Shafer-Weaver et al., 1996; Asai et al., 2000), 
changes in other cell types such as macrophages (Goddeeris et al., 1986; Nickerson, 1989) 
and/or memory cell phenotype (Bertotto et al., 1990; Taylor et al., 1994). Indeed, there is a need 
to test various antigens, to study the possibility of vaccinating dams to protect the newborn via 
adoptive cellular immunity. 
 
5. CONCLUSIONS 
 
Increasing evidence demonstrates the relevance of viable leukocytes in bovine 
colostrum. Most studies focus on colostral leukocytes in terms of mastitis; however, the 
possible important role of colostral leukocytes as part of the adoptive immunity transfer to 
newborn calves should not be overlooked. Body condition score of periparturient cows had a 
significant effect on the percentage of macrophages and B-lymphocytes resident in colostrum. 
Higher serum BHBA concentrations were significantly associated with a higher percentage of 
colostral T-lymphocytes and macrophages. Heifers furthermore had a significantly higher 
mitogen- and antigen- induced proliferation of colostral lymphocytes in comparison to higher 
parity cows. Further studies are warranted to deepen the knowledge concerning colostral 
leukocytes and to research possible adverse effects of the negative energy balance in 
periparturient dairy cows on the adoptive immunity transfer to their neonatal calves. 
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ABSTRACT 
 
Whether colostral leukocytes (CL) of vaccinated dams influence the immune response 
of neonatal calves following vaccination against the same antigen as their respective dams 
remains unanswered. Therefore, we compared the induction of humoral as well as cellular 
immune responses after vaccination between calves which had received CL-free or maternal 
CL-enriched colostrum from a cell-free colostrum bank of non-vaccinated cows. Also, 
vaccinated calves which had received their own vaccinated dam fresh maternal colostrum were 
included in the study. Moreover, we analysed whether the post partum time of primo-
vaccination (days 2, 5 or 10) of the calves could influence the outcome of the immune 
responses. All calves received a booster vaccination 23 days after the primo-vaccination. 
All calves showed only an increase in TT-specific antibodies and TT-induced 
proliferation after booster vaccination. Tetanus toxoid-specific antibody responses in calves 
increased immediately after booster vaccination, irrespective whether or not their cell-free bank 
colostrum had been enriched with their own dam CL. Conversely, calves receiving their own 
plain dam colostrum displayed a later response. After booster vaccination, calves of the CL-
enriched colostrum group had a more pronounced antigen-specific proliferative response but a 
less pronounced antigen-specific humoral response than the calves of the CL-free colostrum 
group. The present study suggests a negative influence of CL on the development of the TT-
specific antibodies but a positive influence on the TT-specific lymphocyte proliferation of 
newborn calves upon TT vaccination. 
 
KEYWORDS: dairy calves, colostrum, leukocytes, passive immunity  
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1. INTRODUCTION 
 
The bovine synepitheliochorial placenta prevents the transfer of both antibodies and 
leukocytes from the cow to the calf during pregnancy. Consequently, neonatal calves rely on 
the ingestion of colostrum to be protected against infectious diseases. The importance of 
colostrum as a source of protective antibodies has been recognized for long time. Still, there is 
increasing evidence that colostrum also contributes to the cellular arm of the neonatal immune 
system by providing maternal colostral leukocytes (CL; Zhou et al., 2000; Liebler-Tenorio et 
al., 2002; Donovan et al., 2007). Leukocytes found in bovine colostrum consist of macrophages, 
lymphocytes and polymorphonuclear leukocytes in concentrations ranging from 23.2 to 50.0 
%, 25.0 to 67.8 % and 9.0 to 25.0 %, respectively (Concha, 1986; Duhamel et al., 1987; 
Meganck et al., 2014). Maternal CL enhance the development of neonatal antigen-presenting 
capacity and the responses of neonatal calves to Escherichia coli (Reber et al., 2005; Riedel-
Caspari and Schmidt, 1991). Interestingly, lambs that had received CL from dams vaccinated 
with a tetanus toxoid (TT) vaccine reacted with a faster and higher production of antibodies 
after vaccination with the same TT-vaccine in comparison to lambs that had not received CL 
(Tuboly et al., 1995). Also, calves that had received whole colostrum from dams vaccinated 
against bovine viral diarrhea virus (BVDV) had enhanced in vitro proliferative responses to 
BVDV antigen as compared to calves that had received frozen or cell-free colostrum (Donovan 
et al., 2007). To our knowledge, it has not been studied whether CL of vaccinated dams 
influence the immune responses of neonatal calves following vaccination against the same 
antigen as their respective dams. Therefore, in the present study we evaluated the difference in 
induction of humoral as well as cellular immune responses to vaccination with TT between 
neonatal calves that had received colostrum from a cell-free colostrum bank of unvaccinated 
dams, enriched with or free from CL of their own dams vaccinated with TT. Calves receiving 
fresh full maternal colostrum from their vaccinated own dams were also included in the study 
in order to investigate the influence of TT-specific antibodies on the resulting immune response 
of the calves upon vaccination with TT: maternal antibodies impair the ability of the newborn 
calf to mount its own antibody response (Morein et al., 2002; Chase et al., 2008), as maternal 
antibodies can block the recognition of antigen by B-lymphocytes, and consequently block their 
production of antibodies.  
Humoral immune responses were determined by quantifying the specific TT-antibodies 
in a TT-specific ELISA. The cellular immune response was determined using a 3H-thymidin 
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TT-specific proliferation assay. Moreover, we analysed whether the time of primo-vaccination 
after birth had an influence on the outcome of the humoral and cellular immune responses. 
Calves were primo-vaccinated 2, 5, or 10 days after birth as CL have been shown to exert their 
effects shortly after colostrum uptake (Donovan et al., 2007). 
 
2. MATERIALS AND METHODS 
 
2.1 Animals  
 
This randomized controlled trial was approved by the Ethical Committee of the Faculty 
of Veterinary Medicine, Ghent University, Belgium (EC2011/146). Twenty-seven Holstein 
Friesian pregnant cows were selected from 2 commercial dairy herds in Flanders (Belgium). 
Each dam was intramuscularly vaccinated 60 and 30 days before the expected calving date with 
2 ml of a TT vaccine (Tetapur®, Merial Limited, Duluth, GA). All calves tested negative in a 
BVDV antigen ELISA test on blood collected before ingestion of colostrum and appeared in 
good health: APGAR index > 11 (scoring of appearance, pulse, grimace, activity and respiration; 
Probo et al., 2012).  
 
2.2 Colostrum cell-free bank preparation from unvaccinated cows 
 
A cell-free colostrum bank was assembled from 57 TT-unvaccinated cows of 7 
commercial dairy herds in Flanders (Belgium). Immediately after collection, colostrum was 
filtered over a gauze-pad and centrifuged (10,000 g, 60 min, 18°C). The cell-free supernatant 
was collected and stored at -20°C until use for the experimental calves. Colostrum batches did 
not exceed 40,000 colony forming units per ml and contained at least 50 g IgG/l as determined 
by a commercial radial immunodiffusion kit (Bovine IgG Test Kit, Triple J Farms, Bellingham, 
WA).  
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2.3 Isolation of colostral leukocytes for supplementation 
 
To supplement the colostrum of the cell-free colostrum bank with CL of the vaccinated 
calf own dams, 4 l of fresh colostrum of each individual calf’s own dam was filtered over a 
gauze-pad, diluted 1:2 in phosphate buffered saline (PBS; Sigma-Aldrich, Diegem, Belgium) 
and centrifuged at 5,000 g for 30 min at 18°C. Fat and supernatant were discarded and the 
resulting cell pellet was resuspended in PBS. Cells were counted with a DeLaval cell counter 
(DCC®, DeLaval, Tumba, Sweden) and 5 x 108 CL were added to 4 l of thawed colostrum of 
the colostrum cell-free bank. 
 
2.4 Experimental design 
 
Calves (n = 27) were randomly divided in 3 experimental groups: 11 calves were given 
unsupplemented colostrum from the cell-free colostrum bank of unvaccinated cows (COLnocells), 
12 calves were given colostrum from the same cell-free colostrum bank to which CL of their 
respective TT-vaccinated dams had been added (COLcells), and 4 calves received fresh 
colostrum from their respective TT-vaccinated dams (COLfresh). In other words, COLnocells 
calves received no TT-specific antibodies and no TT-specific leukocytes; COLcells calves 
received TT-specific leukocytes but no TT-specific antibodies; and COLfresh calves received 
both TT-specific leukocytes and TT-specific antibodies. Colostrum (4 l) was heated in a bain-
marie to 42°C and given manually to all calves within the first 12 hours after birth using a 
sanitized plastic nipple bottle. The COLcells and COLnocells calves were primo-vaccinated at 
either 2 (COLcells2, n = 4 and COLnocells2 , n = 4), 5 (COLcells5, n = 4 and COLnocells5, n = 3) or 10 
(COLcells10, n = 4 and COLnocells10, n = 4) days of age. The COLfresh10 calves (n = 4) were only 
primo-vaccinated at 10 days of age. Serum IgG concentrations at 48 hours of age averaged 36 
g/l with a minimum of 19 g/l and a maximum of 51 g/l.  
All calves were intramuscularly vaccinated with the same vaccine used for maternal 
vaccination (2 ml Tetapur®) and received a booster vaccination 23 days after their first 
vaccination.  
Calves were blood sampled from the jugular vein immediately at birth, 1 and 2 days of 
age, the day of primo-vaccination and 3, 7, 10, 15 and 21 days after primo-vaccination, and 7, 
14 and 21 days after booster vaccination. At each time point, blood was collected in 2 tubes 
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containing EDTA as anticoagulant (Venosafe®, Terumo Europe NV, Leuven, Belgium) and 1 
silicone coated tube (Venosafe®) to isolate peripheral blood mononuclear cells (PBMC) and 
determine the specific anti-TT titer, respectively. 
 
2.5 Isolation of Peripheral Blood Mononuclear Cells 
 
Peripheral blood mononuclear cells were isolated as described before with some 
modifications (Goddeeris et al., 1986). Fifteen ml EDTA-blood was diluted into an equal 
volume of Alsever’s solution (AS; Sigma-Aldrich) and layered over 20 ml Lymfoprep® 
(specific gravity 1.077, Axis-Shield, Oslo, Norway) in 50 ml conical tubes (BD Falcon, Becton 
Dickinson, Franklin Lakes, New Jersey, USA) and centrifuged (30 min, 900 g, 18°C). Cells at 
the interface were aspirated, transferred to new 50 ml Falcon tubes and washed twice (10 min 
at 450 g followed by 10 min at 300 g, 4°C) with ice-cold AS containing 1% FBS (Greiner Bio 
One, Wemmel, Belgium). The resulting cell pellets were resuspended in 1 ml RPMI 1640 
medium (Sigma-Aldrich), containing 10% FBS, 2 mM L-glutamine (Gibco, Life Technologies, 
Carlsbad, CA, USA), 50 µg/ml gentamycin (Sigma-Aldrich) and 5 x 10-5 M 2-mercaptoethanol 
(Merck, Darmstadt, Germany) (hereafter named ‘plain medium’). The isolated PBMC were 
counted in a Neubauer counting chamber using eosin-nigrosin. 
 
2.6 Proliferation Assay 
 
Isolated PBMC were cultured in plain medium as a negative control for background 
proliferation, in the presence of 5 µg/ml concanavalin A (ConA; Sigma-Aldrich) as a positive 
control for proliferative capacity or in the presence of 10 flocculation units/ml (= 33.6 g/ml) 
of purified TT (kindly provided by Merial Limited, Duluth, GA). All wells contained 2 x 105 
cells in a final volume of 200 l and all proliferation assays were performed in  triplicate. Cells 
were incubated for 3 (plain medium, ConA) or 5 days (TT) at 37°C in a humidified atmosphere, 
containing 5% CO2. Cells were pulse-labeled for 18 hours with 1 Ci of 3H-thymidine per well 
and harvested on glass fibre filters (Whatman, GE Healthcare), to measure radioactivity as 
counts per minute (CPM) in a Beckman -scintillation counter (Beckman, Suarlée, Belgium). 
Tetanus toxin-induced proliferation is expressed as CPM of cells stimulated with TT subtracted 
with CPM of cells cultured in plain medium.  
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2.7 Analysis of TT-specific Antibodies 
 
Analysis of the TT-specific antibodies was performed using an ELISA. The wells of a 
96-well Nunc-ImmunoPolysorp plate (Life Technologies, Carlsbad, CA) were coated with TT 
at 5 g/ml in carbonate/bicarbonate buffer (pH 9.7). After overnight incubation at 7°C, the 
remaining binding sites were blocked for 1 hour with PBS containing 0.2% Tween 80 (Sigma-
Aldrich) at 37°C. Serum samples diluted 1:20 in PBS containing 3% bovine serum albumin 
(Sigma-Aldrich) and 0.2% Tween 20 (Sigma-Aldrich) were added to the plates. Plates were 
incubated for 1 hour at 37°C. Thereafter, plates were incubated for 1 hour at 37°C with anti-
bovine IgG-peroxidase conjugates (bovine IgG-heavy and light chain, Bethyl Laboratories, 
Montgomery, TX). The substrate 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) 
(ABTS, Roche, Mannheim, Germany) was added and the optical density (OD) was 
spectrophotometrically measured at 405 nm after incubation for 30 min at 37°C. Between each 
incubation step, plates were washed 3 times with PBS containing 0.2% Tween 20. The OD of 
sera collected from the calves prior to colostrum intake were used as a negative control.  
 
2.8 Statistical Analyses 
 
To determine the effect of the colostrum group on antibody responses and TT-induced 
proliferation, respectively, linear mixed regression models were fit with OD-values and TT-
induced CPM of PBMC of calves primo-vaccinated at 10 days of age as dependent variables, 
respectively, and colostrum group (COLcells10, COLnocells10 and COLfresh10; predictor of main 
interest), days relative to primo-vaccination (-10, -9, -8, 0, 3, 7, 10, 15, 21, 30, 37, and 44 days 
after the primo-vaccination), and the interaction between colostrum group and days relative to 
vaccination as categorical independent variables (PROC MIXED, SASv9.4).  
Again, to determine the effect of the addition of CL on antibody responses and TT-
induced proliferation, 3 separate linear mixed regression models were fit with OD-values and 
TT-induced CPM of PBMC of COLcells and COLnocells calves vaccinated at 2 days, 5 days and 
10 days as dependent variables, respectively, and days post vaccination (0, 3, 7, 10, 15, 21, 30, 
37, and 44 days after the primo-vaccination), colostrum group (COLnocells and COLcells) and the 
2-way interaction term between days post vaccination and colostrum group, as categorical 
independent variables (PROC MIXED, SASv9.4).  
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In all models, a first-order autoregressive correlation structure was used to account for 
clustering of repeated observations within calves. The goodness-of-fit measures included -2 x 
log-likelihood, Akaike Information Criterion, and the Bayesian Information Criterion. 
Statistical significance was assessed at P < 0.05. 
 
3. RESULTS 
 
3.1 TT-specific induced antibody responses of calves 
 
To analyze the effect of the presence/absence of TT-primed CL on antibody titers in the 
neonatal calf, the antibody responses of COLfresh10, COLcells10 and COLnocells10 calves were 
compared (Figure 21, Table 17). Before booster vaccination, the COLfresh10 calves, which 
received colostrum from their TT-vaccinated dams, had significantly higher TT-specific serum 
antibody titers than the COLcells10 and COLnocells10 calves which received colostrum from the 
bank of unvaccinated cows (P < 0.05; Figure 21). These higher antibody titers in the COLfresh10 
calves are obviously due to the colostral transfer of TT-specific antibodies from their respective 
vaccinated dams. Conversely, after booster vaccination, COLnocells10 and COLcells10 calves 
developed higher TT-specific antibody titers than COLfresh10 calves throughout the remainder 
of the study period, indicating the blocking effect of TT-antibodies in the fresh colostrum of 
the vaccinated dams on humoral immune responses of the neonatal calf (Figure 21).  
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Figure 21. Antibody responses in calves fed with cell-free (COLnocells10, n = 4) or maternal cell-
enriched (COLcells10, n = 4) frozen non-maternal colostrum differ significantly from titers in calves fed 
fresh maternal colostrum (COLfresh10, n = 4). Calves were primo-vaccinated at 10 days of age and were 
booster vaccinated at 33 days of age (arrows). Blood samples were taken prior to colostrum feeding 
through 21 days after booster vaccination. Data represent mean optical density (OD) values indicating 
TT-specific IgG. Within a time point, values with different letters differed significantly (P-values were 
not adjusted for multiple comparisons). 
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Table 17. Linear mixed regression model for antibody responses in calves primo-vaccinated at 10 
days of age and fed with cell-free frozen non-maternal colostrum (COLnocells10), maternal cell-
enriched frozen non-maternal colostrum (COLcells10) or fresh maternal colostrum (COLfresh10). 
Independent variable N
1 ß SE LSM P-value2 
      
Intercept 12 10.00 0.55  < 0.001 
      
Colostrum group     0.02 
      COLnocells10 4 Ref. … 10.96 … 
      COLcells10 4 -0.11 0.78 11.03 0.82 
      COLfresh10 4 1.47 0.78 11.83 0.01 
      
Days relative to primo-vaccination     < 0.001 
      -10 days 12 -0.33 0.75 9.76 0.11 
      -9 days 12 0.00 0.71 11.05 0.15 
      -8 days 12 0.25 0.60 10.88 0.22 
      0 days 12 Ref. … 10.45 … 
      + 3 days 12 0.00 0.60 10.84 0.28 
      + 7 days 12 -0.33 0.71 10.54 0.83 
      + 10 days 12 0.23 0.75 10.82 0.40 
      + 15 days 12 0.12 0.77 10.53 0.87 
      + 21 days 12 0.55 0.77 10.83 0.40 
      + 30 days 12 3.67 0.78 12.99 < 0.001 
      + 37 days 12 4.20 0.78 13.55 < 0.001 
      + 44 days 12 3.07 0.78 13.03 < 0.001 
      
Colostrum group x days relative to primo-vaccination 12 … … … < 0.001 
      
 
1Number of calves 
2P-value for overall effect 
 
To analyze the effect of the presence/absence of TT-primed CL (depending on the time 
of vaccination after birth) on antibody titers in the neonatal calf, the antibody responses of 
COLnocells and COLcells calves primo-vaccinated at 2, 5, or 10 days after birth were compared 
(Figures 22a-c; Tables 18-20). Immediately after booster vaccination, the TT-specific 
antibody titers increased in all calves except for COLcells5 calves. In calves vaccinated at 2 days 
after birth, COLnocells calves had higher antibody titers than COLcells calves after booster 
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vaccination, with a significant difference on 7 days post booster vaccination (P = 0.034; Figure 
22a). In calves vaccinated at 5 days after birth, COLnocells calves had significantly higher 
antibody titers than COLcells calves after booster vaccination (P < 0.007; Figure 22b). In calves 
vaccinated at 10 days after birth, there were no significant differences between COLnocells and 
COLcells calves (Figure 22c). All these data indicate that CL do not play a major role in the 
development of the humoral immune response in newborn calves. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22a. Antibody responses in calves fed with frozen cell-free non-maternal colostrum (COLnocells2, 
n = 4) were higher than titers in calves fed maternal cell-enriched frozen non-maternal colostrum 
(COLcells2, n = 4) after booster vaccination. Calves were primo-vaccinated at 2 days of age and were 
booster vaccinated at 25 days of age (arrows). Blood samples were taken at the day of vaccination 
through 21 days after booster vaccination. Data represent mean optical density (OD) values indicating 
TT-specific IgG. Within a time point, values with different letters differed significantly (P-values were 
not adjusted for multiple comparisons). 
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Figure 22b. Antibody responses in calves fed with frozen cell-free non-maternal colostrum (COLnocells5, 
n = 3) were significantly higher than titers in calves fed maternal cell-enriched frozen non-maternal 
colostrum (COLcells5, n = 4) after booster vaccination. Calves were primo-vaccinated at 5 days of age 
and were booster vaccinated at 28 days of age. Blood samples were taken at the day of vaccination 
through 21 days after booster vaccination (arrows). Data represent mean optical density (OD) values 
indicating TT-specific IgG. Within a time point, values with different letters differed significantly (P-
values were not adjusted for multiple comparisons). 
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Figure 22c. Antibody responses in calves fed with cell-free (COLnocells10, n = 4) or maternal cell-
enriched (COLcells10, n = 4) frozen non-maternal colostrum did not differ significantly. Calves were 
primo-vaccinated at 10 days of age and were booster vaccinated at 33 days of age (arrows). Blood 
samples were taken at the day of vaccination through 21 days after booster vaccination. Data represent 
mean optical density (OD) values indicating TT-specific IgG. Differences were never significant. 
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Table 18. Linear mixed regression model for antibody responses in calves primo-vaccinated at 2 days 
of age and fed with cell-free frozen non-maternal colostrum (COLnocells2) or maternal cell-enriched 
frozen non-maternal colostrum (COLcells2). 
Independent variable N
1 ß SE LSM P-value2 
      
Intercept 8 10.66 0.73 … < 0,001 
      
Colostrum group     0,50 
      COLnocells2 4 Ref.  … 11.27 … 
      COLcells2 4 -1.62 1.03 10.95 0,50 
      
Days post vaccination     < 0,001 
      0 days 8 Ref.  … 9.85 … 
      + 3 days 8 -1,94 0,84 8.86 0,10 
      + 7 days 8 -1.72 0,97 9.01 0,23 
      + 10 days 8 -1.58 1,01 9.33 0,47 
      + 15 days 8 -0.96 1,02 10.05 0,78 
      + 21 days 8 0.35 1,02 10.58 0,32 
      + 30 days 8 4.54 1,03 14.07 < 0,001 
      + 37 days 8 3.72 1,03 14.43 < 0,001 
      + 44 days 8 3.09 1,03 13.80 < 0,001 
      
Colostrum group x days post vaccination 8 … … … 0,35 
      
 
1Number of calves           
2P-value for overall effect      
 
 
 
 
 
 
 
Chapter 4.3 Colostral leukocytes and development of immunity 
126 
 
Table 19. Linear mixed regression model for antibody responses in calves primo-vaccinated at 5 days 
of age and fed with cell-free frozen non-maternal colostrum (COLnocells5) or maternal cell-enriched 
frozen non-maternal colostrum (COLcells5). 
Independent variable N
1 ß SE LSM P-value2 
      
Intercept 7 10,65 0,59 … < 0,001 
      
Colostrum group     0,004 
      COLnocells 3 Ref.  … 11,06 … 
      COLcells 4 -0,22 0,78 12,21 0,004 
      
Days post vaccination     < 0,001 
      0 days 7 Ref.  … 10,44 … 
      + 3 days 7 0,09 0,74 11,07 0,85 
      + 7 days 7 1,53 0,81 10,69 0,33 
      + 10 days 7 -0,30 0,83 10,44 0,79 
      + 15 days 7 -0,11 0,83 10,54 0,85 
      + 21 days 7 -0,50 0,83 13,24 0,99 
      + 30 days 7 3,83 0,92 13,81 < 0,001 
      + 37 days 7 4,74 0,83 13,94 < 0,001 
      + 44 days 7 4,72 0,83 10,54 < 0,001 
      
Colostrum group x days post vaccination 7 … … … 0,004 
            
 
1Number of calves 
2P-value for overall effect 
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Table 20. Linear mixed regression model for antibody responses in calves primo-vaccinated at 10 
days of age and fed with cell-free frozen non-maternal colostrum (COLnocells10) or maternal cell-
enriched frozen non-maternal colostrum (COLcells10). 
Independent variable N
1 ß SE LSM P-value2 
      
Intercept 8 10,00 0,60 … < 0,001 
      
Colostrum group     0,69 
      COLnocells10 4 Ref.  … 11,38 … 
      COLcells10 4 -0,11 0,72 11,28 0,69 
      
Days post vaccination     < 0,001 
      0 days 8 Ref.  … 9,90 … 
      + 3 days 8 0,01 0,70 9,91 0,93 
      + 7 days 8 -0,33 0,72 10,28 0,95 
      + 10 days 8 0,23 0,72 10,27 0,51 
      + 15 days 8 0,12 0,72 10,37 0,53 
      + 21 days 8 0,55 0,72 13,60 0,41 
      + 30 days 8 3,67 0,72 14,08 < 0,001 
      + 37 days 8 4,20 0,72 13,64 < 0,001 
      + 44 days 8 3,07 0,72 9,95 < 0,001 
      
Colostrum group x days post vaccination 8 … … … 0,89 
            
 
1Number of calves 
2P-value for overall effect 
3.2 TT-induced proliferative responses of calves 
 
Comparing the calves that had received colostrum from the cell-free bank of 
unvaccinated dams (COLcells and COLnocells calves) with the calves receiving colostrum from 
their vaccinated dams (COLfresh calves) gave interesting results (Figure 23; Table 21). For all 
calves, the TT-induced proliferation before booster vaccination was absent with a slight 
increase just before booster vaccination. Surprisingly, this increase was more pronounced in 
COLcells10 and COLnocells10 calves than in COLfresh10 calves. Consequently, these data suggest a 
blocking effect of TT-specific antibodies in the fresh colostrum of the vaccinated dams on T-
lymphocyte responses. 
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Figure 23. Proliferation responses in calves fed with maternal cell-enriched frozen non-maternal 
colostrum (COLcells10, n = 4) were higher than responses in calves fed fresh maternal colostrum 
(COLfresh10, n = 4) or cell-free frozen non-maternal colostrum (COLnocells10, n = 4) after booster 
vaccination. Calves were primo-vaccinated at 10 days of age and were booster vaccinated at 33 days 
of age (arrows). Blood samples were taken prior to colostrum feeding through 21 days after booster 
vaccination. Data represent mean counts per minute (CPM) indicating TT-induced proliferation of 
blood mononuclear leukocytes. Within a time point, values with different letters differed significantly 
(P-values were not adjusted for multiple comparisons). 
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Table 21. Linear mixed regression model for proliferation responses in calves primo-vaccinated at 10 
days of age and fed with cell-free frozen non-maternal colostrum (COLnocells10), maternal cell-
enriched frozen non-maternal colostrum (COLcells10) or fresh maternal colostrum (COLfresh10). 
Independent variable N
1 ß SE LSM P-value2 
      
Intercept 12 1.09 0.84 … 0.20 
      
Colostrum group     0.65 
      COLnocells10 4 Ref. … 2.77 … 
      COLcells10 4 0.85 1.18 3.10 0.96 
      COLfresh10 4 0.90 1.18 3.12 0.41 
      
Days relative to primo-vaccination     < 0.001 
      -10 days 12 0.68 1.18 1.05 0.36 
      -9 days 12 -0.27 1.16 1.51 0.81 
      -8 days 12 -0.22 1.05 1.26 0.50 
      0 days 12 Ref. … 1.67 … 
      + 3 days 12 0.93 1.05 2.30 0.30 
      + 7 days 12 1.32 1.16 3.24 0.02 
      + 10 days 12 0.80 1.18 2.96 0.06 
      + 15 days 12 2.24 1.18 3.45 0.01 
      + 21 days 12 3.31 1.18 4.01 < 0.001 
      + 30 days 12 3.70 1.18 4.41 < 0.001 
      + 37 days 12 3.89 1.18 4.97 < 0.001 
      + 44 days 12 3.83 1.18 5.12 < 0.001 
      
Colostrum group x days relative to primo-vaccination 12 … … … 0.80 
      
 
1Number of calves 
2P-value for overall effect 
 
To analyze the effect of the presence/absence of TT-primed CL on TT-specific cellular 
immune responses in the neonatal calf in the absence of maternal TT-specific antibodies 
(colostrum bank originated from non-vaccinated cows), the TT-specific proliferations of PBMC 
of COLcells and COLnocells calves vaccinated at 2, 5 or 10 days after birth were compared (Figure 
24a-c; Table 22-24). In calves vaccinated at 2 days after birth, COLcells calves had significantly 
higher TT-induced proliferations than COLnocells calves at 14 days after booster vaccination (P 
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= 0.009; Figure 24a). In calves vaccinated at 5 days after birth, there were no significant 
differences in TT-specific proliferations between COLcells and COLnocells calves, although 
COLcells calves had higher TT-induced proliferations from 15 days post primo-vaccination 
onwards (Figure 24b). After booster vaccination, the TT-induced proliferation for COLcells10 
calves increased faster compared to COLnocells10 calves. The numerical difference in TT-induced 
proliferation between COLcells10 and COLnocells10 calves never became statistically significant 
(Figure 24c). All these data argue for a beneficial effect of the CL on neonatal T-lymphocyte 
responses.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24a. Proliferation responses in calves fed with maternal cell-enriched frozen non-maternal 
colostrum (COLcells2, n = 4) were significantly higher than responses in calves fed cell-free frozen non-
maternal colostrum (COLnocells2, n = 4) 14 days after booster vaccination. Calves were primo-
vaccinated at 2 days of age and were booster vaccinated at 25 days of age (arrows). Blood samples 
were taken at the day of vaccination through 21 days after booster vaccination. Data represent mean 
counts per minute (CPM) indicating TT-induced proliferation of blood mononuclear leukocytes. Within 
a time point, values with different letters differed significantly (P-values were not adjusted for multiple 
comparisons). 
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Figure 24b. Proliferation responses in calves fed with maternal cell-enriched frozen non-maternal 
colostrum (COLcells5, n = 4) were numerically albeit not significantly higher than responses in calves 
fed cell-free frozen non-maternal colostrum (COLnocells5, n = 3) after booster vaccination. Calves were 
primo-vaccinated at 5 days of age and were booster vaccinated at 28 days of age (arrows). Blood 
samples were taken at the day of vaccination through 21 days after booster vaccination. Data represent 
mean counts per minute (CPM) indicating TT-induced proliferation of blood mononuclear leukocytes. 
Differences were never significant. 
 
 
 
 
 
-100 
-50 
0 
50 
100 
150 
200 
250 
300 
350 
T
T-
in
du
ce
d 
pr
ol
ife
ra
tio
n 
(C
PM
*1
0-
3 ) 
Proliferation in COLnocells5 and COLcells5 calves 
                   0                      3                      7                     10                    15                    21                      7                     14                    21 
 Days after primo-vaccination                                                Days after booster vaccination 
Chapter 4.3 Colostral leukocytes and development of immunity 
132 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24c. Proliferation responses in calves fed with maternal cell-enriched frozen non-maternal 
colostrum (COLcells10, n = 4) were higher than responses in calves fed cell-free frozen non-maternal 
colostrum (COLnocells10, n = 4) after booster vaccination. Calves were primo-vaccinated at 10 days of 
age and were booster vaccinated at 33 days of age (arrows). Blood samples were taken at the day of 
vaccination through 21 days after booster vaccination. Data represent mean counts per minute (CPM) 
indicating TT-induced proliferation of blood mononuclear leukocytes. Differences were never 
significant. 
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Table 22. Linear mixed regression model for proliferation responses in calves primo-vaccinated at 2 
days of age and fed with cell-free frozen non-maternal colostrum (COLnocells2) or maternal cell-
enriched frozen non-maternal colostrum (COLcells2).  
Independent variable N
1 ß SE LSM P-value2 
      
Intercept 8 1,02 0,68 … 0,14 
      
Colostrum group     0,96 
      COLnocells2 4 Ref.  … 2,63 … 
      COLcells2 4 -1,02 0,96 2,61 0,96 
      
Days post vaccination     < 0,001 
      0 days 8 Ref.  … 0,51 … 
      + 3 days 8 -1,02 0,86 0,59 0,90 
      + 7 days 8 0,69 0,94 1,07 0,41 
      + 10 days 8 1,04 0,96 2,32 0,01 
      + 15 days 8 1,98 0,96 1,95 0,04 
      + 21 days 8 3,14 0,96 4,13 < 0,001 
      + 30 days 8 3,21 0,96 4,55 < 0,001 
      + 37 days 8 1,31 0,96 3,63 < 0,001 
      + 44 days 8 4,15 0,96 4,84 < 0,001 
      
Colostrum group x days post vaccination 
 
8 
 
… 
 
… 
 
… 
 
0,02 
 
      
1Number of calves 
2P-value for overall effect 
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Table 23. Linear mixed regression model for proliferation responses in calves primo-vaccinated at 5 
days of age and fed with cell-free frozen non-maternal colostrum (COLnocells5) or maternal cell-
enriched frozen non-maternal colostrum (COLcells5). 
Independent variable N
1 ß SE LSM P-value2 
      
Intercept 7 0,55 0,90 … 0,54 
      
Colostrum group     0,27 
      COLnocells5 3 Ref.  … 2,22 … 
      COLcells5 4 -0,01 1,19 2,74 0,27 
      
Days post vaccination     0,001 
      0 days 7 Ref.  … 0,55 … 
      + 3 days 7 0,36 1,19 0,80 0,75 
      + 7 days 7 0,83 1,27 1,54 0,24 
      + 10 days 7 1,54 1,28 2,01 0,09 
      + 15 days 7 1,17 1,28 2,70 0,01 
      + 21 days 7 2,51 1,28 3,06 0,00 
      + 30 days 7 4,12 1,28 4,68 < 0,001 
      + 37 days 7 2,19 1,28 3,15 0,004 
      + 44 days 7 2,30 1,28 3,85 < 0,001 
      
Colostrum group x days post vaccination  … … … 0,79 
            
 
1Number of calves 
2P-value for overall effect 
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Table 24. Linear mixed regression model for proliferation responses in calves primo-vaccinated at 10 
days of age and fed with cell-free frozen non-maternal colostrum (COLnocells10) or maternal cell-
enriched frozen non-maternal colostrum (COLcells10). 
Independent variable N
1 ß SE LSM P-value2 
      
      
Intercept 8 1,09 0,88 … 0,22 
      
Colostrum group     0,31 
      COLnocells10 4 Ref.  … 3,82 … 
      COLcells10 4 0,85 1,24 3,31 0,31 
      
Days post vaccination     0,004 
      0 days 8 Ref.  … 1,51 … 
      + 3 days 8 0,93 1,13 2,49 0,004 
      + 7 days 8 1,32 1,22 2,76 0,15 
      + 10 days 8 0,80 1,24 2,62 0,21 
      + 15 days 8 2,24 1,24 3,62 0,02 
      + 21 days 8 3,31 1,24 4,05 0,006 
      + 30 days 8 2,94 1,24 4,83 0,004 
      + 37 days 8 3,28 1,24 5,09 < 0,001 
      + 44 days 8 3,36 1,24 5,11 < 0,001 
      
Colostrum group x days post vaccination 8 … … … 0,9834 
            
 
1Number of calves 
2P-value for overall effect 
 
4. DISCUSSION 
 
Increasing attention is currently given to the potential role of maternal CL in the 
development of the immunity of the neonatal calf (Reber et al., 2005; Donovan et al., 2007; 
Reber et al., 2008a, 2008b). In comparison to bovine colostral antibodies, little is known about 
the influence of CL on the development of the immunity of the newborn calf. The aim of the 
present study was to evaluate this influence by TT-vaccination of newborn calves that had or 
had not received TT-primed maternal CL, all or not in the presence of maternal TT-specific 
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antibodies. Furthermore, we investigated whether the time of primo-vaccination of these calves, 
i.e. 2, 5 or 10 days after birth, had an influence on the kinetics of the development of the immune 
response.  
 
In the analysis of the influence of maternal CL on the vaccination outcome of calves 
that had or had not received CL (COLcells versus COLnocells), we intentionally used colostrum 
from a cell-free colostrum bank of TT-unvaccinated dams, thus in the absence of maternal TT-
specific antibodies. This was done in order to avoid interference of TT-specific antibodies 
which are present in colostrum of the TT-vaccinated dams, on the induction of the immune 
response of the calf after TT-vaccination. This enabled us to give a clearer picture of the 
influence of only TT-specific CL on the response to TT-vaccination, without interference of 
TT-specific maternal antibodies. In the calves receiving TT-specific CL and not TT-specific 
antibodies (COLcells calves), a secondary immune response on TT-primo-vaccination is 
expected. Indeed, it has been shown that lambs receiving maternal CL from TT-vaccinated ewes 
display a secondary type immune response to primo-vaccination against TT (Tuboly et al., 
1995). However, this could not be demonstrated in our current study, as calves did not react 
after primo-vaccination and reacted only clearly after booster vaccination, indicating that 
maternal CL did not promote a secondary immune response upon primo-vaccination of these 
calves. On the contrary, it appeared that CL exerted a negative influence on the antibody 
responses as the COLcells calves generally had lower antibody responses than the COLnocells 
calves, what became statistically significant in calves vaccinated at 5 days of age. It appeared 
that the response after booster vaccination was a primary response originating from the calf’s 
own immune system. The earlier and stronger antibody responses of COLnocells than COLcells 
calves (statistically with calves vaccinated 5 days after birth) would rather suggest a suppressive 
effect of CL on the antibody responses of calves upon vaccination. 
 
The TT-induced proliferation of PBMC of COLcells calves was generally higher (albeit 
not significantly) than this of COLnocells calves immediately after booster vaccination. The latter 
finding suggests a more important role of CL in the development of the cellular immune 
response in newborn calves compared to the humoral immune response. This higher cellular 
reaction in calves receiving maternal CL together with the negative influence of CL on the 
antibody responses, would indicate the ability of specific vaccines to break the Th2 bias in 
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young livestock and to induce an early cell-mediated response (Chase et al., 2008). The precise 
role of CL in this phenomenon remains to be elucidated. The latter finding could have 
implications for calves receiving colostrum from other herds, i.e. deprived of specific colostral 
antibodies and specific maternal CL. Also, CL are non-viable in frozen colostrum collected at 
the own herd due to the freeze and thaw process. Furthermore, when giving fresh colostrum of 
another cow of the same herd, CL are of non-maternal origin (= deprived of specific maternal 
CL) and consequently also histo-incompatible to the calf. In sheep and pigs, it has been shown 
that only maternal CL can cross the intestinal epithelium (Tuboly et al., 1988; Williams, 1993; 
Tuboly et al., 1995). Conversely, colostral antibodies can always cross the neonatal intestinal 
epithelium and enter the circulation whether or not they are from another dam or even in some 
cases from another species (Klobasa et al., 1981).  
 
Interesting data were obtained from the experiments with calves receiving fresh 
colostrum from their vaccinated dams, thus containing TT-specific antibodies and CL. The 
higher antibody titers of COLfresh10 calves than COLcells10 and COLnocells10 calves shortly after 
birth are obviously due to the passive transfer of TT-specific antibodies from the fresh 
colostrum these calves received from their respective vaccinated dams. However later on, it 
were the COLcells10 and COLnocells10 calves that showed a clear humoral immune response after 
booster vaccination which appeared absent in the COLfresh10 calves. This absent response was 
most obviously due by maternal interference of antigen-specific antibodies on the B-cell 
recognition of antigen. However, even more interesting was that also the TT-induced 
proliferation in COLfresh10 calves was hampered as it only clearly increased from 21 days 
onwards after booster vaccination, as opposed to the COLcells10 and COLnocells10 calves. As 
antibodies block the uptake of antigen by B-lymphocytes and/or are responsible for antibody-
mediated removal of the antigen from the circulation, antigen cannot anymore be processed and 
presented to T-lymphocytes from the colostrum or the calf itself. This might explain the lower 
TT-specific proliferative responses in COLfresh10 calves. 
As a conclusion, the present study confirms that the effect of CL on the development of 
the cellular and humoral immunity of the newborn calf is a complex matter. The present study 
suggests a negative influence of CL on the development of the humoral immunity but a positive 
influence on the cellular immunity of newborn calves.  
 
Chapter 4.3 Colostral leukocytes and development of immunity 
138 
 
5. ACKNOWLEDGEMENTS 
 
The present study was funded by a PhD grant to V. Meganck (no. 83216) by the 
Institute for the Promotion of Innovation through Science and Technology in Flanders. We 
wish to thank the owners of the enrolled farms for their cooperation. The authors also like to 
thank Merial for kindly providing the tetanus toxoid peptide. A special word of thanks goes to 
Griet De Smet, Joanna Rybarczyk and Simon Brabant for their technical assistance in the lab. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 139 
 
 
CHAPTER 5 
 
 
 
GENERAL DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 140 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 General Discussion 
141 
 
1. INTRODUCTION 
 
The principal aim of this thesis was to broaden our knowledge concerning the 
possibilities in the field to lower the incidence of neonatal calf diarrhea (NCD) in dairy herds 
and to broaden our knowledge concerning colostral leukocytes. 
In Chapter 3, a preventive action plan to reduce the incidence of NCD on dairy herds 
was evaluated. Chapter 4.1 describes the development of a validated method for the isolation 
of bovine colostral mononuclear cells (CMC) to further characterize the different subtypes and 
their functionality. In Chapter 4.2, body condition score, parity, and BHBA serum 
concentrations were related to the phenotypic distribution and/or proliferative capacity of CMC 
in high yielding dairy cows. Finally, in Chapter 4.3, the difference in cellular and humoral 
immune response to vaccination between neonatal dairy calves receiving colostral leukocytes 
or not was determined (Chapter 4.3).  
 
2. NEONATAL CALF DIARRHEA ON DAIRY HERDS 
 
2.1 Prevalence and causes of neonatal calf diarrhea 
 
Enterotoxic Escherichia coli, rota- and coronavirus and Cryptosporidium parvum are 
the four most important enteropathogens causing NCD worldwide (Trotz-Williams et al., 2007; 
Gulliksen et al., 2009; Bartels et al., 2010; Silverlås et al., 2010). In Belgium and more 
specifically in Flanders, prevalence studies on NCD are sparse. Although we did not execute 
this kind of study, we can provide some data on prevalence numbers regarding the causing 
agents of NCD. Percentages of NCD found in the study of Chapter 3 are high as we selected 
for dairy herds with NCD problems (> 10% of calves suffering from NCD). Rotavirus and C. 
parvum were the 2 most common enteropathogens found in faeces of calves (Chapter 3; 
Figure 25), confirming data reported worldwide (Ok et al., 2009; Bartels et al., 2010; Izzo et 
al., 2011). Cryptosporidium parvum is considered the most common enteropathogen of 
neonatal calves (de la Fuente et al., 1998). The prevalence of this parasite in calves with diarrhea 
ranges from 27.8-58.5% (Geurden et al., 2008; Ok et al., 2009; Bartels et al., 2010; Izzo et al., 
2011). The other 3 major causes of NCD are E. coli, rota- and coronavirus. The prevalence for 
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E. coli, rota- and coronavirus in calves with diarrhea ranges from 2.6-45.1%, 17.7-79.9%, and 
3.1-21.6%, respectively (Ok et al., 2009; Bartels et al., 2010; Izzo et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. On control and treated herds, both before inclusion and at the end of the study, faecal 
samples of 5 randomly selected calves between 0 and 14 days of age were analysed with an ELISA 
(Rainbow Calf Scour 4, Bio-X Diagnostics, Jemelle, Belgium) to test for the presence of E. coli, rota- 
and coronavirus, and C. parvum. Percentages of samples positive for none, one or a mixed infection of 
these four pathogens are represented.   
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2.2 Metaphylactic use of halofuginone and vaccination of dams against 
Escherichia coli, rota- and coronavirus 
 
It is important on NCD problem herds to distinguish the causing pathogen(s), as the 
preventive approach to e.g. the parasite C. parvum is different from the approach to e.g. 
rotavirus diarrhea. 
Control of the parasite C. parvum can only be achieved by hygienic measures such as 
not mixing animals of different ages and placing newborn calves in an uncontaminated 
environment, and the prophylactic use of drugs such as halofuginone lactate (De Waele et al., 
2010). Halofuginone lactate is currently the only registered product for prevention and 
treatment of C. parvum in Europe. The average percentage of faecal samples positive for C. 
parvum differed significantly (P < 0.05) between control herds (34%) and treated herds (11%) 
after implementation of the protocol (Chapter 3). Moreover, within the treated herds, 
significantly (P < 0.001) less animals excreted C. parvum after the protocol  was implemented 
(11%) in comparison to the situation before protocol implementation (46%). These results 
demonstrate the efficacy of halofuginone lactate which is a cryptosporidiostatic. A 
metaphylactic treatment with this product is expected to decrease and delay the peak of oocyst 
excretion, delaying the onset of diarrhea to an age when calves are better able to cope with 
dehydration and acid-base balance disturbances (Silverlås et al., 2009; De Waele et al., 2010; 
Trotz-Williams et al., 2011).  
 
Specific IgG titers in the serum of calves against E. coli, rota- and coronavirus were not 
determined (Chapter 3). However, specific serum IgG titers are likely to be higher in calves 
that received colostrum from vaccinated dams in comparison to calves that received colostrum 
from non-vaccinated dams (Parreño et al., 2004). This presumption of a higher specific passive 
immunity might also explain the lower percentage of calves with NCD on treated herds 
(Chapter 3). However, despite the use of a specific vaccine against E. coli, rota- and 
coronavirus, no significant differences could be observed in the number of calves excreting E. 
coli or rotavirus prior versus following the implementation of the vaccination protocol in the 
treated herds. Still, as the tetrakit used to determine pathogen excretion is not a quantitative but 
rather a qualitative to semi-quantitative test, the exact level of pathogen excretion per calf could 
not be assessed. An individually lowered excretion could potentially also contribute to less 
Chapter 5 General Discussion 
144 
 
calves scouring. Besides protecting against E. coli, rota- and coronavirus by increasing the 
specific quality of the colostrum, calves born out of vaccinated dams are also significantly less 
likely to shed C. parvum (Trotz-Williams et al., 2007). This is most likely a reflection of a 
generally higher standard of herd management in vaccinated herds rather than a direct 
protective effect. Another explanation could be that calves are less susceptible to C. parvum 
because they are better able to cope with E. coli, rota- and coronavirus. 
 
In herds where the colostrum management suffices, dam vaccination and metaphylactic 
halofuginone lactate administration can be successful in the reduction of incidence of calf 
diarrhea. Implementation of the described protocol in NCD problem herds is straightforward 
for practitioners. 
 
2.3 Colostrum and neonatal calf diarrhea 
 
As with all infectious diseases, the balance between the host’s resistance (i.e. active and 
passive immunity) and the pathogen (virulence and pathogen pressure) is cardinal (Lorenz et 
al., 2011). As colostrum is of vital importance in the passive immunity transfer of the neonatal 
calf, the study described in Chapter 3 was at first set up as a 3-step protocol with the third step 
being an optimization of the colostrum management (Figure 26).  
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Figure 26. Optimal colostrum management according to the author. Leaflet that can be handed over to 
the farmer as a standard operating protocol. 
OPTIMAL COLOSTRUM MANAGEMENT 
= 3 Q’s – 2 F’s  Quick – Quantity – Quality – Fresh - oFten 
 
QUALITY* 
 
- Antibodies: measure with colostrometer 
 Good quality:  
- OK to feed calf. 
- OK to freeze. 
 Bad quality: 
- NOT OK to feed calf. 
- NOT OK to freeze. 
 
- Start with a clean udder and a clean bucket. 
- Keep colostrum that is not given immediately refrigerated!  
 
QUICK 
 
- Milk cow within 2 hours of calving. 
- Feed colostrum to calf within 6-12 hours after birth. 
 
QUANTITY 
 
- Feed at least 4 l of first milking colostrum.  
 
FRESH 
 
- Feed fresh colostrum, unless quality is not good* 
 
OFTEN 
 
- 2 x 2 l is better than 1 x 4 l. 
 
SUMMARY 
 
Feed at least 4 l of  good quality first milking colostrum to a calf within 
the first 6-12 hours after birth  
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Calves from both treated and control herds received on average 1.9 l (range 0.0-6.0  l) 
colostrum at the first colostrum feeding. The average time until a newborn calf received its first 
colostrum was 2.9 hours (range 0.1-20.0 hours) on control herds and 2.0 hours (range 0.1-10.5 
hours) on treated herds. Within the first 6 hours after birth, a calf received on average 1.8 + 1.1 
or 2.2 + 1.2 l on a control or treated herd, respectively. The apparent discrepancy on control 
herds between the amount of colostrum fed at the first colostrum feeding (1.9 l) and within the 
first 6 hours (1.8 l) can be explained by the fact that in quite some cases the first colostrum was 
not fed within the first 6 hours after birth (range of 0.1-20.0 hours!). Because many treated 
herds did not comply with the colostrum management as stated in the protocol, this study was 
further handled as having implemented a 2-step protocol. Nonetheless, the overall passive 
immunity in the calves of both the treated and control herds, both before and after inclusion in 
the study was adequate, as indicated by the average IgG serum content (> 21 g IgG/l). Several 
other authors reported lower average serum IgG values ranging from 12 to 19 g/l. When 
defining failure of passive transfer as a serum IgG concentration < 10 g IgG/l (FPT10), numbers 
have been reported as high as 50% of the studied calf population (Tyler et al., 1996b; Calloway 
et al., 2002; Filteau et al., 2003). In Chapter 3 the FPT10 percentages ranged from 5 to 17%. 
McGuirk and Collins (2004) set the alarm level for FPT10 to be a herd problem at 20%, whilst 
Chigerwe et al. (2009) consider an FPT10 prevalence < 10% as a rational and achievable goal. 
Percentages of FPT range from 8.4 to > 90.5% depending on the cut-off value, the population 
studied, and/or the method used to estimate calf serum IgG levels (Uhde et al., 2008; Trotz-
Williams et al., 2008; Beam et al., 2009; Todd et al., 2010 Windeyer et al., 2014). The fact that 
despite the overall adequate passive immunity several calves did develop diarrhea (Chapter 3) 
furthermore suggests that the historical cut off value (10 g IgG/l) to determine the passive 
transfer status of neonatal calves may be too low, and should be revised (Güngör et al., 2004; 
Chigerwe et al., 2008b; Windeyer et al., 2014). In Chapter 3 the FPT15 percentages ranged 
from 15 to 27%. We suggest that farmers should seek to have < 10% of calves with a serum 
IgG content of < 15 g IgG/l at 48 h of age. A routine screening of the serum total protein with 
a refractometer is an easy to implement and fairly cheap method to estimate the passive transfer 
status of the calves.  
 
Also surprisingly, no significant differences were observed in diarrhea incidence 
between calves receiving at least 200 g IgG compared to calves receiving less than 200 g IgG 
within the first 6 and 12 hours after birth. The same was found when calculating data with 100, 
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150, 250 or 300 g IgG used as thresholds for administration of colostral IgG (data not shown). 
It has already been shown that the association between the level of passive immunity and the 
occurrence of NCD is less clear in comparison to the occurrence of respiratory disease 
(Donovan et al., 1998). Different explanations for this phenomenon can be found in literature 
(Logan et al., 1974; Saif et al., 1983; Harp et al., 1989; Ungar et al., 1991; Whitmire and Harp, 
1991; Chen et al., 1993; Wyatt et al., 1997; Donovan et al., 1998; Harp and Goff, 1998). For 
example, colostral IgG is less protective for diarrhea cases caused by C. parvum (Trotz-
Williams et al., 2007).  
However, both the FPT-status and the calculated amount of IgG administered to a calf 
only take into account the passive transfer of colostral antibodies. Still, colostrum is much more 
than solely a supplier of antibodies. As summarized in Chapter 1, colostrum is also important 
as a source of nutrients, cytokines, lactoferrin, transferrin, lactoperoxidase, lysozyme, 
hormones, defensins, growth factors, and oligosaccharides which all might have additional 
relevance to the passive immune transfer from cow to calf (Foley and Otterby, 1978; Oda et al., 
1989; Sordillo et al., 1991; Tokuyama and Tokuyama, 1993; Rewinski and Yang, 1994; 
Hadjipanayiotou, 1995; Blum and Hammon, 2000; Hagiwara et al., 2000; Blum, 2006). All 
these colostral constituents are not routinely measured in practice. Moreover, bacteriological 
quality of colostrum was not assessed (Chapter 3), despite being an important part of the 
colostrum management (McGuirk and Collins, 2004; Stewart et al., 2005; Morrill et al., 2012). 
Finally, as we have shown in Chapter 5.3, CL have a beneficial influence on the development 
of the cellular immunity of the neonatal calf. The number and/or function of CL were not 
addressed in the study of Chapter 3, but these cells may have additional relevance apart from 
the indispensable colostral antibodies, especially when dealing with pathogens that need a 
strong cellular immunity to overcome the infection such as C. parvum. 
 
2.4 Hygienic measures and neonatal calf diarrhea 
 
No significant associations were found between diarrhea incidence during the study and 
the risk factors defined in the questionnaire (Chapter 3). This can be explained by a lack of 
variation in NCD management along with a high variation in the incidence of neonatal diarrhea 
among the herds and the relatively small number of herds. Moreover, the absence of statistical 
significance in the presence of relevant biological differences is not the same as the absence of 
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statistical significance for observed minor differences without biological or epidemiological 
importance. Although the numbers were too small in this study to draw conclusions, herds 
where the calves were immediately post partum separated from their dams, where weaned and 
non-weaned calves had no contact with each other, where the calf box was disinfected after 
each calf, where the calving pen was cleaned, and where one bucket per calf was used, showed 
a numerically lower risk of diarrhea in comparison to other herds. The latter findings are in 
accordance with those of other studies (Bartels et al., 2010; De Waele et al., 2010). 
 
3. IN VITRO FUNCTIONALITY OF BOVINE COLOSTRAL LEUKOCYTES 
 
3.1 Technical notes on isolation, flow cytometric analysis and proliferation of 
colostral leukocytes 
 
Validated and reliable methods to isolate and identify the different leukocyte 
subpopulations from colostrum are required to facilitate investigation of their potential role in 
passive immunity. Different protocols have been described for isolation of leukocytes or, more 
specifically, lymphocytes from colostrum and milk (Nonnecke and Kehrli, 1985; Nonnecke et 
al., 1986; Park et al., 1992). However, these studies do not report the repeatability of their 
methodology and, in some cases, large quantities of colostrum have been processed to obtain 
sufficient numbers of cells for further experimental procedures. Therefore, we optimized a 
protocol to isolate and further characterize CMC with a smaller amount of colostrum and we 
tested the repeatability of this protocol. 
 
One of the benefits of the optimized and validated method described in Chapter 4.1, is 
the relatively small volume of colostrum (360 ml) needed to perform both the flow cytometric 
and the proliferation assays. In milk and colostrum, the concentration of lymphocytes is 
relatively low compared to blood (as also demonstrated in Chapter 4.2), requiring rather large 
volumes of milk to be used (Nonnecke and Kehrli, 1985; Nonnecke et al., 1986; Archambault 
et al., 1988a; Ebling et al., 2000). In some studies, volumes up to 3 and even 8 l were used 
(Archambault et al., 1988a; Ebling et al., 2000). Specifically for colostrum, this amount is not 
always available and it is important that the calf receives this colostrum. Moreover, processing 
Chapter 5 General Discussion 
149 
 
large amounts of milk is labour intensive and time consuming. In the flow cytometric and 
proliferation assays used in Chapter 4.1 and 4.2 the number of cells was reduced to 2 × 106 
cells per ml instead of the larger numbers (1 x 107 cells per ml) proposed by others (Kiku et al., 
2010). This approach allowed us to identify and quantify the different CMC subpopulations and 
to determine their proliferative capacity with a volume of colostrum of only 360 ml. 
 
The mean cell count of the isolated CMC was 3.0 × 104 – 1.2 x 105 per ml colostrum 
(Chapter 4.1 and 4.2). These numbers are intermediate to those obtained in other studies 
ranging from 1.0 x 104 up to 1.6 x 106 CMC per ml colostrum (Archambault et al., 1988a; 
Gomes et al., 2010). The final yield of CMC is dependent upon the initial somatic cell count, 
the proportion of the different cell types in the colostrum and the technique used to isolate the 
cells from the colostrum (Ebling et al., 2000). Also, similar to milk, the proportion of CMC 
depends on the infection/inflammation status of the mammary gland (Ebling et al., 2000; 
Leitner et al., 2000). Finally, the more steps that are performed during the isolation process, the 
more cells can be lost throughout the procedure (Ebling et al., 2000).  
There is often an initial loss of cells, because cells can be trapped in the cream layer 
which is discarded after the first centrifugation step (Concha et al., 1980; Nonnecke and Kehrli, 
1985; Prescott and Breed, 1910). In this view, there is discussion concerning the correct 
temperature of storing milk or colostrum samples until analysis. Our protocol consisted of 
storing colostrum samples on ice until further processing (Chapter 4.1 and 4.2). However, 
storing colostrum cooled may have a higher risk of trapping cells in the cream layer after 
centrifugation, thereby reducing the recovery of cells (Prescott and Breed, 1910; Dosogne et 
al., 2003). Leukocytes are trapped in the fat that forms an essentially solid layer when the 
colostrum is centrifuged at cold temperatures (Concha et al., 1980). On the other hand, storing 
colostrum at room temperature is correlated with an explosion in bacteria growth (Stewart et 
al., 2005), which would have affected our proliferation assays. Although the samples were all 
analysed within a few hours after sampling, 20 minutes is enough to double the bacteriological 
load in milk/colostrum. Therefore, colostrum samples were stored on ice immediately after 
milking until further processing (Chapter 4.1 and 4.2). Moreover, the absolute count of cells 
was not as important in these studies as the phenotypic distribution and the proliferative 
capacity of the cells. However, as mentioned previously, the mean cell count of the isolated 
CMC (3.0 × 104 – 1.2 x 105 per ml colostrum) was intermediate to those obtained in other 
studies (1.0 x 104 up to 1.6 x 106 CMC per ml colostrum). Also, to prevent loss of cells as much 
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as possible, colostrum was mixed with phosphate buffered saline (PBS, 3:5) prior to 
centrifugation at 18°C (Chapter 4.1 and 4.2). Dilution with PBS improves the cell harvest by 
dispersing the milk fat that normally entraps leukocytes during centrifugation (Nonnecke and 
Kehrli, 1985). 
 
Flow cytometric analysis of CMC showed an overall viability of 81.0-84.5% (Chapter 
4.1 and 4.2) which is only slightly lower than the results (87.1%) reported by Duhamel et al. 
(1987). Viability was estimated by using propidium iodide (PI) staining which is a rather robust 
parameter. Propidium iodide does not stain live or early apoptotic cells due to the presence of 
an intact plasma membrane (Vermes et al., 2000). Staining cells simultaneously with annexin 
V and PI would have allowed for the discrimination between intact cells (annexin-/PI-), early 
apoptotic (annexin+/PI-) and late apoptotic or necrotic cells (annexin+/PI+; Piepers et al., 2009b).  
Although all samples were analysed within 24 hours after collection, the isolation of 
CMC immediately after collection of colostrum could have given higher viability percentages 
because milk mononuclear cells, and monocytes/macrophages in particular, are already in an 
activated state (Asai et al., 2000; Concha et al., 1980; Nonnecke and Kehrli, 1985; Park et al., 
1992-1993). Unfortunately, under field conditions, it is not always possible to transport or 
collect the colostrum immediately after parturition. In contrast to this disadvantage, the use of 
commercial dairy herds has huge advantages regarding the external validity of the data. 
Moreover, as mentioned in Chapter 4.1, a pilot experiment showed no significant differences 
between samples processed immediately or at 12 or 24 hours after sampling. 
 
The summation of the percentages (B-lymphocytes + T-lymphocytes + macrophages) 
did not reach 100% (Chapter 4.1 and 4.2). This can mainly be explained by the presence of 
debris in the samples. Based on SSC-FSC plots, debris was omitted in the calculations. 
However, this is not the most straightforward step, and rather subjective. As epithelial cells are 
also monomorphonuclear and present in colostrum, these cells could account for some 
additional error. Secondly, the primary antibodies were added in separate tubes (no multiple 
staining), increasing the risk for some random errors. A third possibility would be the 
contamination of CMC with neutrophils. Large amounts of neutrophils left in the final 
purification would most probably have greatly affected (declined) the proliferation results. In 
some previous samples (data not shown), neutrophils were identified with the primary antibody 
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CH138A. The average neutrophil content (+ SD) was 19.3 + 29.9%. This percentage was 
greatly affected by 1 cow suffering from a coliform mastitis. The average neutrophil percentage 
without this cow was 11%. Finally, other subtypes of monomorphonuclear cells are without 
doubt present in the CMC fraction.  
 
As for the conditions of the proliferation assays used in Chapter 4.1, 4.2, and 4.3, the 
temperature of the incubator should have been set higher (around 38-39°C), especially for the 
PBMC, as this would better reflect the physiological inner core temperature of the cow. 
However, there are several other studies that used 37°C with good results (Ayanwale et al., 
1981; Thanasak et al., 2005; Gorjão et al., 2007). Moreover, milk and colostral leukocytes 
reside in the udder which has a slightly lower temperature (even lower than 37°C) in 
comparison to the inner core temperature of a cow (38-39°C; Berry et al., 2003). As PBMC and 
CMC were analysed together, 37°C was chosen as a ‘compromise’. 
 
3.2 Negative energy balance and its influence on the phenotypic distribution and 
the proliferation of colostral leukocytes 
 
Periparturient dairy cows are challenged by a sudden increase in energy requirements 
imposed by the onset of lactation and a concomitant decrease in voluntary dry matter intake 
(Goff et al., 2002). As a consequence, these cows are going through a period of negative energy 
balance (NEB) which most but not all animals are able to adapt to without life-threatening 
health problems. Adaptation to this NEB is to a great extent based on mobilization of fat from 
body stores and the release of non-esterified fatty acids (NEFA) and beta-hydroxy-butyric acid 
(BHBA) into the blood stream. Unfortunately, we could not show that serum NEFA and BHBA 
significantly influence the proliferative capacity of CL (Chapter 4.2.), which would have 
confirmed data found in other studies using bovine blood leukocytes (Franklin et al., 1991; 
Lacetera et al., 2004; Thanasak et al., 2005). These insignificant effects were probably due to 
the fact that the number of animals with high values and thus expected to suffer from negative 
energy balance was almost negligible. There were only 32 cows with high NEFA (> 0.70 
mmol/l) and/or high BHBA (> 1.4 mmol/l) serum concentrations at the day of parturition. The 
prevalence of subclinical ketosis (BHBA > 1.2 mmol/l) in other studies has been reported to be 
as high as 47.2% (Nielen et al., 1994; Vanholder et al., 2014). As this study was carried out 
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with high yielding dairy cows, a larger number of cows suffering from high NEFA and/or 
BHBA serum concentrations was expected. However, the herds participating in this study were 
all well managed with a sound herd health management program. This could partly explain the 
relatively low numbers of cows suffering from NEB. Moreover, the peak of NEB in high 
yielding dairy cows is around the 2nd week in milk (Schwarm et al., 2013). For this reason, cows 
were also blood sampled at 10 days post partum (data not shown). Compared to the day of 
parturition (n = 2) there were more cows with high serum BHBA concentrations (n = 21). 
Surprisingly, less animals had high NEFA serum concentrations at 10 days post partum (n = 
17) compared to the day of parturition (n = 32). A better approach would have been to select 
cows based on their serum BHBA and NEFA concentrations, to have more equally distributed 
groups. 
A second problem in the study described in Chapter 4.2 was that mitogen-induced and 
antigen-induced proliferation results were only available for 14 and 7 cows with high NEFA 
serum concentrations, respectively.  
Serum BHBA was positively associated with the percentage of colostral T-lymphocytes 
and macrophages. The latter results comply to the theory of the impaired immunity of cows 
caused by ketosis. 
 
3.3 Body condition score and its influence on the phenotypic distribution of 
colostral leukocytes 
 
Under-conditioned cows (BCS < 3) had a significantly higher percentage of colostral 
macrophages than normal conditioned animals (Chapter 4.2). Also, over-conditioned cows 
(BCS > 3.5) had a significantly higher percentage of colostral B-lymphocytes than normal 
conditioned animals. These findings are somewhat comparable with results obtained in Piepers 
et al. (2009a) who showed that heifers losing 0.25 points or more of their body condition in the 
periparturient period had higher proportions of apoptotic blood neutrophils in early lactation 
compared with heifers losing less than 0.25 points. We can conclude that the condition of the 
cow affects the immune system but more research is needed to clarify these findings in detail.  
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3.4 Age of the cow and its influence on proliferation of colostral leukocytes 
 
Studies investigating the effect of aging on immune function in human blood 
mononuclear cells have indicated a diminished role of type 1 cytokines, such as IFN- and IL-
2 which promote cell-mediated immunity (Alberti et al., 2006). This is in line with the results 
of Chapter 4.2 that showed a lower proliferative capacity of CMC of older cows. In contrast, 
Ohtsuka et al. (2010) found that mammary gland immune cells are more active in cows with 
higher parity compared with heifers at calving. Cows with parity > 4th suffered more profound 
periparturient impairment of neutrophil function than younger cows (Gilbert et al., 1993), again 
comparable to the results presented in Chapter 4.2. Proliferation of CMC thus seems higher in 
younger cows while the IgG concentration of colostrum is generally lower in younger cows.  
 
4. MATERNAL INTERFERENCE: NEGATIVE INFLUENCE ON DEVELOPMENT OF 
BOTH HUMORAL AND CELLULAR IMMUNITY OF NEONATAL CALVES 
 
Interesting data were obtained from the experiments with calves receiving fresh 
colostrum from their vaccinated dams, thus containing TT-specific antibodies and CL. The 
higher antibody titers of COLfresh10 calves than COLcells10 and COLnocells10 calves shortly after 
birth are obviously due to the passive transfer of TT-specific antibodies from the fresh 
colostrum these calves received from their respective vaccinated dams. However later on, it 
were the COLcells10 and COLnocells10 calves that showed a clear humoral immune response after 
booster vaccination which appeared absent in the COLfresh10 calves. This absent antibody 
response was most obviously due by maternal interference of TT-specific antibodies on the B-
cell recognition of the TT-antigen. However, even more interesting was that also the TT-
induced proliferation in COLfresh10 calves was hampered as it only clearly increased from 21 
days onwards after booster vaccination, as opposed to the COLcells10 and COLnocells10 calves. As 
antibodies block the uptake of antigen by B-lymphocytes and/or are responsible for antibody-
mediated removal of the antigen from the circulation, antigen cannot anymore be processed and 
presented to T-lymphocytes from the colostrum or the calf itself. This might explain the lower 
TT-specific proliferative responses in COLfresh10 calves. 
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5. BOVINE COLOSTRAL LEUKOCYTES: CONTRADICTORY INFLUENCE ON 
DEVELOPMENT OF HUMORAL AND CELLULAR IMMUNITY OF NEONATAL 
CALVES 
 
In the analysis of the influence of maternal CL on the vaccination outcomes of calves 
that had or had not received CL (COLcells versus COLnocells), we intentionally used colostrum 
from a cell-free colostrum bank of unvaccinated dams, thus in the absence of maternal TT-
specific antibodies (Chapter 4.3). This was done in order to avoid interference of TT-specific 
antibodies which are present in colostrum of the TT-vaccinated dams, on the induction of the 
immune response of the calf after TT-vaccination. This enabled us to give a clearer picture of 
the influence of only TT-specific CL on the response to TT-vaccination, without interference 
of TT-specific maternal antibodies. In the calves receiving TT-specific CL and not TT-specific 
antibodies (COLcells calves), a secondary immune response on TT-primo-vaccination is 
expected. Indeed, it has been shown that lambs receiving maternal CL from TT-vaccinated ewes 
display a secondary type immune response to primo-vaccination against TT (Tuboly et al., 
1995). However, this could not be demonstrated in our current study, as calves did not react 
after primo-vaccination and reacted only clearly after booster vaccination, indicating that 
maternal CL did not promote a secondary immune response upon primo-vaccination of these 
calves. On the contrary, it appeared that CL exerted a negative influence on the antibody 
responses as the COLcells calves always had lower antibody responses than the COLnocells calves, 
what became statistically significant in calves vaccinated at 5 days of age. It appeared that the 
response after booster vaccination was a primary response originating from the calf’s own 
immune system. The earlier and stronger antibody responses of COLnocells than COLcells calves 
(statistically with calves vaccinated 5 days after birth) would rather suggest a suppressive effect 
of CL on the antibody responses of calves upon vaccination. 
The TT-induced proliferation of PBMC of COLcells calves was generally higher (albeit 
nog significantly) than this of COLnocells calves after booster vaccination. The latter finding 
suggests a more important role of CL in the development of the cellular immune response in 
newborn calves compared to the humoral immune response. This higher cellular reaction in 
calves receiving maternal CL together with the negative influence of CL on the antibody 
responses, would indicate the ability of specific vaccines to break the Th2 bias in young 
livestock and to induce an early cell-mediated response (Chase et al., 2008). The precise role 
of CL in this phenomenon remains to be elucidated.  
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6. BOVINE COLOSTRAL LEUKOCYTES: INFLUENCE ON CLINICAL OUTCOMES 
 
As for the clinical outcomes, differences among the 3 colostrum groups were never 
significant (Chapter 4.3). This agrees with the findings of Riedel-Caspari (1993): clinical 
observations were not different between calves receiving cell-deprived pooled colostrum or 
pooled colostrum supplemented with colostral cells. All calves had high serum IgG 48 hours 
after birth with the average being 36.49 g IgG/l (Chapter 4.3). Average daily growth before 
weaning was 596 g in COLnocells, 625 g in COLcells and 651 g in COLfresh calves. Calves in the 
COLnocells, COLcells, and COLfresh group had on average 3.2, 2.7, and 5.3 days of diarrhea and 
2.1, 2.5, and 5.8 days needing antibiotic treatment, respectively. Other clinical scores did also 
not differ significantly. Overall, studies reporting the clinical effect of CL are divided between 
studies showing clear positive effects versus studies showing minor or no effects (Archambault 
et al., 1988b; Head and Beer, 1979; Kumar et al., 1989; Pitt et al., 1977; Riedel-Caspari, 1993). 
Stieler et al. (2012) reported that the role of fresh CL may not be as important as once thought; 
however, they only used non-maternal fresh and frozen colostrum. In frozen colostrum there 
are no living leukocytes and when using non-maternal colostrum it is highly unlikely that CL 
are absorbed by the neonatal calf as has been discussed in Chapter 1. 
 
7. DOES A CALF NEED COLOSTRUM OF ITS OWN DAM? 
 
The positive influence of CL on the development of the cellular immunity in neonatal 
calves could have implications for calves receiving colostrum from other herds, i.e. deprived of 
specific colostral antibodies and specific maternal CL. Also, CL are non-viable in frozen 
colostrum collected at the own herd due to the freeze and thaw process. Furthermore, when 
giving fresh colostrum of another cow of the same herd, CL are of non-maternal origin and 
consequently also histo-incompatible to the calf. In sheep and pigs, only maternal CL can cross 
the intestinal epithelium (Tuboly et al., 1988; Williams, 1993; Tuboly et al., 1995). Conversely, 
colostral antibodies can always cross the neonatal intestinal epithelium and enter the circulation 
whether or not they are from another dam or even in some cases from another species (Klobasa 
et al., 1981).  
The mechanism involved in selective CL transfer remains to be clarified, but is 
presumably due to MHC incompatibility. Cross-fostering prevents maternal cell transfer, as 
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evidenced by a lack of maternal-derived antigen-specific T-lymphocyte responses in cross-
fostered piglets (Bandrick et al., 2008; Bandrick et al., 2011). It can be concluded that feeding 
fresh dam own colostrum is the best choice, given the colostral antibody content is adequate (> 
50 g IgG/l). The maternal CL have a beneficial influence on the development of the cellular 
immunity of the neonatal calf. More importantly, the dam has also transferred antibodies 
specific to the diseases at that time in the herd and so fresh colostrum of the own dam is the 
best choice for the newborn calf. 
 
8. CONCLUSIONS 
 
From the results of this thesis, the following conclusions can be drawn:  
 
1) From Chapter 3 it can be concluded that in problem herds where the colostrum 
management suffices, dam vaccination against E. coli, rota- and coronavirus and 
metaphylactic halofuginone lactate administration can be successful in the reduction 
of NCD. Implementation of the described protocol in NCD problem herds is 
straightforward for practitioners. 
 
2) From Chapter 4.1 it can be concluded that we optimized and validated a robust and 
practical density gradient centrifugation-based protocol for isolating colostral 
monomorphonuclear cells. Further analysis of phenotype and proliferative capacity 
can be executed through the flow cytometric analysis and the 3H-thymidin-
proliferation assay.  
 
3) From Chapter 4.2 it can be concluded that the BHBA serum concentration, the BCS 
and parity of periparturient cows have an impact on the phenotypic distribution and 
the mitogen- and antigen-induced proliferation of CL, possibly thereby influencing 
adoptive immunity of the newborn calf. The influence of the serum NEFA 
concentration was less clear. Further studies should be carried out to deepen the 
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knowledge concerning CL and to look at possible adverse effects of NEB in cows 
on the adoptive immunity transfer to neonatal calves. 
 
4) From Chapter 4.3 it can be concluded that the effect of CL on the difference in 
cellular and humoral immune response to vaccination between neonatal dairy calves 
receiving colostral leukocytes or not is a complex matter. The higher TT-induced 
proliferation in COLcells calves compared to COLnocells calves after booster 
vaccination suggests a beneficial role of CL in the development of the neonatal 
cellular immune response.  
 
Although many more is left to be discovered concerning CL, results of this thesis and 
other studies clearly show that colostral antibodies are by far more important for neonatal 
survival than CL. However, it appears that simply measuring the concentration of transferred 
antibodies may not be sufficient to fully comprehend the extent of immunity transferred from 
dam to neonate via colostrum. This knowledge offers the potential benefit of providing new 
approaches to immunological intervention strategies for disease prevention in the neonatal calf.  
 
9. PERSPECTIVES FOR FUTURE RESEARCH 
 
Based on the results of this thesis, some ideas for future work can be formulated. 
 
1) The optimized protocols described in Chapter 4.1 can be used in further studies to 
explore the exact function of bovine CMC in vitro. However, the unidentified cell 
percentages warrant further research to tackle these subsets of CMC. Flow 
cytometric analysis with a wider array of membrane antigens in a multi-colouring 
set-up would be interesting. 
 
2) Whether the influence of the NEB on the CMC described in Chapter 4.2 can affect 
the neonatal calf, remains to be elucidated. It would be interesting to divide cows in 
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2 groups: cows with high serum NEFA and high serum BHBA concentrations and 
cows with low serum NEFA and low serum BHBA concentrations to discover the 
difference in neonatal immunity between calves receiving colostrum of their 
respective dams in the 2 groups.  
 
3) Proliferation of CMC after stimulation with ConA and TT was higher in younger 
cows while the IgG concentration of colostrum is generally lower in younger cows. 
Additional studies could be interesting to unravel whether a ‘better’ colostral 
cellular immunity could help outweighing a lower colostral antibody quality. 
 
4) Apart from the influence of colostral leukocytes on the adaptive neonatal immunity 
studied in Chapter 4.3, it would be interesting to look for influences of colostral 
leukocytes on the neonatal innate immunity. For example, the phagocytes of human 
colostrum were able to ingest G. lamblia trophozoites and presented microbicidal 
activity in vitro, suggesting that these phagocytes may act as an additional 
mechanism of protection against infant giardiasis through breastfeeding. The latter 
finding is promising in the prevention of C. parvum in neonatal calves (França-
Botelho et al., 2006).  
 
5) Also, the exact role of maternal colostral leukocytes in the long-term development 
of pathogen-specific acquired immunity is yet not clear. As there are contradictory 
results in literature concerning the time period colostral leukocytes can be 
found/exert their function in the neonatal animal (Williams, 1993; Zhou et al., 2000; 
Nechvatalova et al., 2011), the long-term persistence of maternal colostral 
leukocytes in neonates could be examined by more sensitive methods, for example 
by PCR (that can distinguish maternal from calf DNA), to assess the biological 
functions of these cells.  
 
6) Also, more research is needed to study the exact effects of colostral leukocytes on 
the neonatal immune system: is this effect mediated by soluble factors released from 
colostral leukocytes and/or by a direct interaction of the colostral leukocytes with 
the neonate’s immune system? 
 
Chapter 5 General Discussion 
159 
 
7) The better cellular reaction of COLcells calves compared to the humoral response 
confirms the ability of specific vaccines to break the Th2 bias in young livestock and 
to induce an early cell-mediated memory response. The precise role of colostral 
leukocytes in this phenomenon remains to be elucidated. Dam vaccination may 
represent the best option to maximize the transfer of responsive maternal colostral 
leukocytes to the neonate, especially when aiming to combat diseases that need 
cellular rather than humoral immunity, like C. parvum. It could be interesting to 
divide calves in 2 groups: one group receiving fresh full colostrum (containing living 
colostral leukocytes) and one group receiving frozen colostrum (containing dead 
colostral leukocytes) and follow up these calves after challenging them with a C. 
parvum infection. 
 
Concluding, further studies on interactions of colostral leukocytes with the development 
of neonatal cellular immunity will contribute to our knowledge of immunology and could 
contribute to an amelioration of prophylaxis and treatment of neonatal diseases. 
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Dairy herds need calves to grow as fast and healthy as possible to produce high yielding 
dairy cows. However, all too often the young stock management is neglected on a dairy herd. 
The herdsmen has to wait at least 2 years before he is able to harvest some return on investment 
in the young stock. Neonatal calf diarrhea (NCD) is one of the major health challenges in dairy 
cattle herds. This disease brings along large economic losses with mortality and costs of therapy 
as direct losses and retarded growth as main indirect loss. Also, the welfare issues of calves 
suffering from neonatal diarrhea should not be forgotten. One of the most important measures 
in prevention of NCD is a good colostrum management. The synepitheliochorial placenta of 
ruminants does not allow passive transfer of immunity during gestation. Therefore, 
administration of sufficient amounts of high quality colostrum during the first 6–12 hours 
following parturition is recommended as one of the most effective measures of protecting 
neonatal animals against respiratory and gastrointestinal infections. It is a well-known fact that 
administering enough good quality colostrum as soon as possible after birth is very important, 
yet a lot of mistakes are made in this.  
 
Chapter 1 gives an overview of the current knowledge on the bovine neonatal immune 
system and discusses the composition and importance of colostrum, further reporting the 
literature concerning colostral leukocytes (CL). The passive specific immunity is transferred 
during the first hours after birth through the colostrum, while the active specific immunity 
develops later in life. The importance of colostrum as a source of protective antibodies has been 
recognized for long time. Still, there is increasing evidence that colostrum also contributes to 
the cellular arm of the neonatal immune system by providing maternal colostral leukocytes. 
Also, the negative energy balance in high yielding dairy cows peripartum and the concomitant 
decrease in immunity is discussed. 
 
The main aim of this thesis was to broaden our knowledge concerning the possibilities 
in the field to lower the percentage of neonatal calf diarrhea by the implementation of a 
preventive action plan and concerning the importance of colostral leukocytes in the 
development of the cellular and humoral immunity in dairy calves.  
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Chapter 3 describes the results of a study in which we examined whether the percentage 
of calves with NCD can be lowered with the implementation of a 2-step protocol consisting of 
giving halofuginone to newborn dairy calves and administration of a vaccine against 
Escherichia coli, rota- and coronavirus to their dams. The average percentage of calves 
suffering from neonatal diarrhea (14.3% vs. 39.7%) and the average percentage of faecal 
samples positive for C. parvum (11% vs. 34%) were significantly lower on treated herds than 
on control herds.  
 
To learn more concerning the importance and the precise role of colostral leukocytes, a 
repeatable and reliable practical protocol is needed to isolate colostral leukocytes and to further 
quantify their subtypes and determine their functionality. In Chapter 4.1 an optimized and 
validated protocol is described. 
  
High producing dairy cows have a lower functional capacity of both their blood 
neutrophils and lymphocytes around the time of calving. This lower functionality is associated 
with the typical changes in the energy parameters describing the negative energy balance these 
cows experience around the time of parturition. Whether this production-associated 
immunosuppression also reflects the proliferative capacity of colostral leukocytes and thus 
influence the passive immune status of the newborn calf is an open question. In Chapter 4.2 
we aimed at unravelling the potential effect of the negative energy balance experienced by dairy 
cows around the time of calving on the phenotypic distribution and proliferative capacity of the 
colostral leukocytes. Under-conditioned cows had a significantly higher percentage of colostral 
macrophages than normal conditioned animals, while over-conditioned cows had a significantly 
higher percentage of colostral B-lymphocytes. Serum BHBA was significantly associated with 
a higher percentage of colostral T-lymphocytes and macrophages. Heifers had significantly 
higher mitogen- and antigen-induced proliferation of their colostral lymphocytes than 3rd parity 
or older cows. Although not significantly different, cows with low serum non-esterified fatty 
acids (NEFA) at the day of parturition had higher mitogen- and antigen-induced proliferation 
than cows with higher serum NEFA. The same was true for cows with low serum -OH-butyric 
acid at the day of parturition. In conclusion, body condition score, parity and serum BHBA 
concentration of periparturient high yielding dairy cows were shown to influence the 
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phenotypic distribution and/or the mitogen- and/or antigen-induced proliferation of colostral 
leukocytes, possibly influencing the cellular immunity of the newborn calf. 
 
Finally, in Chapter 4.3 the influence of colostral leukocytes on the development of the 
cellular and humoral immunity in neonatal dairy calves was investigated. To evaluate the 
influence of colostral leukocytes on the immunological responses of neonatal calves, calves 
were randomly divided over 3 colostrum groups: COLnocells calves received cell-free, frozen 
colostrum from a colostrum bank of animals not vaccinated against tetanus toxoid (TT), 
COLcells calves received cell-free, frozen colostrum from the same colostrum bank to which 
colostral leukocytes of their respective TT-vaccinated dams had been added and COLfresh calves 
received fresh colostrum of their respective TT-vaccinated dams. All COLfresh calves were 
primo-vaccinated at 10 days of age with the TT-vaccine. The COLcells and COLnocells calves 
were vaccinated at either 2, 5 or 10 days of age with the TT-vaccine. All calves were given a 
booster vaccination at 23 days after the primo-vaccination. Tetanus toxoid-specific antibody 
responses in calves increased immediately after booster vaccination, irrespective whether or not 
their cell-free bank colostrum had been enriched with their own dam colostral leukocytes. 
Conversely, calves receiving their own plain dam colostrum displayed no response. After 
booster vaccination, calves of the CL-enriched colostrum group had a more pronounced 
antigen-specific proliferative response but a less pronounced antigen-specific humoral response 
than the calves of the CL-free colostrum group. The present study suggests a negative influence 
of CL on the development of the humoral immune response but a positive influence on the 
cellular immune response of newborn calves upon vaccination. 
  
Field applications derived from the results of the current dissertation are situated on 
different levels. At the level of the dairy herdsman, often questions are raised on the specific 
approach of calves suffering from NCD. Also, specifically concerning the colostrum 
management, whether giving fresh dam-own colostrum is important and whether the feeding of 
cows and/or their level of milk production has an effect on the colostrum quality are some other 
frequently posed questions by people active in the field. The current thesis give answers to some 
of these questions.  
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At the scientific level, the current dissertation has contributed to the knowledge 
concerning the development of the cell mediated and humoral immunity of neonatal calves 
(Chapter 4.3). By optimizing a method for the isolation of colostral monomorphonuclear 
leukocytes (Chapter 4.1), additional in vitro research can be performed to explore the role of 
the different colostral cell subtypes in the development of bovine neonatal immunity. In 
Chapter 4.2 factors associated with the phenotypic distribution and proliferation capacity of 
colostral leukocytes were described. Further studies should elucidate whether these factors can 
be influenced by an improved transition management. Lowering the negative energy balance in 
our modern high yielding dairy cows can be achieved by adapting the ration and avoiding over-
conditioning of peripartum cows.  
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Op melkveebedrijven is het belangrijk dat de kalveren zo snel en gezond mogelijk 
worden opgefokt om uiteindelijk uit te groeien tot hoogproductieve melkkoeien. Helaas 
verloopt de jongvee opfok vaak niet optimaal omdat de melkveehouder minstens 2 jaar moet 
wachten voordat de  investeringen die hij in deze periode doet, geld opleveren. Kalveren op 
hoogproductieve melkveebedrijven blijken gedurende hun eerste levensweken steeds vaker met 
diarreeproblemen geconfronteerd te worden. Daardoor ontstaat een groot economisch verlies 
dat niet alleen mortaliteit en therapiekosten als directe verliezen omvat maar ook 
groeiachterstand als indirect verlies veroorzaakt. Bovendien mag ook het verminderde 
dierenwelzijn niet uit het oog verloren worden. Eén van de belangrijkste preventieve 
maatregelen om kalverdiarree te voorkomen is een goed colostrummanagement. Kalveren 
worden immers door de ondoorlaatbaarheid van de synepitheliochoriale runderplacenta 
geboren zonder specifieke immuniteit. Ondanks het algemeen bekende belang van het vroeg 
verstrekken van genoeg colostrum van goede kwaliteit, worden hiertegen toch veel fouten 
gemaakt.  
 
In hoofdstuk 1 wordt een overzicht gegeven van de literatuur die betrekking heeft op  
het neonatale immuunsysteem bij het kalf, op de samenstelling en het belang van colostrum en 
op de colostrale leukocyten. Passieve specifieke immuniteit wordt gedurende de eerste 
levensuren overgedragen via het colostrum, terwijl de actieve specifieke immuniteit zich pas 
later ontwikkelt. Het meeste onderzoek naar de lactogene adaptieve immuniteit richt zich op de 
transfer van colostrale antistoffen, terwijl er minder bekend is over het belang van colostrale 
leukocyten. Ook wordt dieper ingegaan op de rond het tijdstip van kalven negatieve 
energiebalans van hoogproductieve melkkoeien en op de daarbij horende vermindering van de 
algemene afweer.  
 
Het algemene doel van dit doctoraatsonderzoek was het vermeerderen van onze kennis 
omtrent de mogelijkheden om het percentage kalveren met neonatale kalverdiarree te doen 
dalen en om een beter inzicht te krijgen in het belang die de colostrale leukocyten hebben voor 
de opbouw van de cellulaire en de humorale afweer. 
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In hoofdstuk 3 worden de resultaten beschreven van een onderzoek waarin werd 
nagegaan of het percentage kalveren met diarree op probleembedrijven kan verlaagd worden 
door het inzetten van een protocol bestaande uit 2 onderdelen: het toedienen van halofuginone 
aan kalveren gedurende de eerste 7 dagen na de geboorte in combinatie met het vaccineren van 
hun moederdieren tegen Escherichia coli, rota- en coronavirus. Uit de resultaten kwam naar 
voren dat zowel het gemiddelde percentage kalveren met neonatale diarree lager was op de 
behandelde bedrijven (14.3% vs. 39.7% op de controlebedrijven) alsook het aantal meststalen 
dat positief testte voor C. parvum (11% vs. 34% op de controlebedrijven). 
 
Om meer te weten te komen over het belang en de precieze werking van colostrale 
leukocyten, is het nodig om een herhaalbaar en betrouwbaar praktisch protocol te hebben voor 
het isoleren van deze leukocyten en voor het onderzoek naar de verschillende subtypes en hun 
functionaliteit. In hoofdstuk 4.1 wordt een geoptimaliseerd en gevalideerd protocol beschreven. 
 
Van hoogproductieve melkkoeien is bekend dat de functionaliteit van zowel hun bloed 
neutrofielen als lymfocyten sterk is gedaald rondom het moment van afkalven. Deze daling valt 
samen met de typische verandering in het patroon van energieparameters die de negatieve 
energiebalans weerspiegelt gedurende deze periode. Of en in welke mate deze productie-
gebonden daling van de immuniteit ook invloed heeft op de proliferatiecapaciteit van de 
leukocyten die aanwezig zijn in het colostrum waardoor het pasgeboren kalf gevoeliger zou 
kunnen zijn voor infectieuze aandoeningen, was tot op heden niet bekend. In hoofdstuk 4.2 
worden de resultaten beschreven van ons onderzoek naar deze problematiek. Magere koeien 
bleken een significant hoger percentage colostrale macrofagen te bezitten dan koeien met een 
normale conditiescore, terwijl koeien met een te ruime conditie een significant hoger percentage 
colostrale B-lymfocyten bleken te bezitten. Serum -OH-boterzuur (BHBA) was significant en 
positief geassocieerd met het percentage colostrale T-lymfocyten en macrofagen. Vaarzen 
hadden hogere proliferatiewaarden van hun colostrale leukocyten dan koeien. Hoewel deze 
cijfers niet significant waren, kon numeriek wel aangetoond worden dat koeien met lage 
serumconcentraties van niet veresterde vrije vetzuren (NEFA) en/of BHBA op de dag van de 
kalving hogere proliferatiewaarden hadden dan koeien met een hoge NEFA en/of BHBA 
serumconcentratie op die dag. Geconcludeerd kan worden dat de conditiescore, de pariteit en 
de serum BHBA concentratie bij hoogproductieve melkkoeien rondom het moment van kalven 
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een invloed hebben op de fenotypische verdeling van de colostrale leukocyten en op de 
proliferatiecapaciteit van de colostrale lymfocyten. Of deze bevindingen op hun beurt de 
cellulaire immuniteit van het pasgeboren kalf beïnvloeden is onbekend.  
 
In hoofdstuk 4.3 tenslotte werd gekeken naar de invloed van de colostrale leukocyten 
op de immunologische respons van kalveren. Hiertoe werden kalveren ingedeeld in 3 colostrum 
groepen: COLnocells kalveren kregen celvrije diepgevroren biest van een centrale colostrumbank 
met colostrum afkomstig van dieren die niet gevaccineerd waren tegen tetanus, COLcells 
kalveren kregen dezelfde celvrije diepgevroren biest maar met toevoeging van colostrale 
leukocyten van hun moeder en COLfresh kalveren kregen verse biest van hun moeder die 
gevaccineerd was tegen tetanus. Vervolgens kregen alle COLfresh kalveren een primovaccinatie 
tegen tetanus op een leeftijd van 10 dagen. De COLcells en COLnocells kalveren werden nog eens 
ingedeeld in 3 groepen: kalveren die een primovaccinatie tegen tetanus kregen toen ze 
respectievelijk 2, 5 of 10 dagen oud waren. Een booster vaccinatie werd 23 dagen na de 
primovaccinatie toegediend. De specifieke humorale respons steeg onmiddellijk na de booster 
vaccinatie, onafhankelijk van het feit of de biest werd aangerijkt met colostrale leukocyten van 
het moederdier. Kalveren die verse biest van hun eigen moeder kregen hadden echter een 
praktisch afwezige respons. Na de booster vaccinatie hadden de kalveren die colostrale 
leukocyten bijkregen een duidelijkere specifieke cellulaire respons maar een minder duidelijke 
specifieke humorale respons. Deze studie suggereert dus een negatieve invloed van colostrale 
leukocyten op de ontwikkeling van de specifieke humorale respons maar een positieve invloed 
op de specifieke cellulaire respons van pasgeboren kalveren na vaccinatie.  
 
Toepassingsmogelijkheden die voortvloeien uit het hier beschreven onderzoek situeren 
zich op verschillende niveaus. Ten eerste op het niveau van de melkveehouder. Momenteel 
bestaan er immers nog heel wat vragen betreffende de juiste aanpak van kalveren met diarree. 
Ook specifiek over colostrum management komen regelmatig vragen naar voren als: moet er 
aan de kalveren steeds colostrum gegeven worden van hun eigen moeder, heeft de voeding van 
de koeien een effect op de kwaliteit van het colostrum en heeft het melkproductieniveau invloed 
op de colostrumkwaliteit. De huidige thesis geeft een antwoord op sommige van deze vragen. 
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Op wetenschappelijk vlak heeft het hier beschreven onderzoek een bijdrage geleverd 
aangaande de kennis betreffende de ontwikkeling van de celgemedieerde en humorale 
immuniteit van pasgeboren kalveren (hoofdstuk 4.3). Door het op punt stellen van een methode 
om monomorfonucleaire cellen uit colostrum van het rund te isoleren (hoofdstuk 4.1), wordt 
verder in vitro onderzoek mogelijk gemaakt om de rol die de verschillende cellen spelen bij de 
neonatale immuniteit, te onderzoeken. In hoofdstuk 4.2 werden de factoren beschreven die 
geassocieerd zijn met de fenotypische distributie en de proliferatiecapaciteit van colostrale 
leukocyten. Met vervolgonderzoek kan nu nagegaan worden in welke mate deze factoren 
beïnvloed kunnen worden. Hierbij kan gedacht worden aan het streven naar een optimale 
lichaamsconditie bij hoog productieve melkkoeien via een aangepast rantsoen en het vermijden 
van vervetting van koeien tijdens de droogstand. 
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Hallo jij daar, ja, jij . Die meteen doorbladert naar het dankwoord (zoals iedereen, 
mezelf inclusief ). Dit dankwoord is er omdat ik het zonder jullie niet had gekund. Hier gaan 
we! 
 
Professor dr. Opsomer, Geert, bedankt om mij de kans te geven om te doctoreren over 
het onderwerp dat ik per sé wou. Ik kan me voorstellen dat je nogal gefronst heb als dat vreemde 
meisje bij jou in de bureau kwam om te vragen of ze geen onderzoek mocht doen over diarree 
of biest. En ik kan me voorstellen dat je nog meer gefronst hebt als je mij weer eens in kliniek 
zag dartelen. Maar weet ook dat ik besef dat ik dankzij die vrijheid, en ook dankzij de 
veldproeven waar ik soms eens durfde op vloeken, wel sta waar ik nu sta. Maar een pietje 
precies zal ik toch blijven hoor . 
Professor dr. Goddeeris, (Bruno durf ik nog altijd niet zeggen hoor), je was de advocaat 
van de duivel zoals je het zelf zei, maar je hebt me daardoor wel leren kritisch nadenken en 
leren discussiëren. Ik apprecieer enorm de vele uren die je in onze raadselachtige resultaten van 
de kalverproef hebt gestoken. Zelfs een tussenstop onderweg naar zee kon eraf om mij te helpen  
bij het finaliseren van de presentatie. 
Professor dr. Cox, zo jammer dat je hier vandaag niet bent, bedankt om altijd klaar te 
staan met een antwoord op mijn immunologische problemen . Ook heel erg bedankt voor de 
kansen die ik kreeg voor een aangename samenwerking bij U op het laboratorium van 
immunologie. 
dr. Piepers, Sofie: ik moet er geen doekjes om winden, jij was mijn rots in de branding 
de laatste maanden als het ging over motivatie (en statistiek )! “De aanhouder wint altijd, ’t 
is alleen een kwestie om aan te houden tot je gewonnen hebt”. Je bent het blijven herhalen en 
kijk, waar we vandaag staan. Ongelooflijk dikke merci daarvoor! Je hebt me leren doorzetten 
en niet zomaar genoegen te nemen met ‘gewoon goed’, maar te streven naar beter. 
Professor dr. de Kruif. Ik was een beetje de vreemde eend in de bijt op de vakgroep, 
maar u was altijd oprecht geïnteresseerd in hoe alles verliep. Bedankt voor de eer om voorzitter 
van de examencommissie te willen zijn! 
dr. Stuyven, Edith: jij hebt me de kneepjes van de wondere immuno-labo wereld bij 
gebracht: ELISA’s en proliferatietesten hebben geen geheimen meer voor me dankzij jou . Ik 
ben heel fier dat je er ook bij deze kers-op-de-taart wilde bij zijn. 
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Dr. Hoflack Geert . Bedankt om mij samen met MSD de kans te geven mij vast te 
bijten in een project dat eigenlijk op mijn lijf geschreven was: kalfjes met diarree! Je enorme 
praktijkkennis, daar heb ik zoveel bewondering voor! 
Professor dr. Deprez Piet: ik ben heel fier dat ook u in mijn examenjury zit. Tijdens de 
lessen kon u mij altijd mateloos boeien, en ik ben ook nog met knikkende knietjes komen vragen 
of ik toch niet iets met diarree en biest bij u kon doen. Uw onuitputtelijke kennis, daar kan ik 
alleen maar van dromen! Hartelijk dank voor de nuttige commentaren op dit werk, en ook 
bedankt voor de vraag af en toe hoe het met onze oude knar gaat: die is ondertussen de liefde 
van haar leven tegen gekomen . 
Professor dr. David Hurley, it is such a big honour for me to have you here. Now my 
colleagues will see who I mean when I talk about the colostral-cell-guru . Your comments 
lifted this thesis to a higher level. I cannot express my gratitude enough for this! 
Cher Dr. Delahaut, merci bien d’avoir accepté l’ invitation pour participer en tant que 
membre du jury de ma thèse. Je suis sûr que notre passion commune puisse être une base d’ 
heures de discussion agréables. 
 
Zonder centjes geen onderzoek mogelijk, dus hartelijk dank aan het IWT-Vlaanderen 
om mij de kans te geven mij te verdiepen in de biestcelletjes, hartelijk dank aan MSD Animal 
health om mij de kans te geven mij te verdiepen in kalfjes met diarree en dank ook voor de 
sponsoring voor het drukken van dit boekje. Ook hartelijk dank aan Merial om het antigen van 
het tetapur vaccin te leveren. Er zijn heel wat proliferatietesten mee uitgevoerd! 
 
En dan de collega’s (sommige zijn echte vrienden geworden!), een hele hoop op ‘den 
DI08’!! Laat ons maar beginnen met ‘den’ bureau! Mieke, jij bent veel meer dan een collega 
van den 28 (waar ik na veel omzwervingen terecht kwam!) geworden. Laat je niet kennen! En 
dank u dank u dank u voor de begeleiding bij de last-minute statistiek van de kalfjes. Ik weet 
nu alles van data import ;-). We hebben uren samen gezaagd, geklaagd. Maar weet dat ik het 
zonder die momenten niet had gered. We like to moo-moo with snollebolleke :-p. Ja, ik weet 
het Miel, “young female vets” . Bij al-dan-niet goed bedoelde mopjes over vrouwen en 
diergeneeskunde, probeer ik daaraan te denken. Dankzij ‘Mieleke’ zal ik je nooit vergeten . 
En ook jij bedankt voor je bijdrage aan de statistische uitdagingen! Jenne, je volledig 
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doorgronden zal ik nooit, bedankt voor de gezellige avonden en weest een volwaardige 
opvolger . En zorg goed voor onze gedeelde bedrijven van BB. Stiekem mis ik ze al! Kristof, 
onze dolle dinsdagen samen zal ik ook nooit vergeten . Sander en Hannes, laat jullie niet doen 
en geef maar wat nieuwe wind op den 28 . Hannes, wel een beetje zorgen dat je ze niet teveel 
gewoon maakt hé! Elke, altijd welkom en ooit gaan we samen nog eens shaken op de nineties! 
Het P-team dan . Kim, ook jij hoort al lang niet meer bij de collega’s maar wel bij de 
echte vrienden. Je zit voor altijd in mijn hartje. Merci om er altijd voor mij te zijn! Als meter 
van James raak je natuurlijk ook nooit meer van mij verlost, dat staat vast :-p. En dan nog dit 
dankwoord last-minute moeten herschrijven seg omdat er ondertussen al een dartel veulen 
rondhuppelt ipv geboren te worden op dit moment :-D. Jan, merci voor het vertrouwen op 
kliniek en om er op alle onmogelijke momenten aan te denken: ’t is just, nen BTP aan’t 
veulenen, Vanessa bellen . Catharina en Maarten, ik zal ons verblijf ten huize Hoogewijs-De 
Schauwere nooit vergeten. Merci voor alle steun onderweg! Cyriel, jij was er ook dikwijls bij 
in het weekend en ’s avonds. Als ik een raar beest moet behandelen, bel ik naar jou ;-). Bart, 
we hebben heel wat kunnen leunen op elkaar in de laatste maanden. You go get them!! Ik 
bewonder jouw rust! Valerie, als we nog eens op reis zijn vraag ik jou terug voor de verzorging 
van Orco, al is’t maar voor de Willy’s met Frank achteraf die erop volgen :-D. Katrien, ook jij 
bedankt voor de ‘alles komt goed’ op het einde . 
Den BP… Jef, jij staat dikwijls in een dankwoord als mentor en begeleider van de 
buitenpraktijk. En dat is maar al te waar! Van jou heb ik zoveel geleerd en ik ben ervan 
overtuigd dat ik nog veel zal leren. Bedankt om altijd klaar te staan met raad en daad! Je hebt 
de gave om je kennis door te geven en mensen zelfvertrouwen te geven. Dat is bijlange na niet 
iedereen gegeven… Johan, merci voor alle tips en tricks! Ilse, bedankt voor de gesprekjes! 
Team KHD . Féline en Eline, zeker tot binnenkort als ik weer eens met een 
verloskundig katten- of hondenprobleem zit . Die eerste sectio is er alvast al geweest :-D. 
De M-teamertjes! Anneleen, Kristine, Marina, bedankt voor alle steun! Anneleen, hoe 
een kleine attentie lang kan bijblijven (achterflap cover al gezien? :-D). Justine, bedankt voor 
de vernieuwde en veel betere 0-1 verdeling van stieren-vaarzen in de dataset :-p. 
Pouya and Osvaldo, thanks for making me smile . Branko, I will never forget your 
hospitality in Macedonia, I promiss I will be back (for more rakija :-D). And I am so happy to 
have you here with us today! Monica, what a joy to have you here! True friendship! You are 
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such a lovely person, I am so happy that I met you. Thank you for being here, and I hope that 
we will have many moments more to share with each other. Here, in Smeerebbe-Vloerzegem 
(try again to pronounce :-D) or in Italy. 
Annelies M., gedeelde smart is altijd een beetje halve smart. Dat klopt wel als ik je 
berichtjes volgde over welke problemen je weer tegen kwam, kon ik toch altijd even denken: 
“you are not alone” . Steven S., heel veel geluk met Sophie! En bedankt, bedankt voor die 
gouden tips in de laatste weken.  
Nadientje, je hebt ons al een tijdje verlaten maar ben je hulpjes in de beginperiode niet 
vergeten! Lars, Isabel en Petra, merci om mij wegwijs te maken in het labo en mij te helpen bij 
101 dingen (‘mijn medium is ‘plots’ op’ )! Elske, nog iemand die eigenlijk niet past bij de 
collega’s. Ik kon en kan altijd bij jou met alles terecht. Ik hoop oprecht dat we elkaar niet uit 
het oog verliezen! Ria, ‘k zal u missen! Misschien moeten we eens denken over een 
carrièreswitch, ik mis mijn BP-Riaatje nu al . Leïla, als we jou iets laten regelen, dan weten 
we dat het in orde is. Nu ik zelf boekhouding en consoorten mag doen, heb ik alleen maar meer 
respect voor al wat je doet. Sandraatje, het kieken-zonder-kop-gevoel was nogal hoog op de 
dag dat dit ‘boekske’ binnen moest zijn. Gelukkig had jij meteen DE oplossing zodat mijn kop 
snel terug op mijn kiekelijf stond :-D. De laatste weken werd je ook overstelpt met emails van 
mij en niks was je te veel. Dat zijn dingen die een mens niet vergeet!! Merci!! Véro, altijd een 
lachend gezicht en altijd bereid om te helpen. We moeten zeker nog eens samen gaan eten! 
Marnik, als er iets is met ons Orco, sta je altijd paraat. Dat zal ik nooit vergeten! Dirk en Willy: 
merci om mijn verblijf op kliniek zo aangenaam te maken! De 29 koters die ik een jaartje heb 
bijgehouden zaten mede dankzij jullie altijd propertjes in vers stro! Özlem, altijd goed gezind! 
Samen met Nicole en Andrea hielden jullie ons varkensstalletje proper . Steven B., merci 
voor deze ramp op het gebied van computers uit de nood te helpen met al dan niet blonde vragen 
:-p. 
Al degenen die ik hier niet bij naam vermeld heb, we zijn gewoon zo’n grote vakgroep 
dat ik niet iedereen apart kan vernoemen, maar de praatjes, de koffietjes, ze maakten stuk voor 
stuk het verblijf op de verloskunde en buitenpraktijk zoveel aangenamer! DanKOEwel! 
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Zovele collega’s die ook al het schip verlaten hebben… Sebastiaan, ik eet dus nu 
effectief meer kalkoen :-p. Davy, je bent de rust zelve enneh… als’t hooi niet van u komt, eet 
Orco het niet op :-D. Ellen, bedankt voor de tip, met een biertje/wijntje/jeneverke gaat het 
inderdaad beter ;-). En merci voor de geruststellende woorden op het einde! Het nineties-shaken 
als echte doctors, wanneer? Iris, van jou heb ik ook heel veel mogen leren en je bent altijd een 
‘rolmodel’ (ook al hoor je dat niet graag ) voor mij geweest! Girl power!! Ik wens je nog veel 
geluk met je gezinnetje! Kim Meerhoff, de veldproeven, op het einde had ik het zonder jou niet 
gehaald: thanks! Stefaan, kennis gecombineerd met geduld en rust, zo herinner ik mij jou! Als 
ik weer een DGZ-vraag heb, weet ik je te vinden . Alfonso en Rubén, you teached me how to 
castrate pigs . And always, a friendly word and a question: “how’s your research going?” 
Thanks a lot! Judith en Karina, jullie waren de laatste interns waar ik mama over mocht spelen. 
De rol van moederkloek zal moeten overgenomen worden nu :-D. Geoff, ik kijk al uit naar onze 
samenwerking om de jongveeopfok in België naar een hoger niveau te tillen. En misschien zelfs 
daarbuiten? Een mens moet dromen . 
 
De vakgroep immunologie: bedankt om jullie labo voor mij open te stellen. Ik ben er 
wel van overtuigd dat jullie mij soms raar bekeken hebben met al mijn flessen witgeel spul waar 
ik mee aan kwam zetten . Griet, Bert, Joanna en Simon, merci om mij te helpen als ik op 
congres moest. 
 
Zonder melkveehouders en daarbijhorende dierenartsen geen biest, geen kalfjes, geen 
mest- en bloedstalen. Bedankt aan iedereen om mij altijd zo gastvrij te ontvangen. Dankzij jullie 
kon dit onderzoek gebeuren! Dikke merci aan Agrivet: Lydia Bommelé, Karel Vermeulen en 
André Turtelboom, Familie Criel, Familie De Bock, Familie De Clercq (inclusief ontvangst met 
rijstpap ), Familie De Maesschalck (binnenkort kom ik nog eens om geitenkaas!), Familie De 
Roo, Familie Everaert, Familie Geelen, Familie Hendrickx, Familie Lievens, Familie Noyens, 
Familie Peters, Familie Rossaert, Familie Ryckaert, Familie Slechten-Smets, Familie Smet, 
Familie Strobbe, Familie Temmerman, Familie Teugels, Familie Van Assche Bart en Sylvia, 
Familie Van Assche Kurt, Familie Van Beek, Familie Van Boven, Familie Van Damme Geert, 
Familie Van Damme Paul, Familie Van den Berk, Familie Van Den Meijdenberg, Familie Van 
Kerckvoorde, Familie Van Remoortele, Familie Veldeman, Familie Verdurmen, Familie 
Wauman, Familie Wauters, Familie Wildemauwe (we zijn nog steeds geïnteresseerd in Berner 
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puppies! ), Familie Xhonneux, ILVO-dier (bedankt ook Sam voor het nalezen van het NEB 
artikel!), Schoolhoeve Axelwalle: Bert Weytens (ik ben ervan overtuigd dat ik al weet wie je 
topkoeien gaan worden :-p), dierenarts Anné Peter, dierenarts Bijtebier Frederik, dierenarts 
Coomans Danny, dierenarst De Coninck Raf, DAP Boskema, DAC Vaccavet, dierenarts 
Thielen Matthieu, dierenarts Vandekinderen Idris, dierenarts Vandesteene Jeroen, dierenarts 
Verheyde Door, dierenarts Verhofstede Eric en dierenarts Theys Luc (pfieuw, dat waren ze ). 
En last but not least de kalfjes zelf. Veel bloed, zweet en tranen hebben jullie mij gekost, maar 
wat hebben we ook leuke momenten beleefd! Het rustgevende moment van de dag: als alle 
kalfjes lustig aan’t drinken waren, die geluiden vergeet ik nooit meer (om dan één voor de één 
de emmers af te smijten, weg rust ). Merci Matilleke, Linda, Maria, Elisabeth, Melleke, Kim, 
William, Kirsten, Bieke, Rienske, Isabel, Jefke, Evy, Yvo, Kevin, Sofie, Ruben, Julie, Jenne, 
Sieglinde, Lars, Els, Etienne, Petra, Anneleen, Miel aka Tine (voor de mensen die niet mee zijn: 
don’t ask!), Mieke, Mostofa en Marieke. Al de koeien van wie ik biest en bloed mocht afnemen, 
en al de kalfjes van de diarreeproef opnoemen zou mij te ver leiden: bedankt alle 1008! 
 
En dan was er mijn overstap naar de ‘echte’ praktijk… Welledel hooggeachte collega 
dr. Patrick Eeman , bedankt voor het vertrouwen. Ik denk dat je het zelf totaal niet beseft, 
maar het is mede dankzij jouw vertrouwen dat ik de stap naar een eigen praktijk aandurfde. Had 
je dat maar op voorhand geweten hé :-p. Jan en Eva, ook jullie bedankt om mij als groentje in 
de streek zo enthousiast te onthalen. Ik ben ervan overtuigd dat het een mooie samenwerking 
wordt! Enorm bedankt om de laatste dagen en weken in te springen. Ik beloof plechtig dat ik 
het allemaal goed maak! Met spruit nummer drie op komst zal ik daar wel de kans toe krijgen 
. Norbert, bedankt voor alle schapenkennis die je mij al gegeven hebt, ik kijk uit naar meer! 
Thierry, Pierre, Jan, en de collega’s van de Molenhoek, ook jullie bedankt voor het positieve 
onthaal . Lies, ook jij bent een voorbeeld voor mij! Jij was denk ik één van de meest 
enthousiaste personen als ik vertelde over de grote praktijkplannen… Merci! 
 
En dan al die mensen die mij zo nauw aan het hart liggen en waar ik zo dikwijls tegen 
moest zeggen: nee ik kan niet, ik ben bezig met biestcellen… We halen alle schade nu wel in! 
Sofie en Joren, Anneleen en Mathieu, Nathalie en Koen, Gwendolyn en Kristof, Tabitha en PJ, 
Katrien en Pieter, Evelien en Robin, Eveline en Stijn: ik beloof: vanaf nu ga ik op elke 
uitnodiging in (ojee ). 
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Bieke, hoe dikwijls stond ik al niet aan je deur met een hond of kat omdat ik er zelf niet 
aan uit geraakte… Merci om altijd klaar te staan voor mij! Ik kijk al uit naar de luxe-versie van 
de B&B . Kirstentje, net hetzelfde voor jou: onze gesprekjes zijn voor mij goud waard. Ik 
wens je alle geluk toe met Cédric, je verdient het! Ik mag zo hard in mijn pollekes wrijven met 
zo’n maatjes. Ik zie jullie graag!  
Marieke, meer down-to-earth maken ze ze niet! Samen met Tine en ons Riens zijn we 
de vier musketiers. Ik zie jullie allemaal veel te weinig, maar jullie zitten des te dichter bij mijn 
hart. Maja, één naar Canada, één naar Holland en één die altijd overal zit. Jamaja , dan ben 
ik toch de normaalste om uit te wijken naar Smeerebbe-Vloerzegem :-p! Als we dan al eens 
samen komen, is het wel als vanouds, en hebben we lekker veel bij te tetteren . Ik zie jullie 
graag!! 
  
De nief geburen! Bert en Stefanie (eigenlijk zijn we schoonouders :-D), Anja (uw 
bloempotten zijn fantastische ijsemmers ;-)), Wim en Stef, Jan (electrabel avant la lettre ), 
Sandra, Bram en Fien, Tiny, Joeri, Siouksi en Kain, Marcel en Maria, Maria en Hilaire, Paul en 
Elise, Marcel en Christianne, en al de anderen van de Varingstraat die deze kip zonder kop 
(zeker de laatste weken) hartelijk ontvangen hebben nog voor we er wonen: merci! Sinds de 
start van ‘diene raren’ bouw werden we gevraagd op alle buurtfeestjes (en ’t zijn straffe feestjes 
) maar moesten helaas door de biestcellen dikwijls nee zeggen of heel rap doorgaan. 
Binnenkort, is het eindelijk zo ver! Worden we echte geburen EN kom ik naar alle feestjes :-p. 
 
Evy en Yvo, Sofie en Kevin, Julie en Ruben. Mijn bijna aangetrouwde familie (wie weet 
wanneer hé Yvo ). Jullie hebben mij altijd met open armen ontvangen en bij de laatste loodjes 
zelfs jullie huis voor mij open gesteld (rustig kunnen schrijven in ‘den bos’ met extra’s zoals 
verse koffie en soep ). Ik kan mij geen betere schoonouders wensen en eindelijk heb ik zussen 
en broers! Evy, ik denk niet dat er zorgzamere moeders dan jij bestaan . Kevin: let de biest 
go! Zoals beloofd :-p. Enne… WAT een dag om te verjaren seg  Happy BIEST-day! :-D. 
Sofietje, ik wens je zo ongelooflijk veel succes toe met MIJN  neefje; ik denk ook niet dat 
Lenn zich een betere mama kan wensen. Ik snap trouwens echt niet hoe je het doet: jij bent 
altijd vrolijk! Julie, ook jij binnenkort als derde je eigen huisje! Opgelet aan allen als de MUG 
passeert… :-p. En Ruben, zotter moeten ze de schoonbroers niet maken . Ik zie jullie allemaal 
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graag! En ik kreeg er ook meteen een nieuwe (grote!) familie bij waarbij ik mij meteen mocht 
thuisvoelen: tante Titin, nonkel Luc, Margot, Hélène en Stefanie, tante Monique, nonkel Filip, 
Saar en Joachim, meter Godelieve en peter Jacques, meter Alice, tant’ Ann en nonkel Josef, 
Isabel, David en Remco, Johan, Cindy, Jarne en Robbe (pfieuw!!). Ook voor jullie was het niet 
altijd makkelijk om data te prikken dat iedereen kon, en meestal was ik de moeilijke :-/. Merci 
om mij zo hartelijk op te nemen in ‘de famille’! 
 
Mijn familie is iets kleiner maar ik zie ze des te liever! Tante Roos, Danny, Annick en 
Geert, Gaby en Godelieve, Paul en Emmy: merci voor het geloof in mijn persoontje! Jan, die 
met de woordenboek ernaast de artikels nalas: bedankt! En Veerle, merci voor de styling .  
 
Mama, papa… ALLES, maar dan ook alles doen jullie voor mij, en voor ons. Dankzij 
jullie mocht ik koetjesdokter worden, dankzij jullie kon ik doctoreren, dankzij jullie hebben we 
een eigen stek. Dit dankwoord zou eigenlijk vier pagina’s enkel over jullie kunnen tellen!! Ik 
weet dat ik een verschrikkelijke dochter ben geweest. Uren, dagen, achter die computer met 
enkel een ‘hmmhm’ als er iets gezegd of gevraagd werd. En de laatste maanden, de hele 
bovenverdieping vol ‘raar’ materiaal en flesjes, de keuken vol keizersnededozen en de living 
getransformeerd naar een inpakwerkplaats voor doekjes en plastiekjes. Merci, bedankt, danke 
schön, ’t zijn allemaal woorden die niet genoeg uitdrukken hoe dankbaar ik jullie ben! 
 
Memé Elisabeth, meter Maria, pepé Marcel en peter Maurice, jullie zouden fier geweest 
zijn op mij, dat weet ik. Wie weet, misschien waren jullie er vandaag wel bij… 
 
Miguel. Mel. Zoetje. Waar moet ik in godsnaam beginnen. Van begin tot einde heb jij 
meegewerkt aan dit doctoraat. Van kalving tot dankwoord. Je hebt mee met kalvers rond 
getsjold, er zelfs een paar mee ter wereld helpen brengen (remember Melleke? “Die krijg ik er 
niet uitgetrokken, bel Bert!! FLOEP ”). Je hebt de cover gemaakt, je hebt artikels nagelezen, 
oefenen van presentaties moeten aanhoren,… ik kan gewoon een heel dankwoord vullen met al 
waar jij aan meegewerkt hebt. Ik was de laatste maanden niet te genieten, en telkens weer was 
jij er met de juiste woorden, de knuffels, de liefde. En de aanpassingen aan de figuren ;-). En 
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de cow chute :-D. Die zal ik op dit moment ook wel nodig hebben. Helaas zou dat een raar 
gezicht zijn, niet . Het mooiste geschenk dat je mij ooit kon geven, was dan ook nog eens dat 
ik ons Orco van den DI08 naar Lennik mocht brengen. Om daarna op zoek te gaan naar een 
huisje in functie van onze ouwe knar. En kijk: ons leven in de Varingstraat (MET boerderij :-
D) kan nu echt gaan starten. Ik kan het niet met woorden beschrijven hoe graag ik je zie en wat 
jij voor mij betekent. IZUG! VLEKJES! 
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